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This dissertation investigated the association of meeting the World Health Organization 
(WHO) 2010 physical activity (PA) recommendations with depression, anxiety, and 
generalised anxiety disorder (GAD). Two meta-analyses of prospective cohort studies 
showed that engaging in physical activity is associated (OR, 95%CI) with 27%, 18%, 
18%, and 27% lower odds of depression (0.73, 0.70-0.76), anxiety symptoms (0.82, 0.77-
0.87), any diagnosed anxiety disorder (0.82, 0.77-0.87), and diagnosed general anxiety 
disorder (0.73, 0.70-0.76), respectively. However, both reviews highlighted a dearth of 
evidence that examined (1) the association of meeting WHO recommendations with the 
onset of depression, anxiety, and GAD, and (2) whether stronger associations are 
observed with increased doses of physical activity. Two cross-sectional studies of 7,000-
10,000 adults from the Mitchelstown Cohort Study and The Irish Longitudinal Study on 
Ageing (TILDA) found that meeting WHO recommendations was significantly, inversely 
associated with anxiety (0.86, 0.76-0.98) and depression (0.56, 0.47-0.65). Stronger 
associations with increased physical activity dose were observed for depression 
symptoms but not anxiety. Three prospective cohort studies of approximately 3,000-
4,500 adults from TILDA found that meeting WHO recommendations was significantly 
associated with lower odds of GAD (0.43, 0.19-0.99), while non-significant associations 
were observed with depression (0.77, 0.58-1.04) and anxiety (0.94, 0.63-1.40). Increased 
physical activity dose was associated with lower odds of developing GAD, but no dose 
response was apparent for depression or anxiety. Overall, the findings of this dissertation 
support the benefits of meeting physical activity recommendations for depression, 
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Glossary of Terms/Definitions 
Physical Activity and Exercise: Physical activity is any bodily movement that is carried 
out by the skeletal muscles that results in energy expenditure.1 Exercise is a planned, 
structured regime of physical activity intended to improve or maintain one or more 
components of fitness (i.e., cardiorespiratory, muscular, flexibility, and body 
composition).1 For health benefits, the World Health Organization recommends adults 
engage in a minimum of 150 minutes of moderate intensity physical activity, 75 minutes 
of vigorous intensity physical activity, or an equivalent combination, typically defined as 
600 metabolic equivalent (MET).minutes of moderate or vigorous intensity physical 
activity, each week.2, 3 For additional health benefits, engaging in ≥300 minutes of 
moderate intensity physical activity, ≥150 minutes of vigorous intensity physical activity, 
or ≥1200 MET.minutes of moderate or vigorous intensity physical activity per week is 
recommended.2, 3 In the non-meta-analytic studies included this dissertation, physical 
activity was measured using the short form International Physical Activity 
Questionnaire.4, 5 This questionnaire records the activity of four intensity levels (i.e., 
vigorous, moderate, walking, and sitting) over the previous seven days and is 
recommended for physical activity surveillance studies.4 
Depression: Clinically defined depression is a mood disorder known as major depressive 
disorder in the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5).6 
People have a major depressive episode when at least five of the following symptoms 
have been present during the same 2-week period, nearly every day, and represent a 
change from previous functioning: depressed mood, loss of interest or pleasure in normal 
activities, feelings of worthlessness, psychomotor agitation, abnormalities in weight 
change, sleep, energy, or concentration, and, often, suicidal thoughts. Additionally, at 
xvi 
 
least one of the symptoms must be either depressed mood or loss of interest or pleasure 
in normal activities. The Center for Epidemiologic Studies Depression Scale (CES-D),7 
used in two studies included in this dissertation, is a measure of eight of these nine 
symptoms (it does not address suicidal ideation/attempt/plan).7  
Anxiety: Anxiety is characterized by apprehensive or worrisome thoughts and is typically 
accompanied by agitation, feelings of tension, and activation of the autonomic nervous 
system.8 A distinction can be made between transient anxiety symptoms (i.e., state anxiety), 
and persistent symptoms (i.e., trait anxiety). When anxiety is experienced without an obvious 
danger, when the reaction is too strong in relation to the danger, or when the expectation of a 
potential anxiety reaction is very high and chronic, symptoms may be classified as an anxiety 
disorder. DSM-5 anxiety disorders include: separation anxiety disorder, selective mutism, 
specific phobia, social phobia, panic disorder, agoraphobia, and generalized anxiety 
disorder.6 In two studies included in this dissertation anxiety was measured using the 
anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A).9 This is a 
measure of seven anxiety symptoms experienced over the past seven days: loss of 
enjoyment and interest in appearance and activities, feelings of restlessness, panic, being 
slowed down, and “butterflies” in the stomach. A third study examined GAD. This is an 
anxiety disorder characterized by recurrent or persistent excessive worry about every day, 
routine life events and activities, occurring most days for at least 6 months.6 Its hallmark 
symptom, worry, was assessed using the abbreviated Penn State Worry Questionnaire 
(PSWQ-A),10 and GAD diagnosed with the short form Composite International 
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This dissertation seeks to understand the association of meeting World Health 
Organization (WHO) minimum recommended levels of physical activity with depression 
and anxiety outcomes in the general population. Depression is the leading cause of 
disability worldwide.1 It affects an estimated 322 million people worldwide and is more 
common among females than males (5.1% vs 3.6%).1 Anxiety disorders are the sixth 
leading cause of disability worldwide.1 They affect an estimated 264 million people 
worldwide and, like depression, are more common among females than males (4.6% vs 
2.6%).1 In Europe in 2010, mood and anxiety disorders cost over €187 billion,2 while in 
Ireland it is estimated that mental health problems cost €11 billion per year.3 In addition 
to their large economic burden, depression and anxiety carry a significant personal 
burden: they are associated with heightened medical comorbidity,4-7 increased healthcare 
costs,8 and premature mortality.9  
Scaled-up treatment for people with depression and anxiety disorders could yield a net 
global economic benefit of $230 billion and €169 billion by the year 2030, respectively.8 
However, between 76% and 85% of people with mental disorders in low- and middle-
income countries, and between 35% and 50% in high-income countries, receive no 
treatment for their disorder.10 Frontline treatments, such as selective serotonin reuptake 
inhibitors and cognitive behavioural therapy,11, 12 can have negative side-effects, such as 
increased weight gain13 suicidality and aggression,14 and are only moderately efficacious, 
respectively.11 Depression patients frequently do not respond to initial treatment and 
many need two or more treatments to reach remission.15 Further, the number of 
individuals with anxiety disorders seeking care can be low. There is often a low perceived 
need to seek treatment and a desire to handle the problem by oneself, likely as the 
symptoms associated with anxiety disorders can be misinterpreted as normal responses.16 
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Exercise has been shown to reduce symptoms among people with depression,17 anxiety 
disorders,18 and chronic-illnesses.19, 20 Much research has examined prospective 
associations of physical activity with the onset of depression,21-23 and some, although 
fewer, with the onset of anxiety symptoms and disorders.24 Meeting the WHO 
recommendations for physical activity has been shown to have substantial health 
benefits;25 however, just two studies have actually examined associations of meeting 
these recommendations with the onset of depression, and none with the onset of anxiety. 
Given the worldwide promotion of the salutary benefits of meeting the WHO guidelines, 
it is important to clearly elucidate the association of doing so with depression and anxiety.  
Of the studies that have attempted to examine this association with depression,26-34 most 
incorrectly define the guidelines as simply ≥150 minutes of moderate or vigorous 
intensity physical activity per week. This definition does not account for two important 
components of the guidelines (i.e., 75 minutes of vigorous intensity physical activity and 
600 MET.minutes of moderate or vigorous intensity physical activity). Just two studies26, 
32 have examined associations of meeting the guidelines as defined by the WHO with 
onset of depression (defined as a CES-D score ≥10). Both used data from different cohorts 
within the Australian Longitudinal Study on Women’s Health (i.e., younger26 and mid-
age32 cohorts), and so examine exclusively women. Ball and colleagues26 (n=6677) did 
not exclude people with depression at baseline from analyses but included baseline CES-
D score as a covariate in analyses. In fully adjusted analyses, compared to people who 
reported engaging in no moderate or vigorous physical activity each week, those who met 
the minimum WHO recommendations at baseline were 18% (OR, 95%CI: 0.82, 0.65-
1.05; p>0.05) less likely to report depression three years later. Mihrshahi and colleagues32 
(n=5117) did exclude people with depression at baseline from analyses. In fully adjusted 
analyses, compared to people who reported engaging in no moderate or vigorous physical 
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activity each week, those who met the minimum WHO recommendations at baseline were 
30% (0.70, 0.55-0.88; p=0.003) less likely to report depression three years. These findings 
provide initial support for meeting the WHO recommendations, although further studies 
including males and older adults, and excluding those with baseline depression, are 
required. Additionally, each study found no evidence of a dose-response, with increased 
doses of physical activity associated with 21% to 34% lower odds of depression across 
the studies. Identifying whether associations of physical activity with mental health are 
stronger with increased physical activity dose is fundamentally important both to guide 
recommendations for clinical practice and public health policy and for satisfying 
evidentiary criteria for a causal association between physical activity exposure and mental 
health outcomes.35 
Although not considered in the current dissertation, the WHO also recommends engaging 
in two days of muscle-strengthening activity (e.g. strength training, resistance training, or 
muscular strength and endurance exercises) each week. Epidemiological evidence on 
associations of this with mental health is scarce, with just one cross-sectional study to 
date demonstrating that those who meet both the aerobic and muscle-strengthening 
components of the WHO recommendations reported lower levels of depressive 
symptoms. Experimental evidence has also demonstrated that resistance exercise training 
interventions can reduce anxiety and depressive symptoms among healthy participants, 
and those with physical and mental disorders. 
Aims 
Therefore, this dissertation sought to: 
• Conduct a systematic review and meta-analysis of prospective associations of 
physical activity with depression to both quantify the magnitude of the estimated 
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population effect and determine the extent to which variables of theoretical or 
practical importance account for variation in the estimated population effect; 
• Conduct a systematic review and meta-analysis of prospective associations of 
physical activity with anxiety symptoms and disorders, in particular GAD, to both 
quantify the magnitude of the estimated population effect and explore key areas 
for future research; 
• Examine cross-sectional and prospective associations of meeting WHO physical 
activity recommendations with depression, anxiety, and GAD; 
• Examine whether associations of physical activity with depression, anxiety, and 
GAD were stronger with increased dose of physical activity. 
As it would not have been feasible to collect sufficient cross-sectional and prospective 
data within the four-year timeframe of the PhD, it was necessary to use pre-existing data 
in order to achieve these aims. This process is outlined in Manuscript Three; however, 
briefly, to identify appropriate datasets we collaborated with the Determinants of Diet and 
Physical Activity Knowledge Hub (DEDIPAC-KH), a multidisciplinary consortium of 
researchers across Europe, that had developed a compendium of large, population-based 
datasets within Europe. Datasets with physical activity and mental health measures were 
identified and project managers contacted seeking access. After non-responses and 
datasets that could not be harmonised, two datasets were made available: these were The 
Irish LongituDinal Study on Ageing (TILDA) and The Mitchelstown Cohort study. 
Therefore, Manuscripts 3-7 used data from these cohort studies. 
Overview and Organisation 
The remaining sections of this dissertation are outlined below. 
6 
 
Chapters II-VII are comprised of seven manuscripts. Each paper has a Preface that briefly 
explains the publication status of the manuscript (i.e., Published or In Review), the 
author’s contribution to it, and its significance both to this dissertation and the wider 
literature. Manuscript One is a systematic review and meta-analysis of the odds of 
incident and elevated depression and depression symptoms among people who engage in 
physical activity in prospective cohort studies: 
1. Physical Activity and Odds of Depression Symptoms: Systematic Review and 
Meta-Regression Analysis (In Review). 
Manuscripts Two and Three are cross-sectional and prospective studies of the odds of 
prevalent and incident depression among people who meet the physical activity 
guidelines, respectively: 
2. Associations of Self-Reported Physical Activity and Depression in 10,000 Irish 
Adults across Harmonised Datasets: a DEDIPAC-study (Published); 
3. Associations of Physical Activity and Depression: Results from The Irish 
Longitudinal Study on Ageing (Published). 
Manuscript Four is a systematic review and meta-analysis of the odds of incident and 
elevated anxiety and anxiety symptoms among people who engage in physical activity in 
prospective cohort studies: 
4. Physical Activity and Anxiety: A Systematic Review and Meta-Analysis of 
Prospective Cohort Studies (In Review). 
Manuscripts Five and Six are cross-sectional and prospective studies of the odds of 
prevalent and incident anxiety among people who meet the physical activity guidelines: 
7 
 
5. Associations of Self-Reported Physical Activity and Anxiety in 10,000 Irish 
Adults across Harmonised Datasets: a DEDIPAC-study (In Review); 
6. Associations of physical activity with anxiety symptoms and status: results from 
The Irish Longitudinal Study on Ageing (Published). 
Manuscript Seven is a prospective study of the odds of incident GAD among people who 
meet the physical activity guidelines: 
7. Physical Activity and Generalized Anxiety Disorder: Results from The Irish 
Longitudinal Study on Ageing (Published). 
Chapter IX (“Conclusions”) provides a concluding discussion of the findings of each 
manuscript, the implications of the dissertation and its strengths and limitations, and 
implications for future research.  
Original Contribution to the Research 
The original contribution to knowledge of this dissertation is: 
• The largest and most comprehensive meta-analysis of prospective associations of 
physical activity with depression; 
• The first meta-analysis of prospective associations of physical activity with 
anxiety; 
• The first prospective cohort study to examine associations of meeting the World 
Health Organization’s physical activity recommendations with onset of 
depression in a mixed-sex sample and sample including older adults; 
• The first two prospective cohort studies to examine associations of meeting the 
World Health Organization’s physical activity recommendations with onset of 
anxiety symptoms and a diagnosed anxiety disorder; 
8 
 
• The first prospective cohort studies to examine associations of physical activity 
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Manuscript One: Physical Activity and Odds of Depression Symptoms: Systematic 
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Relevance: This systematic review and meta-analysis of prospective cohort studies 
examined longitudinal associations of physical activity with subsequent depression. 
Importantly, it informed the subsequent work undertaken for this dissertation (i.e., 
Manuscripts 2 and 3) by highlighting the dearth of research examining associations of 
meeting WHO physical activity recommendations with incident depression, and a 
potential dose-response in associations of physical activity with depression. 
Significance: This paper quantitatively synthesised reported longitudinal associations of 
physical activity with depression in 120 studies consisting of 638,000 people and 
qualitatively reviewed these studies. It is the largest and most comprehensive systematic 
review and meta-analysis on this topic to date. Adjusted odds of elevated symptoms were 
23.5-29.4% lower among active compared with inactive people. Odds reductions were 
larger when people met or exceeded WHO recommendations; however only three studies 






Depression is the leading cause of disability worldwide, affecting approximately 322 
million people.1 Scaled-up treatment of depression could yield a net global economic 
benefit of $230 billion by 2030.2 Major depression is a leading risk-factor for 
cardiovascular morbidity and mortality,3 with a global point-prevalence of 3.2% for men 
and 5.5% for women.4 In the United States, major depression accounts for nearly 400 
million disability days annually among people ages 15 to 44 years with an estimated 
annual cost of $210.5 billion.5 Only half of U.S. adults with major depression receive 
healthcare treatment,6 which is often inadequate.7
 
Patients frequently do not respond to 
initial treatment and many need two or more treatments to reach remission.7 
Exercise has been suggested as a low-risk augmentation therapy for depression.8-11 





patients, with effect sizes ranging from moderately-large to non-significant, 
depending on the presumed rigor used to judge method bias in the studies.12,16,17 There 
are more than 40 meta-analyses, or otherwise systematic reviews, on exercise as therapy 
for depression, which approximates the number of known trials.18 Whether exercise 
confers protection against the onset of depression, however, is less elaborated. Two 
authoritative literature reviews19,20 and two meta-analyses21,22 of a limited number of 
prospective observational studies concluded that physical activity may aid primary 
prevention of depression. Whether the outcome-odds in the studies varied according to 
study features, especially the dose-gradient of exposure, was uncertain from those 
reviews. Identifying whether effects of physical activity are dose-dependent is 
fundamentally important to guide recommendations for clinical practice and public health 





activity exposure and depression.  
A recent meta-analysis of 37 prospective cohort studies of adults22 reported significant 
reductions in crude and adjusted rate ratios for incident depression or elevated depressive 
symptoms that were mainly homogeneous and, hence, unexplained by gender 
composition of the cohorts, length of follow-up, a measure of study quality, or cohort 
size. However, whether the odds or risk of depression varied according physical activity 
exposure dose was not examined. 
Here, we extend the scope and methods of that review with an expanded focus on physical 
activity exposure dose and putative modifiers of exposure dose by conducting a multi-
level meta-regression analysis of expected heterogeneous depression outcomes in an 
additional 83 studies, while assessing risk of bias and adjusting for systematic variation 
between studies and global region of study origin. 
Methods 
Data Sources and Searches 
A systematic review and meta-regression analysis was conducted in accordance with 
established guidelines for conduct and reporting.23,24 The protocol was not registered but 
satisfied contemporary standards.25 Articles published from database inception through 
August, 2018 were located by all authors using MEDLINE, PsycINFO, PsycARTICLES, 
and CINAHL Complete. Keywords included combinations of “physical activity” or 
“leisure time” or “exercise” or “sport*” and “depress*” or “mood” or “dysthymia” and 
“association” or “follow-up” or “risk factor” or “protect*” or “causal*” or “onset” or 
“prospective” or “cohort” or “longitudinal”. Supplemental searches of articles citing, and 





Google Scholar. Inclusion criteria were: (1) a cohort of adults that was not depressed at 
baseline assessment, (2) physical activity exposure assessed at baseline, (3) a defined 
follow-up assessment, (4) a depression outcome assessed at follow-up, (5) crude or 
adjusted odds ratios reported with standard errors or confidence intervals, or frequencies 
of exposed and non-exposed cases and non-cases, or test statistics that could be converted 
to odds ratios.26 When associations were reported but not all data were available, we made 
requests to corresponding authors.27 Investigations were excluded that: (1) sampled 
patients with pre-existing clinically-diagnosed depression or who were taking 
antidepressants at baseline, (2) included physical activity as part of a multi-component 
exposure, (3) used an adjective checklist rather than a validated scale of depression 
symptoms, (4) reported associations that could not be converted to odds ratios (e.g., 
hazard ratio or risk ratio). eFigure 1 illustrates a flowchart of study selection.  
Study characteristics are found in supplementary Appendix A. Most studies were 
population-based, but only nine studies reported crude28 or adjusted28-36 results separately 
for men and women, and only one study reported results stratified by age.33 Also, race 
and ethnicity were poorly represented (number of studies, median % of sample): African 
American or black (18, 18.6%), Mexican American, Latino, Hispanic (14, 9%), Asian 
(17, 5%), Native American (3, 2%) and were not described in two-thirds of the studies. 
A single study37 compared race or ethnic groups (i.e., black and white Americans). 
Seventeen studies sampled patients (HIV, cancer, myocardial infarction or other CVD, 
type 2 diabetes, multiple sclerosis, frailty falls, dual sensory loss, and obesity). Twenty-
nine studies reported the proportion of the cohort with a chronic disease.  
Modifiers identified a priori were: global region, gender, age, exposure dose, follow-up 





quality was evaluated according to selection bias, confounding, exposure measures, and 
outcome measures.38 Consistent with the Grade Working Group 
(http://www.gradeworkinggroup.org/),39 the quality of the summary evidence was 
judged as good, acceptable, or poor according to: risk of bias, directness of evidence, 
consistency and precision of results, risk of publication bias, magnitude of the effect, 
dose-response gradient, and influence of residual plausible confounding 
(Supplementary Table 2). 
Data Analysis 
Odds ratios were retrieved as published values, computed as odds ratios from 2 x 2 
frequency tables of exposure cases and non-cases, or converted from standardized mean 
differences, Pearson correlation coefficients, or standardized linear regression 
coefficients using standard conversion procedures.26,40,41 Odds ratios were log 
transformed, weighted by their inverse variance prior to random effects aggregation or 
mixed effects regression modeling, and then back transformed to odds ratios for 
summary reports. Inter-rater reliability for odds ratios was examined with intra-class 
correlation coefficients (ICC) for absolute agreement. Rater agreement on moderator 
levels and study quality was judged with Kappa.42 Initial rater agreements exceeded 
0.95 for odds ratios and ranged from 90%-100% for three rater agreements on 
moderators (kappa exceeded 0.75) and study quality (kappa was 0.64-0.89 for five 
facets and 0.81-0.94 for overall quality). Discrepancies were resolved by adjudication 
by three raters after re-calculation and/or recoding.  
A multi-level, random-effects model estimated parameters and their standard errors 
after adjustment for correlated effects within random nesting factors of study and global 





regression moderator analysis with restricted-information maximum likelihood 
estimation43,44 was conducted using Metafor45,46 in R 3.5.47 Knapp & Hartung 
adjustment48,49 provided estimates of summary odds ratios and their variation that are 
precise and robust to bias.50 Results were corroborated by Bayes estimation in Mplus 
8.2,51 using standard procedures.52-54 Each moderator variable was coded according to 
planned contrasts among its levels (see Tables 1 and 2) and centered for meta-
regression. Odds from each study’s most adjusted model were used for adjusted 
summary odds ratios. Planned two-way interactions of exposure dose with other 
moderators were conducted. Tests of the regression model (QR) and its residual error 
(QE) are reported. Type I error was constrained by testing each main effect and 
interaction at p<0.01 Heterogeneity of mean effects was tested with Q and I2 statistics.55 
Funnel plots with Egger’s test56 and the rank correlation test57 examined risk of 
publication bias. Fail-safe N1 estimated the number of unpublished or un-retrieved null 
effects that would diminish the significance of observed effects to p>0.05.58 
Results 
One-hundred-forty-one of 149 crude odds (95%) and 166 of 187 adjusted odds (89%) 
were less than 1.0. Ninety-two of 149 (62%) crude odds and 94 of 187 (51%) adjusted 
odds, were statistically significant. Figures 1 and 2 illustrate forest plots with annotation 
of the distribution of crude and adjusted odds ratios.  
Crude Odds 
Physical activity was associated with 37% lower crude odds (OR=0.6317, 95%CI: 
0.5651-0.7061; Q(148)=3762.4, p<0.0001; I
2=96.1 (95%CI: 95.9-96.3; k=149, n=72). 
Odds ratios were correlated within studies (ICC=0.327) and regions (ICC=0.025). Fail-





The meta-regression model (F(8,140)=11.1972; p<0.0001, R
2=0.135 [95%CI: 0.117-
0.152]; QE(140)=2574.3, p<0.0001) indicated that crude odds of depressive symptoms were 
negatively related to exposure dose (p<0.0001), study design (p=0.0049), and the 
interaction of exposure dose with study design (p=0.0007). See Table 3. The model was 
materially the same when exposure was defined as meeting recommended guidelines of 
moderate or vigorous physical activity (F(8,140)=9.4450; p<0.0001, R
2=0.125 [95%CI: 
0.109-0.140]; QE(140)=2320.7, p<0.0001). Odds were negatively related to exposure dose 
(p<0.0001), study design (p=0.0031), and the interaction of exposure dose with study 
design (p=0.0003).  
Odds reductions were: (1) larger when exposure dose was moderate or high (k=40, 
OR=0.6019 [95%CI: 0.5158-0.7025]) compared to low (k=23, OR=0.7603 [95%CI: 
0.6878-0.8405]) or when recommended exposure was met (k=39, OR=0.6607 [95%CI: 
0.5291-0.8250]) compared to not met (k=24, OR=0.7085 [95%CI: 0.5978-0.8397]); (2) 
larger when there was more than one physical activity exposure (k=34, OR=0.5591 
[95%CI: 0.3921-0.7972]) compared to a single exposure at baseline (k=115, OR=0.6742 
[95%CI: 0.6239-0.7285]); and (3) smaller when exposure dose was low in studies with a 
single exposure at baseline (k=22, OR=0.7589 [95%CI: 0.6835-0.8426]) compared to 
other studies (k=127, OR=0.6163 [95%CI: 0.5495-0.6913]). 
The funnel plot (eFigure 2) did not indicate marked asymmetry. The rank correlation test 
of bias was significant (p=0.043). Egger’s test was non-significant (p=0.074).  
Adjusted Odds 
Physical activity was associated with 22% lower adjusted odds (OR=0.7797, 0.7473-
0.8137; Q(186)=1499.7, p<0.0001; I
2=87.7 (95%CI=86.9-88.4; k=187, n=90). Odds ratios 






The meta-regression model (F(7,179)=20.8324; p<0.0001, R
2=0.098 [95%CI: 0.084-0.113, 
QE(179)=651.1, p<0.0001) indicated that adjusted odds of depressive symptoms were 
negatively related to physical activity dose (p<0.0001) and study design (p<0.0001). The 
model was materially the same when exposure was defined as meeting recommended 
guidelines of moderate or vigorous physical activity (p<0.0001), with study design 
similarly significant (p<0.0001) (F(7,179)=6.1591; p<0.0001, R
2=0.079 [95%CI: 0.065-
0.095]; QE(179)=782.2, p<0.0001). See Table 3. There were no interactions with exposure 
dose (all P≥0.4751).  
Odds reductions were: (1) larger when exposure dose was moderate or high (k=61, 
OR=0.7150 [95%CI: 0.6690-0.7642]) compared to low (k=39, OR=0.8340 [95%CI, 
0.7813-0.8903]) or when recommended exposure was met (k=40, OR=0.7615 [95%CI: 
0.7174-0.8083]) compared to not met (k=34, OR=0.8383 [95%CI: 0.7830-0.8975]); and 
(2) larger when there was more than one physical activity exposure (k=54, OR=0.6807 
[95%CI: 0.5959-0.7776]) compared to a single exposure at baseline (k=133, OR=0.8000 
[95%CI: 0.7664-0.8352]. 
Egger’s test was significant (p<0.001), but the funnel plot (eFigure 3) did not indicate 
asymmetry, excepting a few studies that had the smallest sample sizes (N~ 100 to 1000) 
and reported mainly reduced odds. The rank correlation test of bias was non-significant 
(p=0.547).  
Sensitivity Analysis  
We limited analysis to the 37 studies of adults and odds of incident depression after 





odds: (OR=0.647, 95%CI: 0.578-0.725; k=42, n=20; Q(41)=176.1, p<0.0001, I2=77.3, 
95%CI: 73.7-80.4). Adjusted odds: (OR=0.779, 95%CI: 0.730-0.831; k=69, n=31; 
Q(68)=200.8, p<0.0001, I2=66.6, 95%CI: 62.1-70.6). Crude odds were lower when 
physical activity dose was moderate or high compared to low (p<0.0001) or when 
exposure met the recommended level (p<0.0001). Odds were higher when physical 
activity was measured as total volume compared to frequency or time (p<0.0001) and 
when depression outcome was measured as screening cut-scores or diagnosis compared 
to symptoms (p=0.0027). Adjusted odds were lower when physical activity dose was 
moderate or high compared to low (p<0.0001) or when exposure met the recommended 
level (p<0.0001).  
We also limited analysis to a single odds ratio per study using each study’s highest 
exposure dose: Crude (k=72): OR=0.5725 (95%CI: 0.5127-0.6392), p<0.0001, 
Q(71)=2497.6, p<0.0001; I
2=97.2 (95%CI: 97.0-97.4). Adjusted (k=90): OR=0.7362 
(95%CI: 0.6929-0.7822), p<0.0001 Q(89)=1049.5, p<0.0001; I
2=91.6(95%CI: 91.0-92.2). 
Crude odds remained negatively related to study design (p=0.0185). Adjusted odds 
remained negatively related to study design (p=0.0269) and physical activity exposure 
dose (p<0.0199). 
Overall study quality (poor, acceptable, or good) was not related to crude odds (p=0.486) 
or adjusted odds (p=0.920) (see Tables 1 and 2) and did not materially influence the meta-
regression results (Table 3). 
Odds did not differ according to whether they were reported: (crude OR=0.6414 (95%CI: 
0.5656-0.7274; k=97, n=48) Q(96)=1154.4, p<0.0001, I
2=91.8 (95%CI: 91.2-92.3); 
(adjusted OR=0.7841 (95%CI: 0.7476-0.8224; k=135, n=65) Q(134)=1146.0, p<0.0001, 





OR=0.6233 (95%CI: 0.5184-0.7493; k=52, n=24) Q(51)=1521.4, p<0.0001, I
2=96.7 
(95%CI: 96.5-97.0)); (adjusted OR=0.7512 (95%CI: 0.6431-0.8774; k=52, n=25) 
Q(51)=223.2, p<0.0001, I
2=77.6 (95%CI: 74.5-80.4)). After studies were excluded 
whereby odds ratios were converted from other test statistics, odds remained reduced: 
(crude OR=0.6414 (95%CI: 0.5656-0.7274; k=97, n=48), Q(96)=1154.4, p<0.0001, 
I2=91.8 (95%CI: 91.2-92.3); adjusted OR=0.7841 (95%CI: 0.7476-0.8224; k=135, n=65), 
Q(134)=1146.0, p<0.0001, I
2=88.4 (95%CI: 87.6-89.1) and remained negatively related to 
physical activity exposure dose (p<0.0001) or recommended exposure (p<0.001).  
Discussion 
Unlike the recent meta-analysis of cohort studies that reported a fully homogeneous 
association of physical activity with depression odds,22 we found high heterogeneity 
that was partly explained by a dose-dependent association between reduced odds of 
elevated depressive symptoms and exposure to moderate-to-vigorous intensities of 
physical activity in both crude and adjusted analysis. This result held in sensitivity 
analysis limited to a single outcome per study or to the smaller number of studies 
included by Schuch et al. (2018).22 Those authors apparently weighted by sample size 
rather than by the conventional inverse variance of the odds ratio and used an 
estimator of population variance that commonly underestimates true between-study 
variance of odds ratios.44,59  
Randomized trials have provided limited evidence of dose-dependent effects of 
exercise among depressed patients,60,61 and trials showing no effect of exercise 
training may have had an inadequate exposure dose.62 Here, the highest levels of 
activity did not confer more protective benefits than did more moderate levels; each 





studies included three levels of physical activity exposure dose needed to directly test 
whether depression odds differed between high and moderate levels of exposure. 
Similar to the full analysis, adjusted odds from high exposure (OR=0.779, 95%CI: 
0.733-0.829) did not differ from moderate exposure (OR=0.757, 95%CI: 0.720-
0.796), but odds in both of those exposures were lower than after low exposure 
(OR=0.892, 95%CI: 0.822-0.968). Nonetheless, different measures and criteria were 
used to classify people into activity exposure groups that were not equivalent across 
studies, making it impossible to accurately convert the findings to a standard estimate 
of physical activity volume at each level (e.g., MET-hours or kilocalories per 
kilogram). However, among the nearly half of studies that provided enough 
information to determine whether active people were meeting existing World Health 
Organization and US Federal public health recommendations of 150 minutes per 
week of moderate-to-vigorous physical activity, odds reductions were larger when 
people met or exceeded the recommended exposure. These observational findings 
encourage more trials of exercise training that experimentally manipulate varying 
levels of intensity or energy expenditure to clarify the dose-dependent nature of 
physical activity exposure and depression outcomes. 
Studies of eight cohorts used a standardized diagnostic interview and another seven 
used a report of diagnosis by a physician to measure incident depression. Despite the 
high quality outcome measures,63 nine of those studies used a weak measure of 
physical activity exposure. Nonetheless, the protective effect of physical activity seen 
here was not limited to self-rated symptoms.  
More than 90% of the studies reported less depression among physically active than 





often because the sample sizes were too small to provide good precision of the point 
estimate. The median (interquartile range) number of people for each comparison was 
1407 (511-3914) people for crude odds and 1524 (578-3353) people for adjusted odds. 
The baseline depression rate reported in 3/4th of the studies was 12% (4%-20%), 
consistent with 12-month rates in U.S. adults.6,64 
Included studies were biased by self-reporting of physical activity. Only six 
studies31,65-69 used an objective measure of physical activity that nonetheless 
incompletely assesses physical activities. For example, a pedometer measures 
walking distance well, but it is a poor measure of physical activity exposure unless 
walking is the predominant type of habitual activity in a cohort. An accelerometer 
measures intensity, but not accurately for most resistance exercises or other activities 
when force of movement is uncoupled from body displacement. Cardiorespiratory 
fitness provides an objective, surrogate measure of physical activity exposure that is 
linked to health outcomes. Although not reviewed here, adults with low 
cardiorespiratory fitness at baseline were at increased risk of incident depression 
across follow-up periods of 3-40 years70,71 or elevated depression symptoms across 
12 years of follow-up.72 Those studies did not assess change in fitness exposure or 
sequential measures of outcome and inadequately discounted residual confounding. 
However, in cohorts of men and women assessed at four clinic visits across 10-12 
years, maintenance of fitness reduced odds of incident depression complaints made 
to a physician, even after time-varying adjustments for smoking, alcohol use, BMI, 
chronic illness, and anxiety or sleep problems.73 
There is risk of misclassification bias in most of the cohort studies that only assessed 





based studies that track periodicity of physical activity levels in a cohort across 
time.74 One-fourth of the studies reviewed here (17/72 studies that reported crude 
odds and 23/90 studies that reported adjusted odds) assessed physical activity more 
than once, permitting an estimate of change in exposure across follow-up. 
It is biologically plausible that customary physical activity protects against onset of 
depression symptoms. Combination monoaminergic therapy has been shown to be 
superior to monotherapy in treatment-resistant depression,75 and exercise training has 
brain monoaminergic76,77 and neurotrophic78,79 effects. Limited evidence from animal 
models of depression77,80,81 and randomized controlled trials of major depression have 
shown that the efficacy of exercise training is comparable, but not additive, to 
pharmacotherapy,82,83 consistent with redundant or similar biochemical mechanisms. 
However, neurobiological adaptations to exercise in depressed patients are not 
known.84 
Study quality in the Schuch et al. (2018)22 meta-analysis was judged as moderate-to-
high according to the commonly used Newcastle-Ottawa Scale, which has shown no 
association between individual facets of bias and overall score or effect estimates in 
cohort studies.85 There currently is no consensus on the best procedure/tool to assess 
risk of bias in observational designs.86 We used the Q-Coh,38 which is structured 
around common domains of bias: selection and attrition, confounding, exposure 
measures, and outcome measures, consistent with criteria endorsed by the GRADE 
working group.39 Here, it yielded high rater agreement. We also judge the quality of 
the studies that most fully-adjusted for putative confounders as moderate-to-high in 
quality, when they used a valid physical activity measure. However, about half the 





confounding. Nonetheless, we have good confidence in the summary evidence from 
about 40 well done studies that adjusted for confounders and used a validated measure 
of exposure, albeit derived from self-reported rather than objectively-measured 
physical activity. Only one study68 adjusted for confounders and measured volume of 
physical activity using an accelerometer that assesses time and intensity. 
Crude odds inherently are vulnerable to confounding bias, but here the summary crude 
odds did not differ according to known unmodifiable depression risk factors of gender 
and age. Hence, the overall risk of bias due to potential confounding can be upgraded 
to moderate. Similarly, the inherent bias potential from poorly measured exposure and 
reliance on validated symptom measures, rather than clinically-diagnosed depression, 
in about half the studies permits upgrading the summary evidence from poor to 
moderate, because summary odds did not differ based on measures of physical activity 
exposure or depression outcome. Few studies directly tested whether participant 
characteristics such as age, gender, race/ethnicity or medical condition modified the 
association between physical activity and depression.  
There was possible publication bias of the fully adjusted odds. However, funnel plot 
asymmetry and Egger’s test can yield false-positive indication of bias when the true 
effect is heterogeneous,87 as observed here. Statistical tests of funnel asymmetry have 
uncertain validity as an indicator of publication bias when effects are heterogeneous, 
and they are not recommended as a sole indicator.88 Although the outcome estimate in 
each analysis had sufficient precision and consistency and low publication bias, 
heterogeneity of the cumulative evidence, even after adjusting for variation within 
studies, suggests residual confounding in the studies or effect modification not 





We conclude that the studies collectively were of moderate (i.e., acceptable to good) 
quality. The common use of poorly validated self-reports of physical activity and 
measures of depression symptoms based on varying self-ratings of symptoms rather 
than standard diagnostic criteria were limitations of the studies included here. Few 
studies fully accounted for participants lost to follow-up. The common study design 
limited exposure to a single measure of physical activity at baseline, with less than half 
the studies assessing varying exposures or change in outcome. Only eight studies 
assessed change in physical activity exposure using a measure of volume and also 
adjusted for confounders.34,37,89-94  
Although modifiable risk factors are incompletely understood, future cohort studies 
should especially include widowhood, physical abuse during childhood, obesity, 
metabolic risk factors, sexual dysfunction, and job strain.95 The results encourage more 
large-scale studies using a standardized diagnosis of depression and multiple follow-up 
exposures using objective measures of physical activity or fitness with time-varying 
confounders, including family history of depression and comorbidity with anxiety or 
emotional stress. 
Shortcomings notwithstanding, the cumulative evidence supports that customary 
moderate-to-vigorous physical activity confers a small protective effect against 
developing depression symptoms among adults regardless of global region, gender, age, 





Tables and Figures 
Table 1. Depression symptoms associated with physical activity: Crude odds ratio and 
heterogeneity 
 Contrast K(N) Mean OR 95%CI Q I2 (95%CI) 
Region       
North America  67(31) .6949d [.6304, .7660] 1074.1d 94.0(93.5,94.4) 
Europe  47(25) .5684d [.4566, .7077] 1532.8d 97.1(96.8,97.3) 
Asia   14(8) .6698d [.6237, .7194] 27.5b 56.4(40.5,68.0) 
Australia  21(8) .6050c [.4669, .7841]  182.0d 89.6(87.6,91.2) 
Gender       
Females  1 61(21) .6749d [.5936, .7674] 660.2d 91.1(90.2,91.9) 
Males -1 18(9) .6878c [.5832, .8111] 41.5c 61.4(49.8,70.4) 
Mixed (55% female, 8-
94%,IR=49% to 61%) 
0 70 (43) .6087d [.5228, .7086] 2100.1d 96.8(96.6.97.0) 
Age (years)       
18-44 1 42(17) .7152d [.6471, .7905] 106.1d 62.3(55.4,68.1) 
45-64 2 63(26) .5768c [.4260, .7812] 2289.3d 97.3(97.2,97.5) 
65+ 3 44(29) .6411d [.5730, .7172] 908.2d 95.4(94.9.95.8) 
Study Quality       
Low  1 52(33) .6404d [.5380, 7474] 2156.2d 97.7(97.5,97.8) 
Acceptable 2 52 (26) .5930d [.4849, .7251] 558.7d 91.1(90.1,91.9) 
Good 3 45(13) .7370d [.6373, .8525] 175.8d 75.5(71.7.78.8) 
Study Design       
Baseline exposure  -.5 109(52) .6655d [.6067, .7301] 1584.6d 93.3(92.8,93.7) 
Change in depression 
outcome  
-.5 6(6) .7304 [.4809,1.1094
] 
29.7d 86.5(80.2,90.9) 
Change in PA exposure .5 15(8) .5415b [.3453, .8490] 91.8d 85.8(82.3,88.7) 
Change in PA exposure 
and depression 
.5 19(11) .5642b [.3818, .8338] 1722.5d 99.0(98.9,99.1) 
Physical Activity 
Measure 
      
Frequency  -.5 45(25) .6170d [.5431, .7009] 270.3d 84.1(81.9,86.0) 




27(9) .6607c [.5148, .8481] 406.5d 93.9(93.0,94.6) 
Metabolic equivalent  .5 59(27) .6583d [.5390, .8040] 2209.4d 97.4(97.3,97.6) 
Depression Measure       
Symptoms  -.5 36(21) .5804d [.4485, .7509] 1494.6d 97.7(97.5,97.9) 
Screening cut-point -.5 90(40) .6426d [.5772, .7152] 1130.4d 92.2(91.6,92.8) 




14(6) .7306b [.5940, .8985] 23.7a 49.4(30.3,63.2) 
Exposure Dose       
Binary or correlation  0 87(53) .6297d [.5439, .7291] 3083.8d 97.2(97.1,97.4) 
Low -1 23(19) .7603d [.6778, .8405] 68.7d 69.4(62.0,75.4) 
Moderate  .5 23(19) .6074d [.5085, .7254] 266.9d 92.1(90.9,93.2) 




     
Not meeting guidelines -1 24(16) .7085c [.5978, .8397] 116.9d 81.2(77.3,84.4) 
Not reported 0 86(48) .6234d [.5344, .7272] 3044.5d 97.2(97.1,97.4) 
Meeting guidelines  1 39(22) .6607c [.5291, .8250] 483.1d 92.3(91.4,93.2) 
       






Table 2. Depression symptoms associated with physical activity: Adjusted odds ratio 
and heterogeneity 
 Contrast  K(N) Mean OR 95%CI Q I2 (95%CI) 
Region       
North America  66(34) .8008d [.7477, .8576] 917.5d 93.0(92.4,93.6) 
Europe  76(35) .7829d [.7281, .8418] 283.4d 73.9(70.8,76.7) 






















Males only -1 21(12) .8306b [.7269, .9489] 357.6d 94.7(93.9,95.4) 
Mixed (56% female, 8-
94%,IR=47% to 58%) 
0 104(59) .7717d [.7323, .8130] 528.1d 80.7(78.9.82.3) 
Age (years)       
18-44  1 49(18) .8265d [.7541, .9059] 163.3d 71.2(66.7,75.1) 
45-64  2 65 (31) .7614d [.7166, .8090] 695.3d 90.9(90.1,91.7) 
65+  3 73(41) .7739d [.7082, .8457] 482.2d 85.3(83.8.86.7) 
Adjustments       
Age, sex, demographics  1 12(6) .8210b [.7194, .9371] 658.2d 98.5(98.3,98.7) 
Plus modifiable risks 2 46(25) .7817d [.7183, .8507] 168.1d 73.8(69.7,77.4) 
Plus chronic disease or 
disability 
3 129(59) .7725d [.7310, .8163] 592.6d 78.6(76.8,80.3) 
       
Study Quality       
Low  1 33(18) .7864d [.6996, .8840] 70.4d 56.0(46.3,63.9) 
Acceptable 2 92 (47) .7681d [.7109, .8299] 1217.9d 92.6(92.1,93.1) 
Good 3 62(25) .7831d [.7146, .8582] 186.9d 67.9(63.4.71.9) 
       
Study Design       
Baseline exposure  -.5 97(48) .8005d [.7592, .8441] 1029.0d 90.8(90.1,91.4) 
Change in depression 
outcome  
-.5 36(21) .7970d [.7373, .8616] 76.3d 55.4(46.1,63.2) 
Change in PA exposure .5 22(12) .6435b [.4735, .8743] 47.0c 57.5(45.8,66.6) 
Change in PA exposure 
and depression 
.5 32(15) .6762b [.5227, .8747] 276.3d 89.1(87.5,90.5) 
       
Physical Activity 
Measure 
      
Frequency  -.5 61(32) .7555d [.6971, .8188] 284.9d 79.3(76.7,81.6) 




21(5) .8453c [.7772, .9192] 93.8d 79.7(75.1,83.5) 
Metabolic equivalent  .5 73(34) .7820d [.7287, .8392] 961.2d 92.6(92.0,93.2) 
       
Depression Measure       
Symptoms  -.5 41(21) .7935b [.6934, .9081] 211.2d 81.5(78.8,84.0) 
Screening cut-point -.5 128(59) .7752d [.7370, .8154] 552.4d 77.2(75.2,79.0) 
Self-reported diagnosis  .5 6(4) .7392d [.7214, .7574] 75.6d 94.7(92.9,96.1) 
Clinical diagnosis  .5 12(6) .8005a [.6442, .9947] 14.1 29.1(00.0,50.2) 
 
Exposure Dose 
      
Binary or correlation  0 87(61) .7903d [.7351, .8499] 540.2d 82.3(82.8,85.6) 
Low -1 39(29) .8351d [.7802, .8939] 182.7d 79.8(76.5,82.5) 
Moderate  .5 38(29) .7106d [.6621, .7626] 150.6d 76.1(72.0,80.6) 
High  .5 23(13) .7617d [.6938, .8362] 59.1d 64.5(55.4,71.7) 
       
Recommended 
Exposure 
      
Not meeting guidelines -1 34(21) .8414c [.7743, .9142] 71.9 55.5(45.9,63.4) 
Not reported 0 113(63) .7644d [.7205, .8111] 699.6d 84.1(82.8,85.4) 
Meeting guidelines  1 40(22) .7615d [.7174, .8083] 183.9d 79.3(76.1,82.2) 
       
Significant at p<.05a at p<.01b p<.001c p<.0001d     






Table 3. Meta-Regression of Effect Modifiers 
 
  
Crude Model  
72 studies (k=149) 
 Estimate SE t-value P-value 95% CI 
Main Effects      
Intercept 




































.3074 .0883 3.4821 .0007 0.1329 to 0.4819 
Adjusted Model 
90 studies (k=187) 
 Estimate SE t-value P-value 95% CI 
Intercept 
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physical activity recommendations was associated with 44.3% lower odds of depression 
and a dose-response was apparent. This laid the foundations for the subsequent 







Depression is a prevalent, debilitating, and often recurrent mood disorder1, 2 that affects 
over 300 million people globally1 and is the second leading cause of global disability.3 
The financial burden associated with depression continues to grow, due largely to 
increasing treatment costs and wider societal costs of lost productivity.4 Depression is the 
mental disorder with the highest cost implications in Europe, accounting for over €90 
billion in direct and indirect cost across Europe.4 
Successful treatment of depression with traditional first-line treatments, such as 
psychotherapy and pharmacotherapy, remains limited.5 Exercise has been shown to be a 
viable treatment for depression and depressive symptoms;6, 7 however, evidence indicates 
that approximately 63% of people with mental health problems, including depression, do 
not seek specialist treatment and only half of those who do appear to improve.8 Thus, 
there is a continued need to identify and investigate cost-effective prevention and 
treatment strategies that are effective and more accessible.  
The salutary benefits of regular physical activity (PA) for mental health are well-
established9 and without the physiologic side effects and costs associated with 
antidepressants and psychotherapy.10 In the context of depression, evidence supports: (i) 
significantly lower PA levels among adults with depression compared to adults without 
depression;11, 12 (ii) inverse associations between PA and onset of depression;13, 14 and 
(iii) that habitual PA may moderate treatment response.15 However, many studies have 
not used validated instruments to capture important features of PA such as type, 
frequency, intensity, and duration, and the use of inconsistent self-report measures of PA 
between studies has limited the ability to examine dose–response relationships between 





depression, though this research question often was not the primary focus of the original 
research.16 Furthermore, in studies that did address PA as potential correlate of 
depression, different methodological approaches have been adopted, limiting the 
possibility to generalize the findings.13 
The cost of gathering such data is significant and research funders often emphasize 
maximising the potential of existing data resources through data sharing and secondary 
analysis.17-19 The research and knowledge potential of existing datasets can be further 
exploited through dataset pooling and subsequent harmonisation of variables.17, 20-23 
Reported benefits of pooling include increased statistical power, potential for subgroup 
analysis and comparative research, increased exposure heterogeneity and generalisability, 
and increased cost-efficiency of research programmes.17, 24-26 
Thus, the aim of the current investigation was to harmonise and integrate two existing 
datasets in order to increase statistical power and generalisability in investigating and 
quantifying the association between meeting PA guidelines and elevated depressive 
symptoms, and to explore whether larger associations are observed with increased PA, in 
a large cross-sectional population sample of Irish adults. It is hypothesised that meeting 
PA guidelines will be associated with lower odds of elevated depressive symptoms, with 
lower odds of elevated depressive symptoms observed with greater volumes of PA. 
Methods 
This study used Strengthening the Reporting of Observational Studies in Epidemiology 





Selection of participating studies 
The platform for the current research was the DEterminants of DIet and Physical ACtivity 
Knowledge Hub (DEDIPAC-KH), a pan-European joint programme initiative active from 
2013 to 2016. The focus of DEDIPAC was to better understand how individual and 
contextual factors influence diet, PA, and sedentary behaviour.28,29 Within DEDIPAC, a 
compendium of relevant and accessible datasets regarding the listed health risk 
behaviours and their determinants was developed.30 Datasets for inclusion in the 
compendium were identified by: i) a search of the CORDIS project platform, which is the 
European Commission's primary public repository and portal to disseminate information 
on all EU-funded research projects and their results, ii) an examination of existing recent 
literature reviews and noting the nature of datasets used, and iii) recommendation from 
the DEDIPAC network and expert consultation. The compendium provides information 
on the study, the study population, the determinants and health behaviours measured and 
level of accessibility. The compendium is accessible through https://www.dedipac.eu. 
On examination of the compendium, 23 datasets were noted that measured both PA 
behaviour and a psychological determinant of some nature (e.g. motivation, perceived 
competence, anxiety, depression etc.). An evaluation of the available data dictionaries 
which were either publicly available or secured directly from the targeted dataset owners 
revealed five relevant datasets (three Irish, one Dutch, and one multi-nation) which had 
potential for harmonisation (i.e., PA and depression measured using a same or similar 
methodology). Target variables (including relevant covariates) were agreed and listed by 
three authors (CMcD, CMacD, MPH). The dataset owners were subsequently approached 
for access to the specific target variables. Of these, all agreed to participate; however, the 





Dutch study was also excluded due to its smaller sample and nationality that differed from 
the remaining three studies. Another study (the Cork Children’s Lifestyle Survey) was 
subsequently excluded as it assessed lifetime diagnosis of depression rather than current 
depressive symptoms. Appropriate data access agreements were signed as required. Only 
cross-sectional data for datasets were available. Thus, two datasets, The Irish 
Longitudinal Study on Ageing (TILDA) and The Mitchelstown Cohort Study together 
consisting of 10,122 Irish adults, were harmonised for the present study. 
Participating Datasets 
The Irish Longitudinal Study on Ageing (TILDA) is a large (n=8,329) prospective cohort 
study that assesses the social, economic, and health circumstances of community dwelling 
adults aged ≥50 years and their partners of any age in Ireland.31 For the current study, the 
first wave of data collected in 2011 was used. PA was measured using the short 
International Physical Activity Questionnaire (IPAQ-SF),32 in which respondents are 
asked to report the number of days and the duration of the vigorous, moderate, and 
walking activities they undertook during the last seven days. Depression was measured 
with the Center for Epidemiologic Studies Depression (CES-D) questionnaire.33 
The Mitchelstown Cohort Study provided data (n=1,804) from the second phase of the 
Cork and Kerry Diabetes and Heart Disease Study,34 designed to assess diabetes and heart 
disease among 55-74 year-old adults. Data collection began in 2010. PA was measured 
with the IPAQ-SF while depression was measured using the CES-D. 
Harmonisation process 
A target list of relevant variables that may influence the association between PA and 





depression, and that had potential for data harmonisation (i.e., same or similar measure) 
was generated from the two included datasets. Appropriate variable harmonisation 
methods for PA, depression, and participant age, sex, and body mass index (BMI) were 
agreed by a six-person expert consensus group from within DEDIPAC (Table 1). These 
variables were then harmonised to form a large PA and mental health integrated dataset.  
Data Analysis 
PA data were processed according to the IPAQ guidelines for data processing and 
analysis,35and respondents were categorised as meeting or not meeting World Health 
Organization PA guidelines (i.e., ≥150 min.week-1 of MVPA, ≥75 min.week-1 of vigorous 
PA, or ≥500 MET.min.week-1).36 As the PA data were positively skewed, within 
individual datasets and across the integrated dataset participants were divided into tertiles 
based on weekly minutes of MVPA (i.e., 0 min.week-1, 10-295 min.week-1, and ≥300 
min.week-1). CES-D scores range from 0 to 60, and individuals at risk for clinical 
depression were indicated by scores ≥16;33 this cut-off score has demonstrated 100% 
sensitivity and 87.6% specificity among adults.37 Respondents above this cut-off score 
are referred to as having elevated depressive symptoms throughout the current manuscript 
as they are at increased risk of depression; however, meeting the cut-off score does not 
necessarily indicate the presence of clinically diagnosed depression. BMI was categorized 
as underweight, normal weight, overweight, and obese using established thresholds of 
<18.5kg.m-2, 18.5-24.99kg.m-2, 25-29.99kg.m-2, and ≥30kg.m-2, respectively.38 Statistical 
analyses were conducted using SPSS Version 22.0 (Armonk, NY: IBM Corp.). 
Within Dataset Analyses 
For descriptive purposes, Chi-square tests examined differences in proportions of 





meeting PA guidelines between datasets. For significant Chi-square tests, Z tests were 
calculated for column proportions for each row in the Chi-square contingency table and 
adjusted using a Bonferroni correction to provide further detail regarding PA and 
depression across the different levels of covariates.39 Within each dataset, binomial 
logistic regression quantified crude and adjusted associations between PA and elevated 
depressive symptoms. Covariates in adjusted models were age, sex, and BMI.  
Integrated Dataset Analysis 
Chi-square tests examined differences in elevated depressive symptom status, age 
categories, sex, and BMI categories, between individuals meeting and not meeting PA 
guidelines. Binomial logistic regression quantified crude and adjusted associations 
between PA and elevated depressive symptom status. Covariates in adjusted models were 
age, sex, BMI, and dataset. Likelihood ratio tests examined covariate significance. One-
way ANOVAs followed by Bonferroni-corrected post-hoc tests quantified differences in 
depressive symptoms between those meeting and not meeting PA guidelines, PA tertiles, 
and sexes. Hedges’ g effect sizes and associated 95% confidence intervals (95%CI) were 
calculated to quantify the magnitude of differences in depressive symptom scores 
between meeting PA guidelines, PA tertiles, and sexes.40 Effect sizes of 0.2, 0.5, and 0.8 
can been used as cut-offs for small, medium, and large effects, respectively.41 
Results 
A total of 10,133 and 7,809 respondents were included in crude and adjusted analyses, 
respectively. The overall prevalence of elevated depressive symptoms was 10.9%. 
Females were more likely to report elevated depressive symptoms (χ2 (1, 





higher depressive symptoms (7.11±7.87) than men (5.74±6.86; F(1,10131)=84.59, p<0.001; 
g=0.18; 95%CI: 0.15 to 0.22). 
Participant Characteristics Within Datasets 
Harmonised data characteristics are presented in Table 2. Elevated depressive symptom 
status (χ2 (1, N=10,133)=65.79, p<0.001), meeting PA guidelines (χ2 (1, 
N=10,133)=156.61, p<0.001), sex (χ2 (2, N=10,133)=11.57, p<0.001), and age (χ2 (4, 
N=10,122)=664.55, p<0.001 were significantly different between studies. Results from 
follow-up Z tests are shown in Table 2. Briefly, a significantly greater proportion of 
Mitchelstown participants reported elevated depressive symptoms, did not meet PA 
guidelines, and were aged 50-59 years and male (all p<0.05). 
Within Dataset Analyses 
Table 3 presents crude and adjusted odds ratios for the associations between meeting PA 
guidelines and PA tertiles, and elevated depressive symptoms within each dataset. 
Significant crude associations remained robust following adjustment for age, sex, and 
BMI. Meeting PA guidelines was associated with 49.8% (95% CI: 39.2 to 58.5; p<0.001) 
and 27.8% (95% CI: 2.8 to 46.4; p<0.05) lower odds of elevated depressive symptoms in 
TILDA and Mitchelstown, respectively. 
Similar to crude associations, following adjustment for age, sex, and BMI, the middle PA 
tertile was associated with 26.4% (95% CI: 7.4 to 41.5; p≤0.001) and 30.2% (95% CI: -
0.5 to 51.5; p>0.05) lower odds of elevated depressive symptoms in TILDA and 
Mitchelstown, respectively; the high PA tertile was associated with 54.6% (95% CI: 43.3 
to 63.6; p<0.001) and 38.5% (95% CI: 11.2 to 57.4; p<0.01) lower odds of elevated 





Participant Characteristics Across Integrated Dataset 
Participant characteristics by PA guideline adherence in the integrated dataset are 
presented in Table 4. Elevated depressive symptom status (χ2 (1, N=10133)=94.60, 
p<0.001), sex (χ2 (1, N=10133) = 243.30, p<0.001), age (χ2 (4, N=10122)=168.63, 
p<0.001), and BMI (χ2 (3, N=7818)=22.03, p<0.001) significantly differed between 
meeting and not meeting PA guidelines. Briefly, people not meeting PA guidelines were 
significantly more likely to report elevated depressive symptoms and be female, aged 70-
79 or ≥80 years, and obese (all p<0.05).  
Integrated Dataset Analyses 
Table 3 presents crude and adjusted odds ratios for the associations between meeting PA 
guidelines and PA tertiles, and elevated depressive symptoms across the integrated 
dataset. Odds ratios for covariates in adjusted analyses are reported in Supplementary 
Table 1. Significant crude associations remained robust following adjustment for age, 
sex, BMI, and dataset. Compared to not meeting PA guidelines, meeting the guidelines 
was associated with 44.3% (95% CI: 34.5 to 52.6; p<0.001) lower odds of elevated 
depressive symptoms. Age, sex, and BMI were significant covariates (all p<0.005). 
Significant crude associations remained robust following adjustment for age, sex, BMI, 
and dataset. The middle and high PA tertiles were associated with 26.4% (95% CI: 10.7 
to 39.4; p<0.01) and 51.1% (95% CI: 40.9 to 59.6; p<0.001) lower odds of elevated 
depressive symptoms, respectively. Age, sex, and BMI were significant covariates (all 
p<0.05). 
Depressive symptoms were significantly higher among people not meeting MVPA 





p<0.001; g=0.28; 95%CI: 0.25 to 0.32). Depressive symptoms significantly differed by 
PA tertile (p<0.001). Post-hoc tests showed significantly lower depressive symptoms for 
the high PA tertile (5.05±6.53) compared to the low (7.60±8.03, p<0.001; g=0.34 95%CI: 
0.30 to 0.39) and middle (6.16±6.99, p<0.001; g=0.17; 95%CI: 0.11 to 0.22) PA tertiles. 
The middle PA tertile also reported significantly lower depressive symptoms than the low 
PA tertile (p<0.001; g=0.19; 95%CI: 0.13 to 0.24). 
Discussion 
Using secondary analyses of pooled data from large-scale Irish studies, this work 
contributes to deepen the knowledge on the association between meeting PA guidelines 
and elevated depressive symptoms, and a potential dose-response in the PA-depression 
relationship, in a European country. A previous umbrella systematic review of 
psychological determinants of PA across the life course highlighted that the negative 
association between PA and depression/depressive symptoms' presents limited and no 
conclusive evidence.42 The present study supports associations between meeting PA 
guidelines and lower odds of depression, and a dose response in the PA-depression 
relationship. 
Approximately 10.9% of the current sample reported elevated depressive symptoms, 
supporting previous findings in worldwide2 and Irish43 samples. Females were 
significantly more likely to report higher depressive symptoms (g=0.18), which is 
consistent with previous evidence.44 Adjusted analyses, both within and across datasets, 
support the association between not meeting MVPA guidelines and elevated depressive 
symptoms, consistent with previous findings regarding the beneficial effects of meeting 





depressive symptoms among people meeting MVPA guidelines is consistent with 
previous findings.9, 45 
A potential dose–response relationship was observed in the present study. Compared to 
the low PA tertile, the middle and high PA tertiles were associated with 26% and 51% 
lower odds of elevated depressive symptoms, respectively, such that participation in the 
highest volume of MVPA appeared to confer more benefits than a more moderate volume. 
Previous findings are limited and contradictory, and a clear dose–response relationship 
between PA and depression has not been readily apparent.13, 15 Research by Dunn et al 
(2005)46 observed similar findings to ours in that significantly lower post-intervention 
depression scores among adults with mild to moderate major depressive disorder whose 
total energy expenditure was 17.5 kcal/kg/week for 12-weeks compared to those whose 
total energy expenditure was 7.0 kcal/kg/week.46 Further, those who routinely engage in 
higher levels of PA have been shown to respond better to depression treatment than those 
who are less active.15 Collectively, these findings support the need to engage in at least a 
moderate level of PA, with the potential for increased benefits with increased PA.  
Although not examined in the present study, there is also evidence to suggest that 
compared to engaging in no PA, engaging in volumes of MVPA less than recommended 
levels,13 and increasing levels of light intensity PA,47 may also protect against depression. 
This may have important public health implications as, although the current study 
strongly supports the benefits of meeting PA guidelines, the wider research appears to 
indicate that any amount of PA is better than none. 
The iterative steps for effective retrospective data harmonisation published by Fortier and 
colleagues (2017)24 underpinned the harmonisation process within this study (e.g. 





valid data input, etc.). In concordance with an effective data harmonisation process, the 
dataset owners were involved from an early stage and access to detailed information on 
the data collection procedures adopted by the two studies included was available. The 
implementation of such methodological rigour optimised the quality of the harmonisation 
process and, thereby the quality and scientific utility of the final database generated. 
Strengths and Limitations 
The present study benefits from a large sample size, a PA measure that measured 
important components of PA, such as frequency, duration, and intensity of PA, direct 
examination of meeting PA guidelines, and following rigorous harmonisation procedures. 
However, several limitations exist. There is the possibility of differences in sampling 
methodology across studies, while some differences between studies can be impossible 
to reconcile. For example, including other lifestyle and health behaviours, socio-
economic status, and social support as covariates may influence the association between 
PA level and depression, yet differences in how they were measured made it impossible 
to include it as a covariate in the present analyses. Because of this, the field will benefit 
from a more standardised set of measurements across studies. Over-reporting of PA is 
frequently encountered in epidemiological research partly due to influences such as social 
desirability and recall bias48 and may have led to respondents being misclassified as 
meeting PA guidelines in the present study; however, there is no evidence to suggest that 
reporting error should differ according to mental health status. Finally, due to the cross-
sectional design of this study, causation cannot be deduced. Nonetheless, the current 
findings are to the authors’ knowledge the first to provide support for the benefits of PA 






Inverse associations between meeting PA guidelines and odds of reporting elevated 
depressive symptoms were observed, with stronger associations observed with increased 
volumes of MVPA. Future prospective cohort studies should examine this potential dose-
response relationship and focus on potential moderators and mediators of the association 
between PA and depression in large, European-based samples. Further, more large-scale 
prospective studies in large European-based samples using objective measure of PA are 
required to establish cause and effect and to further elucidate the role of potential 
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Table 2. Study characteristics 
 TILDA  Mitchelstown 
MVPA (minutes (median IQR)) 90.00 (600.00) 0.00 (180.00) 
PA (n (%))   
Not Meeting PA guidelines 4471 (53.78) 1259 (69.0) 
Meeting PA guidelines 3858 (46.3) 545 (30.2) 
Depressive symptom status (n (%))   
Not Depressed 7522 (90.3) 1511 (83.8) 
Depressed 807 (9.7) 293 (16.2) 
Age (n (%))   
<50 327 (3.9)a 2 (0.1)b 
50-59 3210 (38.6)a 973 (53.9)b 
60-69 2540 (30.5)a 801 (44.4)b 
70-79 1636 (19.7)a 28 (1.6)b 
80+ 605 (7.3)a 0 (0.0)b 
Sex (n (%))   
Male 3706 (44.5)a 882 (48.9)b 
Female 4623 (55.5)a 922 (51.1)b 
BMI (n (%))   
Underweight 32 (0.5) 7 (0.4) 
Normal 1353 (22.5) 401 (22.1) 
Overweight 2576 (42.8) 821 (45.3) 
Obese 2056 (34.2) 584 (32.2) 
Different subscript letters indicate a subset of each category whose column proportions  
differ statistically significantly at the .05 level 
Abbreviations: BMI= Body Mass Index; MVPA= Moderate-to-vigorous physical 







Table 3. Odds ratios (OR) and 95% confidence intervals (CI) derived from binominal 
logistic regression analyses as indicators of association between physical activity (PA) 










Crude     
PA Guidelines     
Not Meeting PA 
guidelines 




0.509 (0.436 to 
0.594) 
0.685 (0.512 to 
0.915) 
0.514 (0.449 to 
0.589) 
 
     
Adjusted     
PA Guidelines     
Not Meeting PA 
guidelines 




0.502 (0.415 to 
0.608) 
0.722 (0.536 to 
0.972) 
0.557 (0.474 to 
0.655) 
 
     
Crude     
PA Tertiles     
Low PA Tertile REF REF REF  
Middle PA Tertile 
0.681 (0.560 to 
0.829) 
0.704 (0.492 to 
1.008) 
0.663 (0.558 to 
0.787) 
 
High PA Tertile 
0.469 (0.393 to 
0.559) 
0.561 (0.393 to 
0.803) 
0.455 (0.389 to 
0.532) 
 
     
Adjusted     
PA Tertiles     
Low PA Tertile REF REF REF  
Middle PA Tertile 
0.736 (0.585 to 
0.926) 
0.698 (0.485 to 
1.005) 
0.736 (0.606 to 
0.893) 
 
High PA Tertile 
0.454 (0.364 to 
0.567) 
0.615 (0.426 to 
0.888) 
0.489 (0.404 to 
0.591) 
 
Adjusted ORs adjusted for age, sex, and BMI (and dataset for integrated dataset 
analyses) 
Abbreviations: PA=Physical activity; REF=Reference category; TILDA=The Irish 







Table 4. Participant characteristics 
 
Meeting PA Guidelines 
(n (%)) 






Depressed 327 (7.4) 773 (13.5) 
Not depressed 4076 (92.6) 4957 (86.5) 
Age (years)   
<50 175 (4.0)a 154 (2.7)b 
50-59 1987 (45.2)a 2196 (38.4)b 
60-69 1482 (33.7)a 1859 (32.5)a 
70-79 609 (13.9)a 1055 (18.4)b 
80+ 144 (3.3)a 461 (8.1)b 
Sex   
Male 2381 (54.1) 2207 (38.5) 
Female 2022 (45.9) 3523 (61.5) 
BMI   
Underweight 15 (0.4)a 24 (0.6)a 
Normal 787 (22.7)a 966 (22.2)a 
Overweight 1589 (45.8)a 1802 (41.4)b 
Obese 1078 (31.1)a 1557 (35.8)b 
Different subscript letters indicate a subset of each category whose column proportions 
differ statistically significantly at the .05 level. 
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Significance: This is just the third study to examine associations of meeting WHO 
physical activity recommendations with onset of depression, and the first to include males 
and older adults. Furthermore, this study rigorously examines a potential dose-response 
between physical activity and onset of depression. Meeting the recommendations was 
associated with 22.6% lower odds of depression and, as in the meta-analysis, a dose-







Depression and depressive symptoms are recognized by the World Health Organization 
(WHO) as one of the greatest contributors to overall global disease burden, affecting over 
an estimated 300 million people worldwide.1 The 12-month prevalence of major 
depressive disorder (MDD) is highest among those aged 18-64 years, but approximately 
2.3% of people aged ≥65years experience MDD in a 12-month period.2 Among older 
adults depression is associated with increased risk of frailty,3 morbidity, and suicide,4 and 
decreased physical, social, and cognitive functioning.5 Moreover, the financial burden 
associated with depression continues to grow, accounting for at least 1% of the total 
European economy.6 As health services continue to adapt and respond to the implications 
of an aging population within the European Union, research into health promotion and 
disease prevention in older populations is required.7 
Despite this, evidence has shown that many people with mood disorders do not seek 
treatment.8 Studies show that among those that do, delays can range from six to eight 
years,9 many do not have their needs met by evidence-based treatment,10 and depression 
can persist in approximately 67% after first-line treatment11 and at least 30% can remain 
depressed even after four rounds of distinct treatments.12 A recent umbrella review 
examined potential environmental risk factors for depression, finding that, despite the 
large number of putative risk factors investigated in the literature, few associations are 
supported by robust evidence.13 The factors with the most convincing evidence were 
largely stressors, such as children exposed to physical abuse, military personnel exposed 
to combat, recently widowed adults, obese individuals, and people with 4–5 five 





depression and the healthful behaviours that may attenuate those risk factors to better 
inform interventions for prevention and treatment.  
A recent meta-analysis reviewed twenty-two prospective cohort studies in older adults 
that largely support the protective effects of PA on depression, with all except for one14 
reporting reductions in incident depression.15 However, just six studies used validated 
instruments to measure PA dose (i.e., a product of PA duration and intensity).16-21 
Available evidence suggests that meeting WHO recommended PA levels22 may protect 
against other mental health outcomes such as generalized anxiety disorder which is highly 
comorbid with depression23 and convey additional benefit for depressive symptoms. For 
example, depressive symptom reductions following exercise training were significantly 
larger among chronically-ill patients who were meeting recommended PA levels24 and 
recent evidence showed significantly larger improvements in depressive symptoms 
following internet-based cognitive behavioural therapy and usual care among depressed 
patients engaging in PA levels that corresponded to consensus recommendations for 
maximizing general health.24, 25 Further, people with major depression are less likely to 
meet recommended levels of PA26 which is a particular worry given that depression is 
associated with increased risk of cardiovascular disease (CVD) and death from CVD27 
and the well-established role of PA in protecting against CVD. Despite this, of the six 
prospective-cohort studies that measured PA dose, none examined the benefits of meeting 
WHO guidelines. This information is important for clinical practice and public health 
recommendations. 
Therefore, the present study used data from two waves of The Irish Longitudinal Study 
of Ageing (TILDA) to examine associations between: 1) meeting PA guidelines, 2) 





incident depressive symptoms and status, both within age and sex categories, and across 
the total population. 
Methods 
This study used STROBE recommendations to guide reporting.28 
Study Population 
TILDA is an ongoing cohort study that contains a nationally representative sample of 
community dwelling adults aged ≥50 years, and their partners of any age, resident in the 
Republic of Ireland. An initial multi-stage probability sample of addresses was chosen by 
means of the RANSAM sampling procedure,29 with District Electoral Divisions selected 
at the first stage and household addresses selected at the second stage. The response rate 
was 62.0%. Participants gave full informed consent to participate in the study and ethical 
approval was obtained from the Trinity College Dublin Faculty of Health Sciences 
Research Ethics Committee. For the present analyses we report data from Wave 1 (2009-
2010)30 and Wave 2 (2012-2013).31 PA and depression data at Waves 1 and 2 were 
available for 6,977 respondents. Following exclusion of participants with incomplete 
covariate data (n=2,416), the final sample size for the current study consisted of 4,556 
individuals (56.7% female). Respondents who reported depression at baseline (n=415) 
were excluded from longitudinal analyses, leaving a sample of 4,146. 
Study Measures 
Physical Activity 
PA was measured using the short-form International Physical Activity Questionnaire 





16hrs/day were excluded (n=11). The remaining respondents were classified as meeting 
PA guidelines (i.e., reporting ≥150 minutes weekly of MVPA, ≥75 minutes weekly of 
vigorous PA, ≥600 MET.minutes weekly). Three dose categories, Low (0 to <600 
MET.minutes weekly), Moderate (600 to <1,200 MET.minutes weekly), or High (≥1,200 
MET.minutes weekly).22 Weekly minutes of walking were divided into tertiles (i.e., 0-
110 minutes, 120-400 minutes, 420+ minutes). 
Depression 
At Waves 1 and 2, depression symptoms were assessed using the Center for 
Epidemiological Studies Depression Scale (CES-D).33 Reliability coefficients of the 
CES-D are high (0.85-0.91) among older adults.34 We used a score of ≥16 to define 
caseness of depression.33 Respondents above this cut-off score are referred to as depressed 
throughout the current manuscript; however, they are at increased risk of depression but 
do not have clinically diagnosed depression. This cut-score demonstrates 100% 
sensitivity and 87.6% specificity in older populations.35 Positive predictive values can be 
low (13.2%) and negative predictive values can be high (99–100%).35  
Covariates 
Age was divided into four categories (i.e., 50-59yrs, 60-69yrs, 70-79yrs, and 80+yrs). 
Waist circumference was classified as low- or increased-risk according to WHO 
guidelines (i.e., Males: >94cm; Females >80cm).36, 37 Social class was defined according 
to the European Socioeconomic Classification (ESeC) scheme.38 The ESeC classifies 
people into seven categories according to their positions within labour markets and with 
special attention to their employment relations. In order to improve sample coverage, 
those who were not in paid employment were allocated to a “Not Working” group 





smoker. Participants reported whether a doctor had ever told them that they have angina, 
asthma, cancer/a malignant tumour, diabetes/high blood sugar, hypertension, 
osteoporosis, or a stroke. The number of these comorbidities was summed. 
Statistical Analysis 
Statistical analyses were conducted using SPSS Version 22.0 (Armonk, NY: IBM Corp.). 
Chi-square tests examined differences in meeting PA guidelines, depression, sex, age, 
waist circumference, social class, and smoking categories between those included and 
excluded from analyses (i.e., those with complete IPAQ-SF (Wave 1) and CES-D (Waves 
1 and 2) data but missing covariate data). Chi-square tests examined differences in sex, 
age, waist circumference, social class, and smoking categories between those with and 
without depression. For significant Chi-square tests, Z tests were calculated for column 
proportions for each row in the Chi-square contingency table and adjusted using a 
Bonferroni correction.39 
Cross-Sectional and Longitudinal Walking, PA Guidelines, and Dose Categories Analyses 
One-way ANOVAs and Fisher’s LSD planned contrasts quantified differences in Waves 
1 and 2 depressive symptoms between those meeting and not meeting PA guidelines, dose 
categories, and walking tertiles. Hedges’ g effect sizes and associated 95% confidence 
intervals (95%CI) were calculated to quantify the magnitude of differences in depressive 
scores.40 
Binomial logistic regression quantified associations (i.e., odds ratios (ORs)) between 
meeting PA guidelines, dose categories, and walking tertiles, and depression status at 
Waves 1 and 2 within age and sex categories, and the total population. Covariates in 





class, and smoking status (Model 2). The Hosmer-Lemeshow test was performed and 
Nagelkerke R2 calculated to assess the goodness-of-fit of the model. Likelihood ratio tests 
examined covariate significance. Supplementary tables 1 and 2 provide the proportion of 
people with depression by levels of PA and walking and significant covariates at Waves 
1 and 2 respectively. 
Results 
Participant Characteristics 
Compared to the analytic sample, a significantly greater proportion of excluded 
respondents were aged 80+ years (7.5% vs 5.6%), male (46.9% vs 43.3%), and current 
smokers (20.7% vs 15.3%; all p<0.05). There were no significant differences in waist 
circumference, depression, or PA. Wave 1 participant characteristics are presented in 
Table 1. Sex (p<0.01), age (p<0.001), social class (p<0.001), and smoking status 
(p<0.001) significantly differed according to depression, and waist circumference did not 
(p>0.64). Briefly, a greater proportion of respondents with depression were aged 80+ 
years (5.9% vs 2.9%), female (70.2% vs 55.4%) and current smokers (27.8% vs 14.1%; 
all p<0.05). The prevalence of depression was 9.0% (n=410), and the incidence rate was 
5.0% (n=207).  
Cross-sectional Associations Between Meeting PA Guidelines and Depression 
Depressive symptoms were significantly higher among people not meeting PA guidelines 
than those meeting PA guidelines (F(1,4554)=74.83, p<0.001; g=0.26; 95%CI: 0.20 to 0.31).  
In Model 2, meeting PA guidelines was significantly associated with 39.7% (95%CI: 24.3 





(χ2(8)=11.78, p=0.16; R2=0.16). Age, sex, social class, smoking status, and number of 
comorbidities were significant covariates (all p<0.03). 
Cross-sectional Associations Between Dose Categories and Depression 
Planned contrasts showed significantly lower depressive symptoms for the High category 
compared to Low (p<0.001; g=0.27: 0.21 to 0.33) and Moderate (p=0.042; g=0.14: 0.02 
to 0.26), and significantly lower depressive symptoms for the Moderate category 
compared to Low (p=0.013; g=0.14: 0.12 to 0.26). 
In Model 2, the Moderate category was non-significantly, and High category 
significantly, associated with 33.1% (-20.7% to 51.0%; p=0.25) and 42.6% (26.7% to 
45.0%; p<0.001) lower odds of depression, respectively (Table 2). The model fit the data 
well (χ2(8)=11.12, p=0.20; R2=0.16). Age, sex, social class, smoking status, and number 
of comorbidities were significant covariates (all p<0.02). 
Cross-sectional Associations between Walking and Depression 
Planned contrasts showed significantly lower depression for the high tertile compared to 
the low (p<0.001; g=0.24: 0.17 to 0.32) and moderate (p=0.01; g=0.10: 0.03 to 0.16) 
tertiles, and significantly lower depressive symptoms for the moderate compared to the 
low (p<0.001; g=0.15: 0.08 to 0.22) tertile. 
In Model 2, moderate walking was non-significantly, and high walking significantly, 
associated with 21.8% (-0.6% to 39.2%; p=0.056) and 44.0% (26.1% to 57.6%; p<0.001) 
lower odds of depression, respectively (Table 2). The model fit the data well (χ2(8)=11.30, 
p=0.19; R2=0.15). Age, sex, social class, smoking status, and number of comorbidities 





Longitudinal Associations between Meeting PA Guidelines and Depression 
Depressive symptoms were significantly higher among people not meeting PA guidelines 
than those meeting PA guidelines (F(1,4144)=17.46, p<0.001; g=0.13: 0.07 to 0.19).  
In Model 2, meeting PA guidelines was non-significantly associated with 22.6% (-3.9% 
to 42.4%; p=0.09) reduced odds of depression (Table 3). The model fit the data well 
(χ2(8)=2.31, p=0.97; R2=0.06). Sex, social class, smoking, and number of comorbidities 
were significant covariates (all p<0.03). 
Longitudinal Associations between Dose Categories and Depression 
Planned contrasts showed significantly lower depressive symptoms for the High category 
compared to Low (p<0.001; g=0.13: 0.07 to 0.19) but not Moderate (p=0.85; g=0.12: -
0.01 to 0.24) , and non-significantly lower depressive symptoms for Moderate compared 
to Low (p=0.058; g=0.01: -0.11 to 0.14). 
In Model 2, the Moderate and High categories were non-significantly associated with 
37.3% (-21.8% to 67.7%; p=0.17) and 20.0% (-8.8% to 41.2%; p=0.16) reduced odds of 
depression, respectively (Table 3). The model fit the data well (χ2(8)=3.46, p=0.90; 
R2=0.06). Sex, social class, smoking, and number of comorbidities were significant 
covariates (all p<0.02). 
Longitudinal Associations Between Walking and Depression 
Planned contrasts showed significantly lower depressive symptoms for the high (p<0.001; 
g=0.15: 0.07 to 0.23) and moderate (p=0.03; g=0.08: 0.01 to 0.16) tertiles compared to 
the low, and non-significantly lower depressive symptoms for the high compared to the 





In Model 2, moderate and high walking were non-significantly associated with 20.7% (-
12.2% to 43.9%; p=0.19) and 25.1% (-7.0% to 47.6%; p=0.11) lower odds of depression, 
respectively (Table 3). The model fit the data well (χ2(8)=6.25, p=0.62; R2=0.06). Sex, 
social class, smoking status, and number of comorbidities were significant covariates (all 
p<0.02). 
Discussion 
In the current large, nationally-representative cohort of older adults, meeting PA 
guidelines was significantly associated with 40% lower odds of prevalent depression, and 
non-significantly associated with approximately 23% reduced odds of incident 
depression. Results did not support a dose-response for MVPA and depression. Rather, a 
37% reduction in odds of incident depression was observed for moderate volumes of 
MVPA, and a reduction of 20% was observed for high volumes of MVPA. Furthermore, 
walking was significantly associated with lower odds of prevalent depression, with a 
larger effect observed with more time spent walking. Associations of walking with 
prevalent depression were non-significant but indicate a potential 25% reduced odds of 
incident depression across both levels of walking. To the authors’ knowledge, this is the 
first prospective cohort study to examine the protective effect of meeting MVPA 
guidelines, and different volumes of walking, on depression among a sample of older 
adults.  
The present findings demonstrate the potential benefits of meeting PA guidelines for 
reduced risk of depression in addition to previously established reduced risk of mortality41 
and increased healthy ageing.42 Older adults who met PA guidelines were 40% less likely 
to report concurrent depression and 23% less likely to develop depression two years later. 





not meet PA guidelines.43 This is particularly concerning given the ageing population 
within Europe, and the considerable burden of depressive illness. The present findings 
reiterate the necessity to promote meeting, and where appropriate exceeding, 
recommended PA levels at the population-level. 
A dose-response between MVPA and prevalent depression was observed, but not between 
MVPA and incident depression. Compared to inactive older adults, those who engaged 
in Moderate and High activity were 23% and 43% less likely to report concurrent 
depression, respectively, and 37% and 20% less likely to develop new depression two 
years later, respectively. This difference in prospective associations may be driven by 
sex-related differences as, amongst females, Moderate volumes of MVPA exhibited 
greater protective effects than High (31% vs 13%), while there was a relatively smaller 
difference between volumes among males (47% vs 31%). This supports previous findings 
in a smaller sample of elderly Koreans, which found larger effects for mild PA than 
above-moderate, in addition to larger effects overall.16 Similarly, exercise performed at 
either light, moderate, or vigorous intensities have been shown to be equally effective at 
reducing depressive symptoms among people with mild-to-moderate depression.44 Dose-
responses have previously been observed among older females from the Nurses’ Health 
Study,45 and adolescents from The Youth and Mental Health Study,46 although these 
analyses were based on weekly hours of MVPA rather than MVPA volume. Collectively, 
these findings appear to support a potential lower threshold volume for similar benefits 
among males, and a larger protective effect for moderate volumes of MVPA among 
females. 
A non-significant protective effect of walking on the development of subsequent 





to be a threshold effect, with similar effects for those in the moderate (21%) and high 
(25%) tertiles compared to the low tertile. However, when examined within sexes, the 
high tertile (37%) exhibited greater effects than the moderate (12%) among males, while 
the opposite was observed among females (16% vs 26%). Similarly, those in the oldest 
age category appear to derive the greatest benefits from moderate amounts of walking. 
The protective effect of walking on the development of incident depression has previously 
been reported in The Honolulu-Asia Aging Study.47 However, in this all-male sample, a 
threshold effect was observed, with only slight differences between those in intermediate- 
and high-walking-distance groups. Harvey et al (2017)48 also reported that any level of 
PA, even low levels, can be protective against depression, and light PA has been shown 
to be associated with lower depression levels49 and protective of future cognitive ability 
in older adults, irrespective of MVPA levels.50 If future prospective cohort studies or 
randomized controlled trials corroborate these and the current findings, then promotion 
of lighter-intensity and lower volumes of PA among older adults may be more practical, 
as their ability and desire to engage in higher intensity PA can be limited by the ageing 
process. 
Although the examination of plausible mechanisms of the association between PA and 
depression was not the purpose of the current investigation, the available evidence has 
provided some support for several psychological and biological mechanisms that may 
underlie these associations. Briefly, exercise training has brain monoaminergic51, 52 and 
neurotrophic53, 54 effects, and may reduce inflammatory and oxidant markers.55 Further, 
physical activity may be associated with depression through psychological factors such 






The main limitation of the current study is the use of self-reported PA and depressive 
symptoms, predisposing the results to over-reporting or under-reporting. Future studies 
would benefit from objective PA measurement which can indicate both activity duration 
and intensity, such as GPS or accelerometery-based measurements, and more direct 
measures of depression, such as physician diagnosis. Secondly, despite the prospective 
design, causality cannot be inferred from these results. Undoubtedly, depression can lead 
to less PA and vice versa. Nonetheless, the present study included a large sample size, a 
PA measure that measured important components of PA, and direct examination of the 
protective effect of meeting MVPA guidelines, differing volumes of MVPA, and walking 
on depression. 
Future recommendations 
Given the potential increased practicality of walking among older adults, future 
prospective cohort studies or randomized controlled trials should corroborate the present 
findings on the protective effect of walking. Secondly, recent evidence has shown that 
people with MDD engage in higher levels of sedentary behaviour58 and that cross-
sectionally sedentary behaviour is positively associated with depression.59 The influence 
of sedentary behaviour on mental health remains relatively understudied, and research to 
further explore these associations is warranted. Finally, as older adults with pain are less 
physically active than asymptomatic controls,60 and pain is associated with poorer mental 
health,61, 62 the potential moderating/mediating role of pain in the PA-depression 






The present study supports previous research on the protective benefits of PA for 
depression among older adults, and suggests that meeting WHO recommended PA levels 
is could be recommended in order to prevent the onset of depression. Although there is 
no apparent additional benefits for depression to exceeding this dose in the present study, 
additional health benefits to exceeding this dose have previously been identified. Future 
research should focus on associations of depression and volumes of PA less than PA 










(n (%) or mean±SD) 
Probable Depression 
(n=410) 
(n (%) or mean±SD) 
CES-D score 3.97±3.96 23.23±7.29 
Walking (hrs.wk-1) 6.32±7.48 4.78±6.93 
MVPA (hrs.wk-1) 8.13±13.20 9.52±4.44 
Meeting PA guidelines   
Yes 2063b (50.2) 134a (32.7) 
No 2083b (49.8) 276a (67.3) 
Sex   
Female 1851b (44.6) 288a (70.2) 
Male 2295b (55.4) 122a (29.8) 
Age category (yrs)   
50-59 1640b (39.6) 194a (47.3) 
60-69 1438a (34.7) 133a (32.4) 
70-79 825a (19.9) 71a (17.3) 
80+ 243b (5.9) 12a (2.9) 
Waist circumference   
Normal 1993 (48.1) 202 (49.3) 
At risk 2153 (51.9) 208 (50.7) 
Social class   
Professional Workers 176b (4.2) 6a (4.0) 
Managerial and Technical 1079b (26.0) 55a (13.4) 
Non-manual 629b (15.2) 43a (14.7) 
Skilled Manual 412a (9.9) 33a (9.8) 
Semi-skilled 409a (9.9) 44a (9.9) 
Unskilled 116a (2.8) 18a (2.9) 
Farmers 278b (6.7) 8a (6.3) 
Not Working 1047b (25.3) 203a (27.4) 
Smoking status   
Current 585b (14.1) 296a (72.2) 
Past/never 3561b (85.9) 114a (27.8) 
Number of comorbidities 0.47±0.73 1.06±1.07 
Different subscript letters indicate a subset of each category whose column proportions 
differ statistically significantly at the .05 level. 
Abbreviations: hrs: hours; mins: minutes; MVPA: moderate-to-vigorous physical 






Table 2. Odds ratios (OR) and 95% confidence intervals (CI) derived from binominal 
logistic regression analyses as indicators of cross-sectional associations between physical 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3. Odds ratios (OR) and 95% confidence intervals (CI) derived from binominal 
logistic regression analyses as indicators of prospective associations between physical 
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Relevance: This systematic review and meta-analysis of prospective cohort studies 
examined longitudinal associations of physical activity with any subsequent anxiety 
outcome (i.e., self-reported symptoms or a diagnosed disorder). Importantly, it informed 
the subsequent work undertaken for this dissertation (i.e., Manuscripts Five, Six, and 
Seven) by highlighting the dearth of research examining associations of meeting WHO 
physical activity recommendations with incident anxiety and GAD, and a potential dose-
response in associations of physical activity with anxiety and GAD using well designed 
studies with a physical activity measure capable of calculating volume. 
Significance: This paper quantitatively synthesised reported longitudinal associations of 
physical activity with anxiety symptoms, a diagnosis of any anxiety disorder, and a 
diagnosis of GAD, and qualitatively reviewed the included 24 studies of over 80,000 
unique individuals. It is the first systematic review and meta-analysis on this topic. Odds 





(0.6626, 0.5337-0.8227; n=3), and generalised anxiety disorder specifically (0.5438, 







Anxiety disorders are consistently the most prevalent class of mental disorders in the 
general population,1 and are the sixth leading cause of years lived with disability.2 There 
is robust epidemiological and clinical evidence to support associations between anxiety 
disorders and chronic medical conditions, such as irritable bowel syndrome, asthma, 
cancer, chronic pain, and cardiovascular disease, and associated premature mortality.3, 4 
In 2010, the 12-month prevalence of any ICD-10 anxiety disorder was 13.4% in Europe 
(69.1 million people), costing over €74 billion,5 and 22% for any DSM-V anxiety disorder 
in the US.6 Findings from several national and international studies have shown the 
profound economic and societal impacts of anxiety disorders.7-9 
Frontline treatments for anxiety disorders include antidepressants, such as selective 
serotonin reuptake inhibitors (SSRIs), and cognitive behavioural therapy (CBT).10, 11 
However, SSRIs can have negative side-effects, such as increased weight gain12 and 
suicidality and aggression.13 CBT has been only moderately efficacious, with the need 
for more effective treatments identified.10 Further, the number of individuals seeking care 
can be low, as the symptoms associated with anxiety disorders are commonly interpreted 
as normal responses to social adversity, and rigorous biomedical causal models are 
scarce.14 Given the prevalence and individual and economic burden of anxiety disorders, 
and that treatments are often inadequate, strategies that facilitate the prevention of anxiety 
are needed. 
One such strategy is physical activity (i.e., movement that is carried out by the skeletal 
muscles that results in energy expenditure).15 Experimental evidence has shown that 
exercise (i.e., planned, structured, and repetitive movement intended to improve or 





in people with16-18 and without19-21 anxiety disorders, including those with chronic 
illnesses.22  
Whether physical activity can help prevent anxiety is less clear. Cross-sectional evidence 
supports inverse associations between physical activity and anxiety symptoms23 and 
disorders.24 However, population-based evidence of a prospective association between 
physical activity and incident anxiety disorders or elevated symptoms has not been 
synthesized. 
Therefore, this review had three primary aims to: (1) synthesise the available literature, 
(2) assess limitations in this research, and (3) make recommendations for future research. 
As there are few studies with diverse samples and outcome measures, meta-analysis 
quantified associations of physical activity with anxiety across studies of similar samples 
(i.e., adults vs. adolescents) and outcome measures (i.e., self-reported anxiety symptoms 
vs. a clinical diagnosis/self-reported clinical diagnosis). Meta-analytic findings were 
elaborated with a critical narrative review of all studies.  
Methods 
This systematic review and meta-regression analysis adhered to the Meta-analysis Of 
Observational Studies in Epidemiology guidelines.25 
Data Sources and Searches 
Articles published from database inception to June, 2018 were located by two authors 
(CMcD & MPH) using MEDLINE, PsycINFO, PsycARTICLES, and CINAHL 
Complete. Keywords used were “physical activity” or “leisure time” or “exercise” or 
“sport*” and “anxiety” or “GAD” or “panic” or “phobia” and “association” or “follow-





“longitudinal.” Supplemental searches of articles citing and cited by included studies and 
relevant review articles were performed manually in Google Scholar.  
Study Selection 
Inclusion criteria were: (1) physical activity defined by a customary feature and measured 
at baseline by self-report questionnaire, interview, or an objective device and (2) anxiety 
symptoms or disorder subsequently measured at a defined follow-up assessment by self-
reported physician diagnosis, clinical diagnosis, diagnosis using diagnostic interviews 
(e.g., instruments using DSM26 or ICD27 criteria), or established cut-offs and/or 
continuous scores of anxiety screening instruments. Articles were excluded that: (1) 
included a sample solely of people with elevated anxiety symptoms or an anxiety disorder 
at baseline, (2) had an outcome of diagnosed obsessive-compulsive disorder or post-
traumatic stress disorder, which are not currently defined as an anxiety disorder,26 (3) 
used an ill-defined measure of physical activity exposure,28 and (4) had a follow-up period 
from baseline less than one year. eFigure 1 in the Supplement provides a flowchart of 
article inclusion and exclusion. 
Data Extraction  
Data on geographical location, follow-up timeframe, number of participants included in 
analyses, participants’ age and sex, anxiety measure, study design, physical activity 
measure, and physical activity dose were extracted. For studies included in the meta-
analysis, ORs and 95% confidence intervals (CIs) or relevant data to be converted to ORs 
as detailed below were extracted. The ORs for the largest doses of physical activity were 
selected. Multiple ORs from individual studies were included if there was no overlap in 





adjusted associations, the OR relevant association from the fully adjusted model was 
extracted. 
Odds Ratio Calculations 
When ORs and 95% CIs were not reported, they were independently calculated by two 
authors (CMcD, MPH) where possible. ORs and 95%CIs were calculated from 2x2 
tables,29 or converted from standardized regression weights30-32 and Pearson correlation 
coefficients33 using standard procedures.34 When associations were reported with the 
highest or middle physical activity group as the reference group, ORs for the lowest 
physical activity group were inverted.30, 35-38  
Study Quality 
Two authors (CMcD and BRG) used the Q-Coh39 to independently assess study quality. 
This tool assesses seven domains (representativeness of the sample, comparability of the 
groups at the beginning of the study, quality of the exposure measure, maintenance of the 
comparability during the follow-up time, quality of the outcome measure, attrition, and 
statistical analyses). These domains are derived from the extended classification of biases 
(i.e., selection bias, performance bias, detection bias, and attrition bias) and are consistent 
with the Grade Working Group (http://www.gradeworkinggroup.org/). Studies were rated 
as good (risk of bias in 0-1 domain), acceptable (risk of bias in 2 domains), or low (risk 
of bias in 3+ domains). This scale has previously displayed good inter-rater reliability.39, 
40 
Data analysis 
Only two studies examined adolescents and were excluded from analyses. Analyses of 





(2) diagnosis/self-reported diagnosis of any anxiety disorder (i.e., a diagnosis of any 
DSM26 or ICD27 anxiety disorder, including GAD), and (3) diagnosis of GAD specifically 
(there was insufficient data to run analyses for other specific anxiety disorders). Analyses 
of crude ORs were run for studies using self-reported anxiety symptoms as the outcome. 
The logarithm of each OR was computed, weighted by its inverse variance prior to 
analyses, and results converted back to ORs for presentation. DerSimonian and Laird's 
inverse of variance random effects models were used with macros (MeanES)41 to 
aggregate the mean logOR.41, 42 Heterogeneity was quantified with the Q statistic, percent 
of observed variance accounted for by sampling error, and I2.43 Heterogeneity was 
indicated if QTotal reached a significance level of p<0.05.
42 Analyses were conducted for 
both crude and adjusted logORs separately. 
Results 
Study Characteristics 
Study characteristics are reported in Table 1. Over 80,000 unique individuals from 24 
studies were included in this review (median N=2120; IQR=1161-4526). The three largest 
studies used data from Waves 1-237 and Waves 2-329, 44 of the HUNT study. The median 
age was 43.7 (25.6-48.4) years, with just two studies focusing exclusively on children or 
adolescents.45, 46 The median percentage of participants who were female was 54.5% (49-
61). Studies were conducted in North America (n=2), Europe (n=18), Australia (n=2), 
and Asia (n=2). All studies used a self-report measure of physical activity assessed at 
baseline alone (n=18) or as change over time (n=6). Outcomes were anxiety symptoms 
(n=8), a screening level for anxiety (n=10), self-reported diagnosis of anxiety disorder 
(n=1), and diagnosis of an anxiety disorder (n=5). The quality of six studies was assessed 





inferences evaluating the different domains of quality (κ=0.61 to 1.00; all p<0.01), with 
initial agreement on 95.2% domains achieved. Agreement for the overall assessment of 
quality was very good (κ=0.91), with initial agreement on 94.4% studies achieved.  
Self-Reported Anxiety Symptoms  
All crude ORs (k=6; n=5) were less than one, indicating that physical activity was 
associated with lower odds of self-reported anxiety symptoms.29, 32, 47-49 The mean crude 
OR was 0.8436 (95% CI: 0.7638-0.9317; QTotal(5)=7.5913, p=0.1802; I
2=47.31% [95% 
CI: 12.95%-68.11%]).  
All adjusted ORs (k=9; n=9) were less than one.23, 31, 32, 35, 36, 38, 47, 49 The mean adjusted 
OR was 0.8742 (95% CI: 0.7731-0.9886; QTotal(8)=13.6364, p=0.0917; I
2=48.67% [95% 
CI: 23.10%-65.73%]). See Figure 1 for a forest plot of the distribution of adjusted ORs. 
These finding are supported by four50-53 of the five44 other adult studies that measured 
anxiety symptoms and both the adolescent papers.45, 46 
Diagnosed Anxiety Disorders  
For a diagnosis of any anxiety disorder, all ORs (k=3, n=3) were less than one.54-56 The 
mean OR was 0.6626 (95% CI: 0.5337-0.8227; QTotal(2)=2.7218, p=0.2564; I
2=62.26% 
[95% CI: 23.30%-82.40%]). See Figure 2 for a forest plot of the distribution of ORs. 
These findings were supported by one57 of the two58 other studies to examine a diagnosis 
of any anxiety disorder. 
For a diagnosis of GAD, all ORs (k=3, n=3) were less than one.55, 56, 59 The mean OR was 
0.5438 (95% CI: 0.3231-0.9153; QTotal(2)=0.5991, p=0.7412; I
2=0.00%). See Figure 3 for 





physical activity with panic, agoraphobia, social phobia, and specific phobia also 
indicated inverse associations for these outcomes.55, 56 
Physical Activity Dose-Response 
There was insufficient data to quantitatively assess a dose-response, and findings appear 
to be mixed. Six studies30, 35, 36, 49, 54, 59 that used a physical activity measure of volume 
(i.e., a product of time engaged in physical activity and its intensity) reported findings for 
more than one dose. Of these, three30, 54, 59 supported lower odds for increased dose of 
physical activity. Among the six29, 37, 44, 55-57 studies that measured a single parameter of 
physical activity, two55, 57 reported stronger associations for increased amounts of 
physical activity. Three54, 55, 59 of the four56 studies that measured some sort of dose-
response and used a diagnosis/self-reported diagnosis of an anxiety disorder found 
stronger associations with increased amounts of physical activity. 
Discussion 
To our knowledge, this is the first systematic review and meta-analysis of longitudinal 
associations between physical activity and anxiety. All crude and adjusted associations 
included in the current meta-analyses indicated inverse associations between physical 
activity and subsequent anxiety, but just four of 15 (two crude and two adjusted), two of 
three, and two of three ORs reached statistical significance for anxiety symptom, any 
anxiety disorder, and GAD outcomes, respectively. Nonetheless, a small, significant, 
cumulative association between physical activity and anxiety symptoms was observed 
(OR=0.8805, 0.7908-0.9802). Studies not included in the meta-analysis also reported 
small, inverse associations between physical activity and anxiety symptoms.50-53 
Although analyses included only three studies within each category, stronger associations 





disorder (OR=0.6626, 0.5337-0.8227) and a subsequent diagnosis of GAD specifically 
(OR=0.5438, 0.3231-0.9153) were also found. A moderate degree of heterogeneity was 
found for outcomes of self-reported anxiety symptoms and a diagnosis of any anxiety 
disorder; however, the small number of studies included in analyses precluded any 
meaningful attempt to provide quantitative examination (i.e., meta-regression analysis) 
of potential sources of variability.  
The present findings are promising, but there is currently insufficient quantitative 
evidence to justify firm conclusions regarding the protective effect of physical activity 
for subsequent anxiety. Further, critical appraisal of this body of literature, including 
assessment of the study quality of the meta-analysed studies, revealed notable challenges 
in the evidence base. The Q-Coh was used here to assess study quality.39 This tool 
assesses seven domains derived from the extended classification of biases and has 
previously displayed good inter-rater reliability,39, 40 which was again observed here. 
However, it remains less popular than other tools such as the Newcastle-Ottawa Scale, 
which has questionable reliability and validity.60 The studies included here were 
collectively of moderate quality (i.e., 75% acceptable or good), though the quality of six 
studies was assessed as low. The most pertinent issues were exposure and outcome 
measures, adjustment for putative confounders, including controlling for baseline anxiety 
severity, representativeness of samples, and attrition bias, which are discussed further in 
the following sections. 
A number of methods are available to assess physical activity. In general, device-
measured physical activity demonstrates less variability in properties of methodological 
effectiveness than self-report measures.61 Self-report measures may also be susceptible to 





moderate, or overestimation of activity duration;61, 62 however, differences between self-
report and device measured physical activity may be partially attributable to conceptual 
differences.63 For example, accelerometer-based monitors quantify acceleration at a fixed 
point of the body (i.e., hip, wrist, thigh, etc.) over short periods determined by the device 
settings, whereas self-report instruments measure reported time periods of longer duration 
engaged in specific behaviours, many of which are non-continuous in nature.63 Therefore, 
on occasion it may be preferable to use self-report instruments; for example, assessing 
adherence to physical activity guidelines, which were developed based on 
epidemiological relationships between self-reported physical activity and health 
outcomes. All studies included in the current review used self-report measures of physical 
activity, of which thirteen used a measure that assessed physical activity volume.30, 31, 35, 
36, 45, 48-51, 53, 54, 58, 59 If physical activity exposure does indeed reduce odds of anxiety and, 
as expected, overreporting of physical activity occurred, misclassification would 
underestimate the magnitude of this reduction as inactive people who were classified as 
active would have increased likelihood of anxiety. Future research would benefit from 
corroborating self-reported physical activity exposure with objective assessments and, in 
selecting the physical activity measure used, should consider not only its feasibility and 
practicality, but also its methodological effectiveness.61 The common study design of 
included studies largely limited physical activity exposure to a single measure of physical 
activity at baseline. Just six studies31, 35, 36, 45, 46, 51 assessed physical activity more than 
once to permit an estimate of change in exposure across follow-up, reducing the risk of 
misclassification bias. Of these studies, five31, 35, 36, 45, 51 used a physical activity measure 
that could capture volume, but only three also adequately controlled for putative 
confounders.31, 35, 36 Two of these studies supported inverse associations between change 





rigorously quantify associations between change in physical activity exposure and 
anxiety. The influence of cardiorespiratory fitness, an objective surrogate measure of 
physical activity exposure, and maintenance of fitness over time on anxiety is not well-
known. One study reported a significant, inverse association between cardiorespiratory 
fitness and development of any anxiety disorder over a 4.5-year follow-up (RR=0.69, 
0.50-0.95).58 However, this study did not fully address residual confounding and only 
used a single measure of cardiorespiratory fitness. Maintenance of fitness over 10-12 
years has been associated with lower odds of depression complaints made to a 
physician;64 but similar associations have not been examined for anxiety outcomes. 
In addition to inconsistent physical activity measures, though analyses aggregated the 
associations reported for the greatest physical activity dose in each study, inconsistent 
doses across studies likely explain some of the observed heterogeneity and are also a risk 
of bias. Identifying whether associations are dose-dependent is fundamentally important 
to guide recommendations for clinical practice and public health policy, but also for 
satisfying evidentiary criteria for a causal association between physical activity exposure 
and anxiety outcomes. One30 of seven,29, 35-37, 44, 49 two54, 55 of three,56 and two55, 59 of 
three56 studies that examined a dose-response (i.e., included three or more levels of 
physical activity) reported lower odds of anxiety symptoms, any diagnosed anxiety 
disorder, and GAD, respectively, for increased amounts of physical activity. Of these 
eleven studies that assessed a dose-response, six30, 35, 36, 49, 54, 59 used a physical activity 
measure that considered volume. However, different measures of exposure were used and 
criteria for classification into dose categories was not equivalent across studies. Just two 
studies reported associations for comparable dose categories (IPAQ categories),30, 49 
making it difficult for future meta-analyses to accurately convert the findings to a standard 





minimum, future research examines a consistent set of dose categories. As the World 
Health Organization promotes engaging in ≥150 minutes of moderate, ≥75 minutes of 
vigorous, or ≥600 MET.minutes of moderate-to-vigorous activity per week for health, 
and ≥300 minutes of moderate, ≥150 minutes of vigorous, or ≥1200 MET.minutes per 
week for additional health benefits,65 these would be logical categories to examine.  
Physical activity can occur in many modes and domains which may have different 
associations with anxiety and/or confound physical activity volume as derived from self-
reported measures.66 For example, light intensity physical activities or walking may have 
enhanced practicality and accessibility compared to other forms of physical activity; 
however, the association between these activities and anxiety is unclear. A recent scoping 
review highlighted the potential importance of walking for mental health,67 but just one 
study57 included here examined walking and another29 examined light intensity physical 
activity (i.e., not sweating or being out of breath). In unadjusted analyses, walking ≥105 
minutes/week compared to <105 minutes/week was non-significantly, inversely 
associated with the onset of any anxiety disorder (OR=0.72, 0.38-1.37).57 In adjusted 
analyses, compared to women who engaged in no light intensity physical activity, those 
who engaged in <1 hour, 1-2 hours, or ≥3 hours/week were non-significantly less likely 
to develop anxiety (RRs=0.83 to 0.91). No inverse associations were observed among 
men (RRs=0.99 to 1.13); however, adjusted models differed between males and females 
as body mass index was omitted from the female model due to substantially higher p-
values when it was included.29 Further research on associations of different modes and 
domains of physical activity with anxiety is required. In particular, given the potential 
enhanced convenience and availability of walking, more rigorous investigation of the role 
of objectively-assessed lighter-intensity physical activity in total physical activity 





The rigor and quality of the conceptualization and assessment of anxiety has varied. All 
studies included here used validated measures of anxiety except one,46 which assessed 
two items rated on a Likert scale. Only five55-59 studies used a standardized diagnosis of 
an anxiety disorder, and another54 used self-reported physician-diagnosis of an anxiety 
disorder to measure incident anxiety. Despite the high quality of these outcome measures, 
only half of these studies used high quality measures of physical activity exposure (i.e., 
volume and MET.hours).49, 54, 58 Additionally, though there are commonalities in the 
symptom profiles of anxiety disorders, they are a heterogeneous class of disorders with 
differing symptoms that may be more or less sensitive to physical activity exposure. The 
studies included here sampled diverse disorder groups, with three reporting associations 
for GAD55, 56, 59 and two for panic, agoraphobia, social phobia, and specific phobia, 
specifically.55, 56 Studies that measured anxiety symptoms most commonly used the 
anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A).68 However, 
four of these studies used a cut-score of ≥8 to classify anxiety caseness,29, 37, 44, 49 two used 
a cut-score of ≥11,50, 53 and one used a continuous measure of symptoms.51 Three studies 
classified anxiety caseness as scores in the top decile of their respective inventory.35, 36, 47 
Given the clear heterogeneity in the assessment of anxiety symptoms and disorders, 
comprehensive assessment approaches that corroborate standardized diagnostic 
interviews or self-reported physician-diagnosis of an anxiety disorder with self-report 
diagnostic screeners and measures of symptom severity are warranted. 
Inconsistent adjustment for putative confounders, representativeness of samples and 
diversity in key sample characteristics, and attrition bias are also key sources of bias in 
this body of literature. Six studies32, 33, 35, 36, 44-46 failed to control for baseline anxiety, 
either in their study design or analyses. Varying symptom scores will remain within each 





Because, the low physical activity groups will be expected to have higher symptoms at 
baseline, failure to adjust for baseline anxiety symptoms risks selection bias or reverse 
causation. The diverse sample groups included, and resultant heterogeneity across 
participant characteristics, likely explain some of the heterogeneity observed in analyses, 
but also question the representativeness of the samples. Samples from studies with an 
outcome of self-reported symptoms included younger and older adults, former elite male 
athletes and military, and patient groups. Similarly, studies with an outcome of any 
anxiety disorder sampled populations of university graduates, adolescents and young 
adults, and adults from the general population. It is plausible that physical activity 
exposures, and the factors that influence physical activity behaviour, differ between these 
groups. There may also be important differences regarding outcome measures used 
among these groups. Anxiety symptom expression can differ based on age69, 70 such that 
older adults may report more somatic symptoms.49, 71 Given that the HADS-A was the 
most frequently used assessment of symptoms in the included studies and is largely 
focused on cognitive symptoms, it is plausible that additional risk of bias resulted from 
differences in responses to the HADS-A across age groups. However, reporting of the 
assessment of and adjustment for putative confounders was poor, and few studies directly 
tested whether participant characteristics such as age, gender, race/ethnicity, medical 
condition, or psychoactive medication use modified the association between physical 
activity exposure and anxiety.  
Just two included studies examined children or adolescents alone,45, 46 both at high risk 
of bias, and one with young adults55 which was also the only study in this population to 
use a diagnosis of anxiety disorders as the outcome. Future research focused on younger 
population groups is imperative as the median age-of-onset of anxiety disorders is 





earliest and latest median age-of-onset are phobias and separation anxiety disorder (ages 
15-17 years) and generalized anxiety disorder (ages 23-30 years), respectively.6 Just two 
studies reported results separately for men and women,29, 44 and one study reported results 
separately for people with and without visual impairment.44 Important information 
including participants’ race/ethnicity and illnesses were reported in three32, 45, 47 and 
seven29, 30, 38, 44, 53, 54, 56 studies, respectively. Additionally, the length of follow-up 
assessments varied, and few studies fully accounted for participants lost to follow-up, 
particularly potential differences in attrition between exposure groups. More rigorous 
consideration of the influence of sample characteristics, differences in putative 
confounders between age groups, and the appropriateness of specific self-report measures 
of anxiety symptoms across age groups is needed. 
Experimental evidence has demonstrated the benefits of exercise alone and or as an 
additive to other treatments for OCD,18 panic disorder,16 GAD,17 and anxiety 
symptoms.19, 21, 22 The available evidence has provided some support for the biological 
plausibility of the association between physical activity and reduced anxiety. People with 
GAD72 and social phobia73 display decreased hippocampal volumes, while there is an 
increasing body of literature demonstrating that exercise can improve hippocampal 
functioning74 and volume.75 A comprehensive narrative review concluded that 
inflammation, oxidative and nitrogen stress, and subsequent alteration of neurotrophins, 
neurogenesis, and neuroplasticity likely play a role in the pathogenesis of anxiety 
disorders, and physical activity is known to influence these same pathways.76  
Conclusions 
Notwithstanding the limitations of included studies, the available evidence suggests that 





However, there are notable challenges in the current evidence base, including issues 
regarding exposure and outcome measures, consistent assessment of and adjustment for 
putative confounders, representativeness of samples, and attrition bias. This manuscript 
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IPAQ=International Physical Activity Questionnaire; LAPAQ=Longitudinal Ageing 
Study Amsterdam Physical Activity Questionnaire; M=mean; 
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Table 2. Assessment of the potential risk of bias within the seven inferences of the Q-Coh 







Figure 1. Forest plot of the distribution of odds ratios (ORs) and 95% confidence intervals 







Figure 2. Forest plot of the distribution of odds ratios (ORs) and 95% confidence intervals 







Figure 3. Forest plot of the distribution of odds ratios (ORs) and 95% confidence intervals 
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the DEDIPAC Knowledge Hub outlined in the Introduction. It found that meeting WHO 
physical activity recommendations was associated with 13.5% lower odds of anxiety and 
a dose-response was not apparent. This laid the foundations for the subsequent 






Anxiety is an adaptive response to perceived threats that can develop into a maladaptive 
anxiety disorder if symptoms become severe and chronic.1 Anxiety disorders, such as 
generalized anxiety disorder, panic disorder, and phobias, are the most prevalent class of 
mental disorders in the general population,2 and have considerable personal and economic 
cost.3 As the sixth leading cause of years lived with disability,2 anxiety disorders are more 
disabling than many self-reported physical conditions, including arthritis, asthma, 
back/neck pain, and cancer, particularly within social life and personal relationship 
domains.4 Anxiety symptoms and disorders are also associated with numerous other 
chronic medical conditions, including cardiovascular disease, and associated premature 
mortality.5, 6 Due largely to increased disability, anxiety disorders also have a large 
economic burden;7 in 2010 they had an estimated cost of over €74 billion in Europe.3 
Among individuals with anxiety, numbers seeking care can be low,8 as anxiety is 
commonly interpreted as a normal response to social adversity.9 Among those who do 
seek treatment, common frontline treatments include serotonin reuptake inhibitors10 
which can be expensive and have negative side-effects11 and cognitive behavioural 
therapy12 which is only moderately effective.13 Thus, there is continued interest in 
investigating potential cost-effective and accessible prevention, self-management, and 
treatment strategies for anxiety symptoms and disorders. 
One such strategy may be physical activity, although associations of physical activity 
with anxiety remain under-researched compared to other mental health disorders such as 
depression. Some cross-sectional evidence exists supporting its inverse association with 
anxiety symptoms14 and disorders.15 The World Health Organization (WHO) 





minutes weekly of vigorous intensity physical activity, or ≥600MET.mins of weekly 
physical activity for health benefits;16 however, epidemiological studies examining the 
association of this physical activity dose with anxiety are sparse.17-20 Further, the WHO 
recommends doubling this dose (i.e., ≥300 minutes of moderate, ≥150 minutes of 
vigorous, or ≥1200MET.minutes of weekly physical activity) for additional health 
benefits. It is important to further elucidate the association of meeting these specific 
physical activity dose recommendations with anxiety symptoms and status given the 
worldwide promotion of the salutary benefits of meeting these guidelines. Furthermore, 
walking is an accessible behaviour performed by all ages and sexes that is known to 
confer many physical health benefits; however, just one longitudinal21 and few cross-
sectional22 studies have examined associations of walking with anxiety.  
Thus, the objectives of the current investigation were to investigate and quantify the 
association of (1) meeting physical activity guidelines, (2) varying doses of physical 
activity and, (3) walking, with anxiety symptoms and status in a large cross-sectional 
population sample of Irish adults. It was hypothesised that meeting physical activity 
guidelines and walking would be associated with lower odds of anxiety, and that stronger 
associations would be seen with increased dose of physical activity. 
Methods 
This study used Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) recommendations to guide reporting.23 
Selection of participating studies 
The selection of participating studies has been described elsewhere.24 Briefly, the 





Knowledge Hub (DEDIPAC-KH), a pan-European joint programme initiative active from 
2013 to 2016. The focus of DEDIPAC was to better understand how individual and 
contextual factors influence diet, physical activity, and sedentary behaviour.25, 26 Within 
DEDIPAC, a compendium of relevant and accessible datasets regarding the listed health 
risk behaviours and their determinants was developed.27 Only cross-sectional data for 
datasets were available for harmonisation and Irish datasets with measures of physical 
activity and anxiety were selected. Thus, two datasets, The Irish Longitudinal Study on 
Ageing (TILDA) and The Mitchelstown Cohort Study, collectively consisting of 7,874 
adults with physical activity and anxiety data and 6,059 with complete covariate data, 
were harmonised for the present study.  
Participating Datasets and Harmonisation 
The Irish Longitudinal Study on Ageing (TILDA) is a large (n=8,329) prospective cohort 
study that assesses the social, economic, and health circumstances of community dwelling 
adults aged ≥50 years and their partners of any age in Ireland.28 For the current study, the 
first wave of data collected in 2011 was used. The Mitchelstown Cohort Study provided 
data (n=1,804) from the second phase of the Cork and Kerry Diabetes and Heart Disease 
Study.29 This study was designed to assess diabetes and heart disease among 55-74 year-
old adults. Data collection began in 2010. A target list of relevant variables that may 
influence the association between physical activity and anxiety, based on a logical, 
theoretical, or prior empirical relation with physical activity and/or anxiety, and that had 
potential for data harmonisation (i.e., same or similar measure) was generated from the 
two included datasets. Appropriate variable harmonisation methods for physical activity, 





and education were agreed by a six-person expert consensus group from within 
DEDIPAC.  
Exposure variable 
Physical Activity was measured using the self-reported short-form International Physical 
Activity Questionnaire (IPAQ-SF).30, 31 Respondents reported the number of days and 
duration of the vigorous, moderate, and walking activities undertaken during the previous 
seven days. Respondents were classified according to whether they met WHO physical 
activity guidelines.16 To examine a potential dose response, based on weekly metabolic 
equivalent,minutes (MET-mins) of moderate and vigorous physical activity, participants 
were also divided into Low (0-599 MET.mins), Moderate (600-1199 MET.mins), and 
High (≥1,200 MET.mins) dose categories.16 Respondents were categorized as Low 
walkers if they reported walking <210 min.week-1 (i.e., <30 min.day-1), Moderate walkers 
if they reported walking 210-419 min.week-1 (i.e., 30-59 min.day-1), and High walkers if 
they walked ≥420 min.week-1 (i.e., ≥60 min.day-1). 
Primary outcome 
Anxiety symptoms were assessed using the anxiety subscale of the Hospital Anxiety and 
Depression Scale (HADS-A).32 The scale consists of seven items rated on a four-point 
Likert scale from 0 (not at all) to 3 (very often indeed), with five items reverse scored. 
The HADS-A is scored such that higher scores indicate greater anxiety symptoms. 
Probable anxiety was indicated by scores ≥8, which has been associated with good 
sensitivity and specificity.33 The HADS-A has previously been validated in a sample of 






Age was grouped into four ten-year categories (50-59, 60-69, 70-79, and 80+ years).Sex 
was categorized as male or female. BMI was categorized as underweight, normal weight, 
overweight, and obese using established WHO thresholds of <18.5kg.m-2, 18.5-
24.99kg.m-2, 25-29.99kg.m-2, and ≥30kg.m-2, respectively.35 Participants self-reported 
smoking status as current smoker, former smoker, or never smoked. Marital status was 
self-reported as married/living with a partner as if married, single (never married), 
separated, divorced, or widowed. Highest level of education achieved was self-reported 
and divided into three categories: primary (some primary (not complete) or 
primary/equivalent), secondary (intermediate/junior/group certificate or 
diploma/certificate), and tertiary (primary degree or postgrad/higher degree) education. 
Within Dataset Analyses 
For descriptive purposes, Chi-square tests examined differences in proportions of 
elevated anxiety symptom status, ten-year age categories, sex, BMI categories, smoking 
status, education, marital status, and meeting physical activity guidelines between 
datasets. To determine the source of statistically significant Chi-square tests, Z tests were 
calculated for column proportions for each row in the Chi-square contingency table and 
adjusted using a Bonferroni correction.36 Within each dataset, binomial logistic regression 
quantified crude and adjusted associations between physical activity and anxiety. 






Integrated Dataset Analysis 
Chi-square tests examined differences in elevated anxiety symptom status, ten-year age 
categories, sex, BMI categories, smoking status, education, and marital status between 
individuals meeting and not meeting physical activity guidelines. To determine the source 
of statistically significant Chi-square tests, Z tests were calculated for column proportions 
for each row in the Chi-square contingency table and adjusted using a Bonferroni 
correction.36  
Binomial logistic regression quantified crude and adjusted associations between physical 
activity and anxiety. Covariates in adjusted models were age, sex, BMI, smoking status, 
education, marital status, and dataset. Likelihood ratio tests examined covariate 
significance in total population analyses in the integrated dataset. Additionally, a separate 
test of the model was run including the interaction between physical activity and sex. 
One-way ANOVAs followed by Bonferroni-corrected post-hoc tests quantified 
differences in anxiety symptoms between those meeting and not meeting physical activity 
guidelines, physical activity dose groups, and sexes. Hedges’ g effect sizes and associated 
95% confidence intervals (95%CI) were calculated to quantify the magnitude of 
differences in anxiety symptom scores between meeting physical activity guidelines, 
physical activity dose categories, and sexes.37 Effect sizes of 0.2, 0.5, and 0.8 were 
considered small, medium, and large effects, respectively.38 
Results 
Dataset characteristics 
Harmonised data characteristics are presented in Table 1. Results from Chi-square tests 






A total of 7874 and 6059 respondents were included in crude and adjusted analyses, 
respectively. Participant characteristics by anxiety status in the integrated dataset are 
presented in Table 2. The overall prevalence of anxiety was 24.5%. Females were more 
likely to report anxiety (χ2 (1, N=7874)=66.76, p<0.001) than males (28.0% vs 20.0%) 
and reported significantly higher anxiety symptoms (5.93±3.55) than men (5.15±3.24; 
F(1,7872)=101.73, p<0.001; g=0.23; 95%CI: 0.18 to 0.27). Meeting guidelines (χ
2 (1, 
N=7874)=4.29, p=0.038), age (χ2 (4, N=7867)=90.89, p<0.001), BMI (χ2 (3, 
N=6518)=11.22, p=0.011), marital status (χ2 (4, N=7871)=12.60, p=0.013), and smoking 
status (χ2 (2, N=7835)=59.61, p<0.001) significantly differed according to anxiety status. 
Results from follow-up Z tests are shown in Table 1. The proportions of people who met 
physical activity guidelines (χ2 (1, N=7874)=0.91, p=0.34) and who had anxiety (χ2 (1, 
N=7874)=0.02, p=0.90) did not differ between those who were included in crude analyses 
but excluded from adjusted analyses due to missing covariate information. 
Primary Analyses 
Results for logistic regression models run within each dataset are reported in Table 3. 
Integrated dataset analyses are reported in Table 3. Following full adjustment, meeting 
physical activity guidelines was associated with 13.5% (95% CI: 2.0 to 23.7; p=0.023) 
lower odds of anxiety. Age, sex, education, and smoking status were significant 
covariates (all p≤0.001). Compared to those aged less than 50 years, those aged 50-59 
(OR=0.957, 95%CI=0.703-1.303; p=0.782), 60-69 (0.617, 0.449-0.847; p=0.003), 70-79 
(0.470, 0.331-0.667; p<0.001), and 80+ (0.359, 0.222-0.581; p<0.001) were less likely to 
report anxiety. Compared to females, males (0.672, 0.590-0.795; p<0.001) were less 





to secondary (0.780, 0.668-0.910; p=0.002) and tertiary (0.745, 0.628-0.883; p=0.001) 
level were less likely to report anxiety. Compared to current smokers, past (0.641, 0.541-
0.759; p<0.001) and never (0.736, 0.619-0.875; p<0.001) smokers were less likely to 
report anxiety. A separate test of the model including the interaction between physical 
activity and sex was run and the interaction was not significant (p=0.858).  
Following full adjustment, Moderate and High physical activity levels were associated 
with 13.5% (95% CI: -11.0 to 32.6; p=0.254) and 13.6% (95% CI: 1.4 to 24.2; p=0.030) 
lower odds of anxiety, respectively. Following full adjustment, Moderate and High 
walking were associated with 2.1% (95% CI: -14.5 to 16.3; p=0.789) and 5.1% (95% CI: 
-9.3 to 17.6; p=0.467) lower odds of anxiety, respectively.  
Anxiety symptoms were significantly lower among people meeting physical activity 
guidelines (5.48±3.35) than those not meeting the guidelines (5.67±3.51; p=0.013; 
g=0.06, 95%CI: 0.01 to 0.10). Anxiety symptoms significantly differed according to 
physical activity dose (p=0.043). Post-hoc tests showed significantly lower anxiety 
symptoms for High (5.48±3.34) compared to Low (5.67±3.51, p<0.001; g=0.06 95%CI: 
0.01 to 0.10) physical activity. There were no significant differences between High and 
Moderate (5.43±3.39, p=0.756; g=-0.01, 95%CI: -0.11 to 0.08) or Moderate and Low 
(p=0.135; g=0.07, 95%CI: -0.02 to 0.16) physical activity. Anxiety symptoms did not 
significantly differ according to walking groups (p=0.740). 
Discussion 
This study examined the association between meeting recommended physical activity 
levels and anxiety among 7,874 Irish adults using secondary analysis of a harmonised 
dataset comprised of data from TILDA and the Mitchelstown Cohort Study. Anxiety 





guidelines and, following full adjustment for relevant covariates, meeting recommended 
physical activity guidelines was significantly associated with 13.5% lower odds of 
anxiety (HADS≥8) in the harmonized dataset, significantly associated with 19.8% lower 
odds of anxiety in TILDA, and non-significantly associated with 8.2% lower odds of 
anxiety in the Mitchelstown Cohort Study. This further highlights physical activity as an 
important modifiable lifestyle factor associated with anxiety symptoms and disorders 
along with other lifestyle factors such as sedentary behaviour,39 sleep,40 smoking,41 and 
alcohol use.42 The magnitude of the present findings are consistent with cross-sectional 
associations between meeting recommended levels of physical activity and elevated 
worry symptoms,20 and smaller than previously found associations with elevated 
depressive symptoms among Irish adults,24, 43 and smaller than cross-sectional 
associations of sedentary behaviour with anxiety.39  
Although a full dose-response between physical activity and anxiety was not supported 
in the current study, compared to Low physical activity, High physical activity (i.e., 
exceeding recommended physical activity levels) was significantly associated with lower 
anxiety symptoms: 13.6% lower odds of anxiety in the harmonized dataset, and 13.9% 
lower odds of anxiety in TILDA. The magnitude of associations for Moderate physical 
activity were similar to the High category, but not statistically significant. This is 
potentially driven by the lower number of respondents in the Moderate category (n=407; 
6.7%), compared with the other categories. The absence of a dose response is consistent 
with previous associations of physical activity with anxiety symptoms measured with the 
HADS-A.14, 19 However, dose-responses have been observed for diagnosed generalized 





There has been some evidence to support that, compared to physical inactivity, engaging 
in physical activity levels less than those recommended and increased light intensity 
physical activity, may convey mental health benefits.14, 22 One accelerometery-based 
study demonstrated using isotemporal substitution models that substituting 30 minutes of 
light intensity physical activity for 30 minutes of sedentary time (while holding total wear 
time of the accelerometer and other activities constant) was significantly associated with 
a decrease in anxiety symptoms.46 However, these findings were not supported in the 
present analyses of walking where anxiety symptoms and status did not differ across 
groups. In the Mitchelstown dataset, Moderate amounts of walking we significantly 
associated with 92.6% higher odds of anxiety among males, and 48.3% lower odds of 
anxiety among females; however, these results were potentially due to few respondents 
in the Moderate walking group as they were not replicated in either the TILDA or 
integrated datasets. The potentially important role of walking has been comparatively 
better-studied for depression, and somewhat remains understudied for anxiety. Given that 
the available literature largely supports that any physical activity is better than none, the 
possibility that even lower levels of moderate or vigorous intensity physical activity, 
increased light intensity physical activity, and increased walking may protect against 
anxiety and other mental health problems warrants further investigation. 
Covariates that significantly contributed to the primary statistical model included age, 
sex, education, and smoking status, although they did not have a large influence on the 
magnitude of the association between physical activity and anxiety. Supporting previous 
findings, younger age, female sex, lower education, and smoking were significantly 
associated with increased likelihood of anxiety.47, 48 From the present analyses, 
potentially modifiable factors such as physical activity and smoking should be considered 





education should be considered when identifying individuals who may be at increased 
risk of anxiety.  
Limitations 
This study has several limitations. Due to the cross-sectional design, causality cannot be 
inferred from these results. Indeed, the bidirectional relationship between physical 
activity and anxiety has been established.49 Secondly, the validity of self-reported 
physical activity can be low, especially among low socio-economic populations,50, 51 
which may predispose the results to over-reporting;52 however, if exposure to physical 
activity does indeed reduce odds of anxiety, misclassification would underestimate the 
magnitude of this reduction as inactive people who were classified as active would have 
increased likelihood of anxiety. Further, evaluation of adherence to physical activity 
guidelines based on self-reported outcomes may be more appropriate than device-
measured physical activity as the guidelines are mostly based on self-reported physical 
activity data, which consider the perceived time spent on physical activities but, unlike 
device measures, do not account for the actual fragmentation of movement throughout 
the activity.53 Nonetheless, future studies would benefit from device measured physical 
activity which can indicate both activity duration and intensity, such as GPS or 
accelerometery-based measurements, in addition to more direct measures of anxiety, such 
as physician diagnosis. Notwithstanding these limitations, this study has some notable 
strengths, including a large nationally representative sample, examination of WHO 
physical activity recommendations, walking, and a focus on anxiety symptoms and status. 
Conclusions 
After adjusting for important covariates, meeting WHO physical activity guidelines was 





relationship between physical activity and anxiety were observed. Additionally, walking 
was found to be non-significantly associated with anxiety symptoms; however, further 
investigation of the associations of low intensity physical activity, such as walking, and 
physical activity doses that do not meet recommendations are required. When considered 
in the context of the wider literature including prospective cohort studies and randomised 
controlled trials, the present findings support meeting WHO guidelines to lower odds of 






Table 1. Study characteristics 
 TILDA (n (%)) Mitchelstown (n (%)) P-value 
Age (years)    
<50 267 (4.2)a 2 (0.1)b 
<0.001 
50-59 2571 (40.4)a 852 (56.9)b 
60-69 1995 (31.3)a 621 (41.5)b 
70-79 1162 (18.2)a 23 (1.5)b 
80+ 374 (5.9)a 0 (0.0)b 
Sex    
Male 2779 (43.6)a 720 (48.1)b 
0.002 
Female 3597 (56.4)a 778 (51.9)b 
Body Mass Index    
Underweight 26 (0.5) 6 (0.4) 
0.281 
Normal 1131 (22.5) 354 (23.7) 
Overweight 2166 (43.1) 667 (44.6) 
Obese 1700 (33.8) 468 (31.3) 
Education    
Primary 1611 (26.9)a 351 (24.7)a 
0.002 Secondary 2669 (44.6)a 706 (49.8)b 
Tertiary 1700 (28.4)a 362 (25.5)b 
Marital status    
Married/ living with a 
partner  
4676 (73.3)a 1180 (78.9)b 
<0.001 
Single (never married) 541 (8.5)a 129 (8.6)a 
Separated 250 (3.9)a 64 (4.3)a 
Divorced 145 (2.3)a 33 (2.2)a 
Widowed 764 (12.0)a 89 (6.0)b 
Smoker    
Never 2820 (44.2)a 726 (49.8)b 
<0.001 
 
Past 2457 (38.5)a 517 (35.4)b 
Current 1099 (17.2)a 216 (14.8)b 
Meeting PA 
Guidelines 
   
Yes 3057 (47.9)a 460 (30.7)b 
<0.001 
No 3319 (52.1)a 1038 (69.3)b 
PA Categories    
Low 3319 (52.1)a 1038 (69.3)b 
<0.001 Moderate 440 (6.9)a 87 (5.8)a 
High 2617 (41.0)a 373 (24.9)b 
Walking categories    
Low 2839 (44.5)a 914 (61.1)b 
<0.001 Moderate 1394 (21.9)a 281 (18.8)b 
High 2143 (33.6)a 301 (20.1)b 
Different subscript letters indicate a subset of each category whose column 













Meeting PA Guidelines     
Yes 2696 (45.3)a 802 (42.6)b 0.038 
No 3252 (54.7)a 1105 (57.4)b 
PA categories    






Moderate 411 (6.9) 116 (6.0) 
High 2285 (38.4) 705 (36.6) 
Walking categories   
Low 2831 (47.6) 922 (47.9) 
Moderate 1259 (21.2) 416 (21.6) 
High 1857 (31.2) 587 (30.5) 
Age   
<50 179 (3.0)a 90 (4.7)b <0.001 
50-59 2436 (41.0)a 987 (51.3)b 
60-69 2062 (34.7)a 554 (28.8)b 
70-79 954 (16.1)a 231 (12.0)b 
80+ 312 (5.2)a 62 (3.2)b 
Sex    
Male 2798 (47.0)a 701 (36.4)b <0.001 
Female 3150 (53.0)a 1225 (63.6)b 
Body Mass Index    
Underweight 20 (0.5)a 33 (0.7)a 0.011 
Normal 990 (25.8)a 1160 (24.9)a 
Overweight 1708 (44.4)a 1883 (40.4)b 
Obese 1126 (29.3)a 1580 (33.9)b 
Education    
Primary 1453 (26.1) 509 (27.9) 0.293 
Secondary 2555 (45.8) 820 (45.0) 
Tertiary 1567 (28.1) 495 (27.1) 
Marital status    
Married/ living with a partner as if 
married 
4443 (74.7)a 1413 (73.4)a 0.013 
Single (never married) 509 (8.6)a 161 (8.4)a 
Separated 223 (3.8)a 91 (4.7)a 
Divorced 118 (2.0)a 60 (3.1)b 
Widowed 653 (11.0)a 200 (10.4)a 
Smoker    
Never 2748 (46.5)a 798 (41.5)b <0.001 
 
Past 2282 (38.6)a 692 (36.0)b 
Current 883 (14.9)a 432 (22.5)b 
Different subscript letters indicate a subset of each category whose column 







Table 3. Odds ratios (OR) and 95% confidence intervals (CI) derived from binominal 
logistic regression analyses as indicators of cross-sectional associations between 
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aAdjusted for dataset (TILDA or Mitchelstown Cohort) 
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Anxiety is the sixth leading cause of disability worldwide,1 affecting 4.2% of people aged 
55+ years globally,2 and accounting for 325–418 years lived with disability per 100 000 
persons aged 50 years and older.1 In Ireland, 13% of older adults have reported clinically 
significant anxiety symptoms.3 Anxiety has also been associated with numerous mental 
and physical comorbidities,4 such as pain, and early mortality.5 Further, health services 
are continually required to adapt and respond to the increasing absolute number of older 
adults with mood disorders requiring treatment as a result of an ageing population within 
the European Union.6 
Although the majority of those who suffer from anxiety do not seek treatment,7 
maladaptive anxiety symptoms are costly because of direct psychiatric and non-
psychiatric treatment costs.8 Among those who do seek treatment, the first-line treatment 
remains pharmacotherapy, such as selective serotonin reuptake inhibitors (SSRIs).9, 10 
Nonetheless, SSRIs do not work for about one-third of patients and are associated with 
the development or worsening of chronic physical diseases, obesity, diabetes and cardio-
metabolic diseases.4, 11-13 Thus, there is a continued need to identify and investigate 
alternative prevention and treatment strategies.  
Through improvements in functional status and wellbeing and social benefits, physical 
activity (PA) has been shown to be pivotal to the concept of ‘healthy ageing’.14 
Additionally, it is easily accessible and has few negative side effects. As a result, there 
has been continued interest in the benefits of regular PA for psychological status among 
the elderly. Compared with depression, the association between PA and anxiety has 
received significantly less attention. Recent large-scale cross-sectional evidence 





longitudinal evidence of the inverse association between PA and subsequent anxiety 
among older adults.16, 17 However, longitudinal associations between PA and anxiety 
symptoms in the general population have been mixed.18-21 Experimental evidence has 
supported the anxiolytic effects of exercise training among non-clinical adult 
populations,22 chronically ill patients.23 and individuals with anxiety disorders24, 25. 
Additionally, experimentally increasing sedentary behaviour has been demonstrated to 
increase anxiety among active young adults.26 
There is limited evidence regarding a dose–response relationship between PA and mental 
health outcomes. Evidence suggests large variability in the preference for and tolerance 
of different exercise intensities, and a ‘one size fits all’ approach may not work, but 
examining this dose–response in large populations may help to best formulate specific 
PA recommendations for mental health. Evidence to support a dose–response relationship 
between PA and anxiety from epidemiological studies16, 21, 27, 28 and randomised 
controlled trials29, 30 is mixed. There is evidence to suggest that the dose and modality of 
exercise considered efficacious for the treatment of depression is similar to that included 
in PA guidelines for the general population;31 however, evidence to support meeting these 
recommended guidelines to improve anxiety is sparse.  
Thus, the present study used data from The Irish Longitudinal Study of Ageing (TILDA) 
to (1) examine cross-sectional and longitudinal associations between meeting PA 
guidelines and anxiety symptoms and status, and (2) characterise the potential cross-
sectional and longitudinal dose–response relationship between PA and anxiety symptoms 
and status. Because anxiety symptoms have higher prevalence among women18, 20 and 





an exploratory objective was (3) to examine potential sex-related differences in the 
association between PA and anxiety. 
Methods  
This study used STROBE recommendations to guide reporting.32 
Study population and measures  
Data for the first3 and second33 waves of TILDA were gathered between October 2009 
and February 2011 and between April 2012 and January 2013, respectively, and analysed 
in 2017. TILDA is a nationally representative, equal probability sample34 of community-
dwelling adults aged ≥50 years, and their partners of any age, resident in the Republic of 
Ireland. Participants gave full informed consent to participate in the study and ethical 
approval was obtained from the Trinity College Dublin Faculty of Health Sciences 
Research Ethics Committee. Further study design details are published elsewhere.35 From 
8504 participants who responded to the first wave, PA and anxiety data at waves 1 and 2 
were available for 6094 respondents. Following exclusion of participants with incomplete 
covariate data (n=1917), cross-sectional analyses in the present study focused on 4175 
participants (56.8% female) aged ≥50 years with complete data. Respondents who 
reported anxiety at baseline (n=1010) were excluded from longitudinal analyses, leaving 
a sample of 3165 anxiety-free older adults who were included in longitudinal analyses. 
Anxiety symptoms were assessed at waves 1 and 2 using the anxiety subscale of the 
Hospital Anxiety and Depression Scale (HADS-A).36 The scale consists of seven items 
rated on a four-point Likert scale from 0 (not at all) to 3 (very often indeed) with five 
items reverse scored. The HADS-A is scored such that higher scores indicate greater 





associated with good sensitivity and specificity.37 The HADS-A has previously been 
validated in a sample of elderly subjects selected from the general population38 and shown 
to have high internal consistency in TILDA (Cronbach’s α=0.84).39 
PA was measured at wave 1 using the short International PA Questionnaire (IPAQ),40 for 
which respondents are asked to report the number of days and duration of the vigorous, 
moderate and walking activities they undertook during the previous 7 days. Data were 
summed within each activity category (i.e. vigorous intensity, moderate intensity and 
walking) to estimate the total number of minutes engaged in PA per week. Respondents 
who reported walking or moderate-to-vigorous PA (MVPA) greater than a combined 16 
h/day were excluded (n=7). The remaining respondents were classified as meeting MVPA 
guidelines (i.e. reporting ≥150 min weekly of MVPA, or ≥75 min weekly of vigorous PA, 
or ≥500 MET.minutes weekly) or not. Three categories, inactive, minimally active and 
very active, were determined as recommended (http://www.ipaq.ki.se). IPAQ categories 
were preferred to IPAQ MET continuous score because of the highly asymmetric 
distribution of this continuous score. For the current study, only wave 1 PA data were 
used.  
Participants also provided information at wave 1 regarding variables that may influence 
the association of PA with anxiety. Participant characteristics and environmental 
variables included age, sex, waist circumference, social class and the presence of pain. 
Pain was assessed by a single question ‘Are you often troubled with pain?’ Age was 
classified using four categories (i.e. 50–59, 60–69, 70–79 and 80+ years). Waist 
circumference was classified as low- or increased-risk according to WHO guidelines (i.e. 
males: >94cm; females >80cm).41, 42 Social class was defined according to the European 





their positions within labour markets and with special attention to their employment 
relations. In order to improve sample coverage, those who were not in paid employment 
were allocated to a ‘not working’ group (n=1112). Smoking status was assessed by self-
reported current or never/previous smoker. 
Statistical analysis 
Statistical analyses were conducted using SPSS Version 22.0 (Armonk, NY, USA: IBM 
Corp.). The χ2 tests examined differences in meeting PA guidelines, anxiety, sex, age, 
waist circumference, social class, smoking and pain categories between those included 
and excluded from analyses [i.e. those with complete IPAQ-SF (wave 1) and HADS-A 
(waves 1 and 2) data but missing covariate data]. The χ2 tests examined differences in 
pain, sex, age, waist circumference, social class and smoking categories between meeting 
and not meeting MVPA guidelines. For significant χ2 tests, Z tests were calculated for 
column proportions for each row in the χ2 contingency table and Bonferroni-corrected for 
multiple comparisons.44 
One-way analyses of variance (ANOVAs) and Fisher’s least significant difference 
planned contrasts quantified differences in waves 1 and 2 anxiety symptoms between 
those meeting and not meeting PA guidelines, IPAQ categories and sexes. Two-way 
ANOVAs examined variation in waves 1 and 2 anxiety symptoms by meeting PA 
guidelines, sex and their interaction, and IPAQ categories, sex and their interaction. To 
move beyond null-hypothesis significance testing in favour of estimation based on effect 
sizes and confidence intervals,45 Hedges’ g effect sizes and associated 95% confidence 
intervals (95% CI) were calculated to quantify the magnitude of differences in anxiety 






Binomial logistic regression quantified associations [i.e. crude and adjusted odds ratios 
(ORs)] between both meeting MVPA guidelines and IPAQ categories and anxiety status 
at waves 1 and 2. Covariates in adjusted models were pain, age, sex, waist circumference, 
social class and smoking status. 
Results  
Participant characteristics  
Compared with the analytic sample, a significantly greater proportion of excluded 
respondents were aged ≥80 years (7.6% v. 5.1%), male (47.2% v. 43.2%), current 
smokers (18.5% v. 14.8%) and did not experience pain (69.0% v. 63.5%; all p<0.05). 
There were no significant differences between excluded and included participants for 
meeting PA guidelines, anxiety status or waist circumference (all p>0.24).Wave 1 
participant characteristics are presented in Table 1. Pain [χ2 (1, N=4175)=21.54, 
p<0.001], sex [χ2 (1, N=4175)=75.50, p<0.001], age [χ2 (3, N=4175)=67.74, p<0.001] 
and social class [χ2 (7, N=4175)=88.98, p<0.001] significantly differed according to 
meeting MVPA guidelines. Waist circumference [χ2 (1, N=4175)=1.03, p>0.31] and 
smoking status [χ2 (1, N=4175)=0.95, p>0.32] did not significantly differ. Results from 
follow-up tests are shown in Table 1. Briefly, a statistically significant greater proportion 
of respondents who were aged 70–79 or ≥80 years, female or experienced pain were not 
meeting MVPA guidelines (all p<0.05). Wave 1 anxiety symptoms were significantly 
higher among females (5.82±3.69) than males (4.76±3.40; F(1,4174)=90.58, p<0.001). The 





Cross-sectional associations between IPAQ categories and anxiety  
Prevalence of anxiety was 24.2% (n=1010). Planned contrasts showed significantly lower 
anxiety symptoms for the very active (5.17±3.50) group compared with the inactive 
(5.60±3.75, p=0.002; g=0.12, 95% CI 0.04–0.20) group, and no significant differences 
between the minimally active (5.35±3.58) group and the very active ( p=0.17; g=0.05, 
95% CI −0.02 to 0.12) or inactive ( p=0.07; g=0.05, 95% CI −0.02 to 0.12) groups.  
There was a significant interaction between IPAQ categories and sex (F(2,4169)=4.19, 
p=0.02). Among females, the magnitude of differences between the inactive and 
minimally active (g=0.02, 95% CI −0.08 to 0.11) and very active (g=0.07, 95% CI −0.03 
to 0.17) groups were statistically non-significant and small. There was a non-significant, 
small difference between the minimally active and very active groups (g=0.05, 95% CI 
−0.05 to 0.15). Among males, the magnitude of differences between the inactive and 
minimally active (g=0.13, 95% CI 0.01–0.26) group was non-significant and small. There 
were also nonsignificant, small differences between the very active and minimally active 
(g=−0.04, 95% CI −0.15 to 0.06) and inactive (g=0.09, 95% CI −0.03 to 0.21) groups. 
Table 2 presents crude and adjusted ORs for the associations between PA tertile and 
anxiety status. Fully adjusted ORs are reported here. Minimally active and very active 
groups were non-significantly associated with 8.4% (95% CI −9.8 to 23.6%; p=0.34) and 






Cross-sectional associations between meeting PA guidelines and anxiety  
Anxiety symptoms were significantly higher among people not meeting MVPA 
guidelines (5.51±3.73) than those meeting PA guidelines (5.22±3.50; F(1,4173)=6.23, 
p=0.01; g=0.08, 95% CI 0.02–0.14). 
There was no significant interaction between meeting PA guidelines and sex 
(F(1,4171)=0.30, p=0.58). The magnitude of difference between meeting and not meeting 
PA guidelines was statistically nonsignificant and small among females (g=0.05, 95% CI 
−0.03 to 0.14) and males (g=0.02, 95% CI −0.08 to 0.11). 
Table 2 presents crude and adjusted ORs for the associations between meeting PA 
guidelines and anxiety status. Fully adjusted ORs are reported here. Meeting the 
guidelines was non-significantly associated with 9.3% (95% CI −5.5 to 21.9%; p=0.21) 
lower odds of anxiety. 
Longitudinal associations between IPAQ categories and anxiety  
Incidence of anxiety was 3.4% (n=109). Planned contrasts showed non-significantly 
reduced anxiety symptoms for the very active group (2.41±2.36) compared with the 
minimally active (2.55±2.51, p=0.15; g=0.06, 95% CI −0.02 to 0.14) and inactive 
(2.48±2.39, p=0.53; g=0.03, 95% CI −0.06 to 0.12) groups, and a non-significant 
difference between the inactive and minimally active ( p=0.48; g=−0.03, 95% CI −0.12 
to 0.06) groups. 
There was no significant interaction between IPAQ categories and sex (F(2,3161)=0.05, 
p=0.95). Among females, there were non-significant differences between the inactive 
group and the minimally active (g=−0.06, 95% CI −0.17 to 0.05) and very active 





between the minimally active and very active (g=0.04, 95% CI −0.08 to 0.16) groups. 
Among males, the magnitude of differences between the inactive group and the minimally 
active (g=−0.04, 95% CI −0.18 to 0.10) and very active (g=−0.03, 95% CI −0.16 to 0.11) 
groups were nonsignificant and small. There was a small, nonsignificant difference 
between the minimally active and very active (g=0.02, 95% CI −0.10 to 0.13) groups.  
Table 3 presents crude and adjusted ORs for the associations between IPAQ categories 
and anxiety status. Fully adjusted ORs are reported here. The very active group was non-
significantly associated with 4.3% (95% CI −62.7 to 43.6%; p=0.87) reduced odds of 
anxiety. The minimally active group was associated with 43.5% (95% CI −12.3 to 
132.3%; p=0.14) increased odds of anxiety. 
Longitudinal associations between meeting PA guidelines and anxiety  
Anxiety symptoms did not significantly differ between people meeting (2.44±3.38) and 
not meeting (2.52±2.47; F(1,3165)=0.69, p=0.41; g=0.03, 95% CI −0.04 to 0.10) MVPA 
guidelines. 
There was no significant interaction between meeting PA guidelines and sex 
(F(1,3163)=0.31, p=0.58). The magnitude of difference between meeting and not meeting 
PA guidelines was statistically nonsignificant and small among females (g=0.01, 95% CI 
−0.09 to 0.10) and males (g=−0.03, 95% CI −0.13 to 0.07).  
Table 3 presents crude and adjusted ORs for the associations between meeting PA 
guidelines and anxiety status. Fully adjusted ORs are reported here. Meeting PA 
recommendations was non-significantly associated with 6.3% (95% CI −39.7 to 37.2%; 






To the authors’ knowledge, this is the largest cross-sectional and longitudinal 
investigation of meeting PA guidelines and anxiety among older adults. The present 
unadjusted cross-sectional and longitudinal findings appear to support the beneficial 
effects of meeting PA guidelines or engaging in high levels of PA to reduce the likelihood 
of anxiety symptoms and status. However, following adjustment only high volumes of 
MVPA were significantly associated with lower prevalence of anxiety, while all 
prospective associations between PA and anxiety were small and no longer significant, 
suggesting a potential moderating effect by one or more covariates. 
A dose–response was observed in cross-sectional analyses; there were no significant 
findings in prospective analyses. Previous research has reported a graded relationship 
between PA and the relative risk of developing anxiety,28 and a cross-sectional dose–
response relationship between PA and cognition in older adults;46 however, evidence has 
been mixed.21 
The crude and adjusted odds of reduced anxiety observed in the current study are small 
compared with previous research. For example, large-scale cross-sectional evidence15 and 
longitudinal evidence in older adults17 has demonstrated a 23.1 and 45% reduction in odds 
of anxiety, respectively. However, similarly small reductions in anxiety symptoms to 
those observed in the present study have previously been observed in older adults.47 
Anxiety symptom expression can differ between age groups,48, 49 and older adults may 
tend to experience and/or report more somatic symptoms.50 Indeed, the potential utility 
of developing specific instruments to measure anxiety symptoms among older adults has 





measure of anxiety symptoms and status in the current population given its focus on 
cognitive symptoms.  
Pain is a well-established comorbidity in anxiety disorders. There is evidence for a reverse 
causal link,52 shared risk factors52 and overlap among the neuroanatomy thought to be 
involved in pain processing and anxiety.53-55 PA and exercise also improve pain and 
anxiety. For example, prolonged exercise in healthy individuals has improved pain 
tolerance56 and modulation.57 Although the present study did not directly examine the 
association between pain and anxiety, pain was included as a covariate in the analyses. 
The presence of pain was associated with a 108.7% (95% CI 79.8–142.3%, p<0.001) 
increase in odds of experiencing concurrent anxiety, and a 109.7% (95% CI 41.5– 
210.8%, p<0.001) increase in odds of developing anxiety during 2-year follow-up. 
Therefore, future research should examine the potential moderating/ mediating role that 
pain plays in the PA–anxiety relationship. 
Anxiety was significantly higher among females, supporting previous epidemiological 
evidence that European females are twice as likely to suffer anxiety disorders58 or possible 
anxiety18 than males. Genetic,59, 60 neurobiological,60, 61 psychological62 and 
bioenvironmental60 factors potentially underlie sex-related differences in mental health. 
Poorer baseline mood, and subsequently larger improvements following acute exercise, 
have also been observed in females;63 however, in the present study, although the cross-
sectional interaction between sex and meeting PA guidelines was significant, the 
magnitude of associations were small among both females and males.  
Although not examined in the present study, social support may play an important role in 
the PA–anxiety relationship. Social support has been shown to play a key role in recovery 





associations between social support and mental health in the general population65 and 
older adults,66, 67 Social support is also positively associated with PA engagement among 
older adults.68, 69 It is plausible that social support plays a moderating/mediating role in 
the PA–mental health relationship. 
Limitations and strengths 
Firstly, questionnaire-based activity measures can be problematic and susceptible to over-
reporting;70 thus, it is plausible that the relationship between PA and anxiety may have 
been underestimated. Indeed, in the current study, the overall average weekly MVPA of 
470 min far exceeds recommendations.71 However, there was substantial variation in 
reported MVPA, and the overall mean weekly MVPA is potentially misleading as the 
median amount of weekly MVPA was 120 min. Secondly, it is plausible that the 
association between PA and anxiety could be bi-directional, and anxiety symptoms and 
disorders cause declines in PA levels.72 It is plausible that anxiety symptoms may take 
longer than 2 years to emerge in a general population survey, and so the 2-year follow-up 
may have resulted in a lower incident anxiety rate; however, as the HADS assesses 
anxiety symptoms experienced in the last week, a two-year follow-up should have been 
more than sufficient to observe the development of new anxiety cases. Additionally, non-
measured variables, such as genetic variation,19 could have influenced both PA levels and 
the development of anxiety. Nonetheless, the present study also has notable strengths, 
including the use of a large national sample of elderly community-dwelling males and 







Future research should investigate (1) the anxiolytic effect of sub-guideline levels of PA, 
which has been shown to reduce odds of mortality,73 (2) the potential 
moderating/mediating roles of pain and/or social support in the PA–anxiety relationship 
and (3) the potential anxiogenic influence of sedentary behaviour independent of PA 






Table 1. Baseline characteristics 
 Not Meeting MVPA 
Guidelines (n=2120) (n 
(%)) 
Meeting MVPA 
Guidelines (n=2055) (n 
(%)) 
MVPA (mins.wk-1) (median 
(IQR)) 
0.00 (0.00) 600.00 (900.00) 
Anxiety symptoms (mean 
(SD)) 
5.51 (3.73) 5.22 (3.50) 
Sex   
  Female 1334 (63.4)a 1029 (50.1)b 
  Male 776 (36.6)a 1026 (49.9)b 
Age Category (years)   
  50-59 784 (37.0)a 892 (43.4)b 
  60-69 701 (33.1)a 759 (36.9)b 
  70-79 485 (22.9)a 339 (16.5)b 
  80+ 150 (7.1)a 65 (3.2)b 
Waist circumference   
  Normal 1020 (48.1) 1021 (49.7) 
  At risk 1100 (51.9) 1034 (50.3) 
Social Class   
  Professional Workers 77 (3.6)a 95 (4.6)a 
  Managerial and Technical 528 (24.9)a 548 (26.7)a 
  Non-manual 349 (16.5)a 294 (14.3)a 
  Skilled Manual 190 (9.0)a, 205 (10.0)a 
  Semi-skilled 188 (8.9)a 231 (11.2)b 
  Unskilled 67 (3.2)a 52 (2.5)a 
  Farmers 69 (3.3)a 170 (8.3)b 
  Not Working 652 (30.8)a 460 (22.4)b 
Smoking status   
  Current 325 (15.3)a 293 (14.3)b 
  Past/never 1795 (84.7)a 1762 (85.7)b 
Pain status   
  Yes 845 (39.9)a 677 (32.9)b 
  No 1275 (60.1)a 1378 (67.1)b 
Different subscript letters indicate a subset of each category whose column proportions 
differ statistically significantly at the .05 level 








Table 2. Odds ratios (OR) and 95% confidence intervals (CI) derived from binominal 
logistic regression analyses as indicators of cross-sectional associations between 
physical activity (PA) and anxiety 




Not Meeting PA Guidelines REF REF 
Meeting PA Guidelines 0.85 (0.74 to 0.97)* 0.89 (0.77 to 1.03) 
   
PA Tertile 1 REF REF 
PA Tertile 2 0.85 (0.71 to 1.01) 0.84 (0.70 to 1.01) 
PA Tertile 3 0.82 (0.70 to 0.96)* 0.85 (0.72 to 1.01) 
*p<0.05 
aAdjusted for pain, age, sex, BMI, social class 
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Generalized anxiety disorder (GAD) is characterized by recurrent or persistent excessive 
worry about every day, routine life events and activities, occurring most days for at least 
6 months.1 Lifetime risk of GAD is estimated to be 9.0%,2 and the 12-month prevalence 
of GAD among adults aged ≥66 years is twice that among those aged <66 years (1.7% vs 
3.4%).3 In a given 12-month period it is estimated that GAD affects 8.9 million people in 
Europe.3 Given the ageing population in Europe, the number of people with GAD can be 
expected to increase. GAD is highly comorbid with other psychiatric disorders,3-5 so 
precise estimates of its specific personal and social costs are difficult to isolate. 
Nevertheless, in Germany, the annual cost per person with GAD is estimated to be 
€1864.6 In Australia, it is estimated that the total medical care costs for GAD amount to 
$112.3 million (AUD).7 However, GAD comorbid with other psychiatric disorders results 
in substantially increased severity and economic and personal burden.4,8 
First-line treatments for GAD include selective serotonin reuptake inhibitors (SSRIs)9 
and psychotherapy.10 However, SSRIs can have negative side-effects, such as increased 
suicidality and aggression,11 and, availability, cost, and extensive specialized training 
needed among practitioners can limit access to psychotherapy. As an accessible potential 
therapy with minimal risk of negative side effects, exercise has received significant 
attention as a treatment for depression,12 but only one randomized controlled trial has 
examined exercise training as a treatment for GAD.13 Among young adult women with 
GAD, exercise improved clinical severity,13 associated signs and symptoms,14 sleep 
initiation and continuity,15 and health-related quality of life.16 Improved symptoms of 
GAD, including worry, state anxiety, and feelings of energy and fatigue, have also 





women with worry scores indicative of probable GAD.17 Despite evidence of the positive 
effects of exercise (i.e., planned, structured, repetitive, and intentional movement 
intended to improve or maintain one or more components of fitness), people with anxiety 
disorders are less likely to engage in regular physical activity (PA; i.e., movement that is 
carried out by the skeletal muscles that results in energy expenditure) and display 
decreasing PA levels over time.18 Additionally, in the National Comorbidity Survey 
Replication, 47.7% of respondents who fulfilled DSM-IV diagnostic criteria for GAD had 
not sought treatment in the past twelve months.19 Although the vast majority of people 
with GAD eventually make treatment contact, delays are typically around nine years.20 
Further, just 42.7% of those that sought treatment were classified as receiving at least 
minimally adequate treatment.19 Thus, there is a critical need to identify both risk factors 
for GAD and the healthful behaviours that may attenuate those risk factors to better 
inform interventions for prevention and treatment. 
PA has myriad benefits among older adults, including reduced risk of mortality21 and 
increased healthy ageing.22 Mental health benefits have also been reported; prospective 
studies have demonstrated the protective effect of PA, even at low levels, for 
depression.23,24 Comparatively, associations between PA and anxiety have received less 
attention. Reported associations between PA and anxiety symptoms25-30 and 
disorders18,31,32 have been mixed and largely confined to cross-sectional analyses. The 
authors are aware of only one longitudinal study that examined associations of PA and 
incident GAD.31 In that study, a low GAD incident rate likely precluded detection of 
statistically significant associations of PA and GAD; however, findings did suggest a 
protective effect of regular PA against GAD (OR=0.51, 95%CI: 0.14 to 1.93) among 





longitudinal studies to confirm or refute these findings and further characterize the 
association of PA and anxiety disorders has previously been identified.33 
Evidence for the mental health benefits of meeting World Health Organization (WHO) 
PA guidelines34 is sparse and, to the authors’ knowledge, no previous study has 
investigated the longitudinal association between meeting WHO PA guidelines and GAD 
among older adults. Although the prevalence of GAD is higher among women,35,36 
women more frequently report GAD symptoms shown to be improved by regular PA and 
exercise,14,37,38 and the limited available evidence of acute and chronic exercise effects 
among individuals with clinical or subclinical GAD has supported positive benefits for 
young women,13,14,17 sex-related differences in the PA-GAD relationship remain 
unstudied. The current study aimed to fill these gaps in the literature.   
Aims of the Study 
Using two waves of data collected over two years from The Irish Longitudinal Study on 
Ageing (TILDA), the key objectives of the current study were to examine associations 
between meeting World Health Organization physical activity guidelines and probable-
GAD at Wave 1 (prevalent GAD; Aim 1) and the likelihood of being diagnosed with 
GAD at Wave 2 (incident GAD; Aim 2). A secondary objective was to examine potential 
sex-related differences in the association between physical activity and GAD (Aim 3). 
An exploratory objective was to examine whether increased protective benefits may be 
associated with increased volumes of PA (Aim 4).  
Methods 






The Irish Longitudinal Study on Ageing (TILDA) is a large prospective cohort study that 
assesses the social, economic, and health circumstances of community dwelling adults 
aged ≥50 years and their partners of any age living in Ireland. An initial multi-stage 
probability sample of addresses was chosen by means of the RANSAM sampling 
procedure,40 with District Electoral Divisions selected at the first stage and household 
addresses selected at the second stage. The response rate was 62.0%. Participants gave 
full informed consent to participate in the study and ethical approval was obtained from 
the Trinity College Dublin Faculty of Health Sciences Research Ethics Committee.  
The present analyses report data from Wave 1 (2009-2010)41 and Wave 2 (2012-2013).42 
Respondents (N=5818) with complete short-form International Physical Activity 
Questionnaire (IPAQ-SF) and abbreviated Penn State Worry Questionnaire (PSWQ-A) 
data at Wave 1 and Composite International Diagnostic Interview – Short Form (CIDI-
SF) data at Wave 2 were included in the present analyses. Respondents (n=1868) were 
excluded for incomplete covariate data, resulting in a sample size of 3950 for cross-
sectional analyses. Participants who reported probable GAD at baseline (n=714) were 
excluded from longitudinal analyses, resulting in a sample size of 3236.  
Physical Activity 
PA was measured using the IPAQ-SF.43,44 Respondents reported the number of days and 
duration of the vigorous, moderate, and walking activities undertaken during the previous 
seven days. Data were summed within each activity category (i.e., vigorous intensity, 
moderate intensity, and walking) to estimate the total number of minutes engaged in PA 
per week. Respondents who reported walking or moderate-to-vigorous PA (MVPA) 





were classified according to whether they met WHO PA guidelines (i.e., ≥150 minutes 
weekly of moderate PA or ≥75 minutes weekly of vigorous PA, or ≥600MET.mins of 
weekly MVPA).34 Based on weekly MET.minutes of MVPA, participants were divided 
into tertiles, categorized into low (0 to <600 MET.mins), moderate (600 to <1,200 
MET.mins), or high (≥1,200 MET.mins) dose categories,34 and three categories, low, 
moderate, and high, were determined as recommended (www.ipaq.ki.se). 
Generalized Anxiety Disorder 
At Wave 1, symptoms of worry were assessed using the PSWQ-A.45 In the present 
sample, the PSWQ-A demonstrated excellent internal consistency (Cronbach’s α=0.94). 
A score of ≥23 defined caseness of probable-GAD.46 This cut-off score has been shown 
to correctly identify clinical status among older adults, with 66.4% sensitivity and 92.5% 
specificity.47 At Wave 2, the CIDI-SF48 was used to assess whether respondents fulfilled 
the Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria for 
GAD.1 The CIDI-SF has been shown to correctly classify CIDI cases of GAD with an 
accuracy of 99.6%.48 
Covariates 
Covariates of theoretical, practical, or prior empirical evidence of association with PA or 
GAD were included. Age was classified using four categories (i.e., 50-59yrs, 60-69yrs, 
70-79yrs, and ≥80yrs). Waist circumference was classified as low- or increased-risk 
according to WHO guidelines (i.e., Males: >94cm; Females >80cm).49,50 Social class was 
defined according to the European Socioeconomic Classification (ESeC) scheme.51 The 
ESeC classifies people into seven categories according to their positions within labour 
markets and with special attention to their employment relations. In order to improve 





Working” group (n=1050). Current smoking status (current vs past/never) was assessed 
by self-report. Baseline depressive symptoms were assessed using the Center for 
Epidemiological Studies Depression Scale (CES-D).52 Reliability coefficients of the 
CES-D are high (0.85-0.91) among older adults.53 
Statistical Analysis 
Statistical analyses were conducted using SPSS Version 22.0 (Armonk, NY: IBM Corp.). 
The difference in sample characteristics between those with and without probable-GAD 
at baseline was tested by Chi-square tests and one-way ANOVAs for categorical and 
continuous variables, respectively. For significant Chi-square tests, Z tests were 
calculated for column proportions for each row in the Chi-square contingency table and 
Bonferroni-corrected for multiple comparisons.54 Supplementary Table 1 provides the 
proportion of people with probable-GAD at Waves 1 and 2 by level of PA and significant 
covariates. 
Cross-Sectional Analyses (Aim 1) 
One-way ANOVA tested differences in Wave 1 worry symptoms between those meeting 
and not meeting PA guidelines. Hedges’ g effect sizes and associated 95% confidence 
intervals (95%CI) were calculated to quantify the magnitude of differences in worry 
scores.55 Binomial logistic regression quantified associations (i.e., Odds Ratios) between 
meeting PA guidelines and probable-GAD at Wave 1 (prevalent GAD). Covariates in 
adjusted models were age and, sex (Model 1); Model 1 and waist circumference, social 
class, and smoking status (Model 2); Model 2 and depressive symptoms (Model 3). The 
Hosmer-Lemeshow test was performed and Nagelkerke R2 calculated to assess the 





Longitudinal Analyses (Aim 2) 
Binomial logistic regression quantified associations between meeting PA guidelines and 
GAD at Wave 2 (incident GAD). The Hosmer-Lemeshow test was performed and 
Nagelkerke R2 calculated to assess the goodness-of-fit of the model. Likelihood ratio tests 
examined covariate significance. 
Potential Sex-Related Differences (Aim 3) 
One-way ANOVA tested differences in Wave 1 worry symptoms between males and 
females. Hedges’ g effect sizes and associated 95%CIs were calculated to quantify the 
magnitude of differences in worry scores.55 Two-way ANOVA examined variation in 
Wave 1 worry symptoms by meeting PA guidelines, sex, and their interaction. 
Potential Dose-Response (Aim 4) 
One-way ANOVA and Fisher’s LSD planned contrasts quantified differences in Wave 1 
worry symptoms between dose levels. Binomial logistic regression quantified 
associations between dose levels, tertiles, and IPAQ categories, and prevalent probable-
GAD and incident GAD.  
Results 
Participant Characteristics 
Compared to the analytic sample, a greater proportion of excluded respondents (i.e., those 
with complete Wave 1 IPAQ-SF and PSWQ-A, and Wave 2 CIDI-SF data but missing 
covariate data) were male (47.7% vs 43.8%), aged 50-59 (46.2 % vs. 41.1%) and ≥80 





differences in meeting PA guidelines, probable-GAD status, or waist circumference (all 
p>0.08). 
Wave 1 participant characteristics for the included sample are presented in Table 1. Sex 
(p<0.001), age (p<0.001), waist circumference (p=0.02), smoking status (p<0.001), social 
class (p<0.001), depressive symptoms (p<0.001), days per week engaged in moderate PA 
(p=0.021), days per week engaged in vigorous PA (p=0.001), weekly minutes of vigorous 
PA (p<0.001), and weekly minutes of MVPA (p=0.015) differed according to probable-
GAD caseness. Results from follow-up tests are shown in Table 1. Briefly, a greater 
proportion of respondents with probable-GAD were female (72.2% vs 52.7%), aged 50-
59 years (51.7% vs 38.7%), had a normal waist circumference (52.7% vs 47.8%), and 
smokers (20.4% vs 13.3%; all p<0.05). Depressive symptoms were higher among 
respondents with probable-GAD (F(1,3949)=15.87, p<0.001; g=1.04, 95%CI: 0.96 to 1.13). 
This is equivalent to a 6.62 (95%CI: 6.08 to 7.15) point difference on the CES-D. 
Cross-sectional Results (Aim 1) 
Worry symptoms were higher among people not meeting MVPA guidelines than those 
meeting PA guidelines (F(1,3949)=16.45, p<0.001; g=0.13, 95%CI: 0.07 to 0.19). This is 
equivalent to a 0.98 (95%CI: 0.51 to 1.45) point change on the PSWQ-A. 
Prevalence of probable-GAD was 18.1% (n=714). Table 2 presents ORs for the 
associations between meeting PA guidelines and probable-GAD. Model 2 and 3 results 
are reported here. Meeting the guidelines was associated with 17.1% (OR=0.83, 0.70 to 
0.98; p=0.032) and 7.0% (OR=0.93, 0.77 to 1.12; p=0.435) lower odds of probable-GAD 
in Model 2 (χ2(8)=3.45, p=0.90; R2=0.08) and Model 3 (χ2(8)=10.94, p=0.21; R2=0.22), 
respectively. Age (χ2(3)=26.72), sex (χ2(1)=16.64), and depressive symptoms 





Longitudinal Results (Aim 2) 
Incidence of GAD was 0.9% (n=29). Table 2 presents crude and adjusted odds ratios for 
the associations between meeting PA guidelines and GAD. Meeting the guidelines was 
associated with 56.9% (OR=0.43, 0.19 to 0.99; p=0.047) and 53.6% (OR=0.46, 0.20 to 
1.08; p=0.075) reduced odds of GAD in Model 2 (χ2(8)=4.31, p=0.83; R2=0.10) and 
Model 3 (χ2(8)=7.72, p=0.46; R2=0.16), respectively. Sex (χ2(1)=5.66, p=0.02), smoking 
(χ2(1)=6.04, p=0.01), and depressive symptoms (χ2(1)=18.53, p<0.001) were significant 
covariates. 
Potential Sex-Related Differences (Aim 3) 
Wave 1 worry symptoms were higher among females (16.87±7.99) than males 
(14.05±6.78; F(1,3949)=137.62, p<0.001). The magnitude of difference was small (g=0.38; 
95%CI: 0.31 to 0.44). This is equivalent to a 2.82 (95%CI: 2.35 to 3.29) point change on 
the PSWQ-A. Females were more likely to report probable GAD at baseline (23.3% vs 
11.4%, p<0.001). There was no interaction between meeting guidelines and sex 
(F(1,3949)=0.02, p>0.88). The magnitude of difference in worry symptoms between 
meeting and not meeting guidelines was small among females (g=0.08, 95%CI: 0.00 to 
0.16) and males (g=0.08, 95%CI: -0.01 to 0.18). 
Dose-Response Results (Aim 4) 
Planned contrasts showed lower worry symptoms for the High dose level compared to 
Low (p<0.001; g=0.13: 0.07 to 0.20) and Moderate (p=0.66; g=0.03: -0.10 to 0.16) levels, 
and lower worry symptoms for the Moderate dose level compared to Low level (p=0.11; 





Table 2 and Supplementary Table 2 present crude and adjusted odds ratios for Aim 4. 
Model 2 results for Low (0 to <600 MET.mins), Moderate (600 to <1,200 MET.mins), 
and High (≥1,200 MET.mins) dose levels are reported here. Compared to the Low dose, 
the Moderate and High dose levels were associated with 12.6% (OR=0.87, 0.62 to 1.23; 
p=0.44) and 17.9% (OR=0.82, 0.69 to 0.98; p=0.032) lower odds of GAD (χ2(8)=4.34, 
p=0.83; R2=0.08). 
In prospective analyses, compared to the Low dose level, the Moderate or High levels 
were associated with 25.9% (OR=0.74, 0.17 to 3.22; p=0.69) or 62.3% (OR=0.38, 0.15 
to 0.95; p=0.039) reduced odds of GAD (χ2(8)=4.26, p=0.83; R2=0.11). 
Discussion 
To the authors’ knowledge, this study is the largest to examine associations of PA with 
incident GAD, the first to do so in an older adult population, and the first study to examine 
potential benefits of meeting WHO PA guidelines for GAD. The primary finding was 
that, after adjustment for age, sex, waist circumference, social class, and smoking, 
meeting WHO PA guidelines reduced the odds of developing GAD after two-years by 
57% (OR=0.43, 95%CI: 0.19 to 0.99). 
Probable-GAD was highly prevalent in the current sample at baseline. The prevalence 
rate was higher than previous findings of GAD in a sample of older European adults.3 
However, prevalence in the current sample was similar to a previous systematic review 
of the prevalence of anxiety disorders in community samples.56 Following adjustment for 
age, sex, waist circumference, social class, and smoking status, meeting PA guidelines 
was associated with significantly lower odds of prevalent probable-GAD and reduced 
odds of incident GAD. However, similar to the association of regular PA and 12-month 





German adolescents and young adults,31 a large effect range estimate that encompassed 
zero association between PA and prevalent GAD was found in the present study after full 
adjustment. Among the same sample of German adolescents and young adults, regular 
PA (defined as exercising daily and several times a week) compared to no PA (defined as 
exercising less than once a month or no exercise at all), was associated with lower 12-
month prevalence of GAD (OR=0.77; 95%CI: 0.30 to 2.01). However, unlike in the 
German sample, the fully adjusted model in the present study was adjusted for baseline 
depressive symptoms. GAD and depression are highly comorbid.57 Indeed, this is 
illustrated in the present study by the differences between Models 2 and 3 (see Table 2), 
and an increase of just one point on the CES-D was associated with 12% (OR=1.12, 1.10 
to 1.13) and 10% (OR=1.10, 1.06 to 1.15) increased odds of prevalent and incident GAD, 
respectively. However, it is plausible that this is an over adjustment. It is unknown 
whether PA affects anxiety differently in older people with or without depressive 
symptoms and an insufficient number of the present sample were on medication to 
provide robust estimates of odds stratified on medication use. 
The magnitude of the longitudinal association of PA and incident GAD reported here is: 
(i) larger than previously reported associations between PA and incident MDD in 
Canadian adults58 and American older adults;59 (ii) comparable to previous associations 
of regular PA and incident GAD (OR=0.51, 95%CI: 0.14 to 1.93) and any incident 
anxiety disorder (OR=0.52, 95%CI: 0.37 to 0.74) among a sample of German adolescents 
and adults;31 and, (iii) comparable to the association between ≥3-hours/week of vigorous 
PA, compared to <1-hour/week of vigorous PA, and any incident ICD-10 anxiety disorder 
in a sample of rural Australian adults (OR=0.47, 95%CI: 0.17 to 1.28).32 Although the 
sample sizes of these studies were not small (n=2,527 and n=638, respectively), the 





are likely required to examine significant variation in incident GAD according to PA. 
However, taken together with previous results, the present findings add to the collective 
support for a protective effect of approximately 50% for PA on incident anxiety disorders, 
including GAD. 
The current sample somewhat precluded a rigorous examination of potential sex-related 
differences in the longitudinal association between PA and incident GAD; however, 
baseline worry symptoms were significantly greater among females (g=0.38) and, 
consistent with previous research, females were twice as likely to meet criteria for GAD 
as males (23.3% vs 11.4%).35,36 Similarly, in fully adjusted models, females were more 
likely to report prevalent (OR=2.06, 1.65 to 2.56) and incident (OR=3.48, 1.19 to 10.21) 
GAD. Despite reporting lower baseline worry symptoms compared to females, 
associations between PA and worry symptoms were similar among males and females. 
Based on the available literature, similar associations between PA and worry symptoms 
among males were not anticipated. First of all, women have a higher likelihood of 
reporting GAD symptoms shown to be improved by regular PA and exercise, including 
fatigue, irritability, muscle tension, and somatic symptoms.14,37,38 Secondly, the limited 
available evidence for acute and chronic exercise effects among individuals with clinical 
or subclinical GAD supports positive benefits for young women,13,14,17 while men remain 
unstudied. The present findings support the need for future investigations that more 
robustly examine potential sex-related differences in both the association between PA and 
GAD and the effects of acute and chronic exercise among individuals with GAD. 
Additional significant covariates in the present study included age in cross-sectional 
analyses and smoking in prospective analyses. Given that the prevalence of GAD seems 





OR=2.12, 1.28 to 3.49) were more likely to report prevalent GAD; however, this is 
potentially driven by the low number of respondents aged ≥80 years (n=169). Consistent 
with previous associations of smoking and GAD,60 current smokers at baseline were more 
likely to develop incident GAD (OR=3.00, 1.04 to 8.17). 
Though the examination of plausible mechanisms, mediators, or moderators of the 
association between PA and GAD was not the purpose here and beyond the scope of the 
current investigation, the available evidence has provided some support for several 
psychological and biological mechanisms that may underlie positive associations of PA 
with and positive effects of exercise on GAD. For example, previous evidence supported 
inverse, indirect associations between PA and symptoms of GAD that were expressed 
through positive associations with physical self-concept and self-esteem among 1,036 
young adult women, providing initial evidence that PA may reduce risk of GAD in young 
women by positively influencing specific and global physical self-concept and self-
esteem.61 Moreover, in addition to evidence that regular PA and exercise training may 
improve depression and anxiety via changes in neurotransmitters and neurotrophic 
peptides, available research also suggests that the positive effects of regular PA on anxiety 
disorders may be underpinned by modulation of inflammatory markers.62 Given recent 
evidence from functional magnetic resonance imaging that pathological worry in GAD 
among older adults competes for the same prefrontal cortex resources that are involved 
in adaptive regulation of emotion,63 along with evidence of interrelations between 
exercise-induced changes in prefrontal oxygenation and mood state responses,64 the 
influence of prefrontal cortex activity on relations of PA and exercise with GAD also 





Strengths and limitations 
This is the largest study to date to examine associations of PA and incident GAD, and the 
first study to do so in an older adult population. The PA measure used allowed 
examination of important features of PA, including frequency, intensity, and duration, to 
more robustly examine the benefits of meeting PA guidelines. However, there were 
several limitations. Firstly, the use of self-reported PA predisposed the results to over-
reporting;65 however, there is no evidence to suggest that reporting errors should differ 
according to anxiety status. Secondly, previous studies have reported sex-related 
differences in associations of PA and anxiety disorders66 and there has been interest in a 
dose-response in the association between PA and anxiety;67 however, the low incident 
rate of GAD among males and across different levels of PA precluded the rigorous 
longitudinal examination of these research questions. Thirdly, the assessment of GAD 
using different measures at Waves 1 and 2 is not ideal; however; the CIDI-SF was only 
introduced in Wave 2 of TILDA. Nonetheless, the present findings provide initial support 
for a protective association of increased PA with reduced likelihood of GAD among a 
sample of older adults.  
The present findings suggest that meeting WHO PA guidelines reduces the odds of 
developing GAD by approximately 57% among older adults. Future research should 
confirm the present findings in other large population samples, as well as more robustly 
examine the influence of PA and exercise among males with clinical or subclinical GAD. 
As first onset of GAD generally occurs at a much younger age,2 younger cohorts may be 







In addition to the established physical health benefits of meeting the PA guidelines, and 
in light of recent findings showing that even one hour of PA is associated with reduced 
risk of depression,24 the present study offers further support for the mental health benefits 
of meeting recommended guidelines. Given that approximately 50% of adults aged ≥60 
years in Europe are physically inactive,68 increasing PA at the population-level should be 






Table 1. Participant characteristics 










PSWQ (8-40) (mean (SD)) 12.72 (4.26) 28.84 (5.01) <0.001 
Moderate PA (days.wk-1) 
(mean (SD)) 
2.34 (2.77) 2.07 (2.72) 
0.021 
Vigorous PA (days.wk-1) 
(mean (SD)) 
1.03 (1.99) 0.77 (1.70) 
0.001 
Moderate PA (mins.wk-1) 
(mean (SD)) 
327.18 (564.26) 309.61 (609.82) 
0.458 
Vigorous PA (mins.wk-1) 
(mean (SD)) 
158.08 (418.03) 98.05 (277.59) 
<0.001 
MVPA (mins.wk-1) (mean 
(SD)) 
485.26 (781.26) 407.66 (727.50) 
0.015 
PA Guidelines    
  Meeting 1626 (50.2)a 308 (43.1)b 
<0.001 
  Not Meeting 1610 (49.8)a 406 (56.9)b 
CES-D (0-60) (mean (SD)) 4.28 (5.30) 10.90 (9.80) <0.001 
Sex    
  Female  1703 (52.6)a 516 (72.3)b 
<0.001 
  Male 1533 (47.4)a 198 (27.7)b 
Age Category (yrs)    
  50-59 1252 (38.7)a 370 (51.8)b 
<0.001 
  60-69 1157 (35.8)a 225 (31.5)b 
  70-79 658 (20.3)a 99 (13.9)b 
  80+ 169 (5.2)a 20 (2.8)b 
Waist Circumference    
  Normal 1550 (47.9)a 376 (52.7)b 
0.021 
  Above Normal 1686 (52.1)a 338 (47.3)b 
Social Class    
  Professional Workers 142 (4.4)a 17 (2.4)b 
<0.001 
  Managerial and Technical 905 (28.0)a 136 (19.0)b 
  Non-manual 501 (15.5)a 110 (15.4)a 
  Skilled Manual 316 (9.8)a 58 (8.1)a 
  Semi-skilled 310 (9.6)a 75 (10.5)a 
  Unskilled 89 (2.8)a 21 (2.9)a 
  Farmers 212 (6.6)a 22 (3.1)b 
  Not Working 761 (23.5)a 275 (38.5)b 
Smoker    
  Current 431 (13.3)a 143 (20.0)b 
<0.001 





Each similar subscript letter denotes a subset of each category whose 
column proportions do not differ significantly from each other at the p≤0.05 
level. Different subscript letters indicate statistically significant differences 
at the p≤0.05 level. 
  
Abbreviations: CES-D: Center for Epidemiologic Studies Depression 
Scale; hrs: hours; MVPA: moderate-to-vigorous physical activity; PSWQ: 








Table 2. Odds ratios (OR) and 95% confidence intervals (CI) derived from binominal 
logistic regression analyses as indicators of association between physical activity (PA) 
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ap<0.05; bp<0.01; cp<0.001 
Model 1 adjusted for, age and sex 
Model 2 adjusted for Model 1 and waist circumference, social class, and smoking 
Model 3 adjusted for Model 2 and depressive symptoms 
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This dissertation provided the most rigorous test to date of the extent to which meeting 
WHO physical activity recommendations protects against the onset of depression, 
anxiety, and GAD. Primary objectives of this research were to (i) conduct a systematic 
review and meta-analysis of the odds of incident and elevated depression and depression 
symptoms among people who engage in physical activity in prospective cohort studies, 
and (ii) conduct a systematic review and meta-analysis of prospective associations of the 
odds of prevalent and incident anxiety among people who meet the physical activity 
guidelines. These meta-analyses reviewed all of the prospective cohort studies that 
examined physical activity associations with depression and anxiety. An inverse 
association between physical activity and the development of depression and anxiety was 
observed; however, just two studies included in the meta-analyses had examined the 
benefits of meeting WHO physical activity recommendations for depression, and none 
for anxiety. This specific physical activity dose recommendation was developed based on 
its apparent physical health benefits, but it is important to further elucidate its association 
with mental health as well as physical given the worldwide promotion of the salutary 
benefits of meeting these guidelines. Therefore, we then conducted two cross-sectional 
and three prospective cohort studies to (iii) examine odds of prevalent and incident 
depression, anxiety, and GAD among people who meet the physical activity guidelines, 
and (iv) examine whether odds of depression, anxiety, and GAD were smaller for people  
who engaged in increased doses of physical activity. Throughout this chapter, the findings 
of each of these seven studies are discussed in the context of how they relate to the 





Summary of Findings – Depression 
Systematic Review and Meta-Analysis – Manuscript One 
This systematic review and meta-analysis explored whether physical activity is associated 
with lower odds of developing depression by accumulating and evaluating findings from 
120 prospective cohort studies (median follow-up 4 years) of 638,482 adults sampled 
from eleven nations in North America, Europe, Asia, Africa, and Australia.1 The 
aggregated crude odds (OR, 95%CI) of elevated symptoms were 23.5-29.4% lower 
among active compared with less active people (0.63, 0.57-0.71). After adjustment for 
risk factors, such as age, sex, race, education, income, smoking, alcohol use, chronic 
health conditions, and other social and psychological variables, the odds remained 25.3-
18.7% lower among active people (0.78, 0.75-0.81).  
These results held in sensitivity analysis limited to the smaller number of studies included 
in a recent, similar review.2 The current review corrects and elevates the methods of this 
recent review which reported a fully homogeneous association of physical activity with 
depression odds, likely as the authors weighted by sample size rather than by the 
conventional inverse variance of the odds ratio and used an estimator of population 
variance that commonly underestimates true between-study variance of odds ratios.3, 4 As 
expected, high heterogeneity was observed in the present study, partly explained by (1) a 
dose-dependent association between lower odds of elevated depressive symptoms and 
exposure to moderate-to-vigorous intensities of physical activity in both crude and 
adjusted analysis, and (2) the study design, such that crude and adjusted odds were lower 
when change in physical activity exposure was assessed compared to a single baseline 





Although associations for the highest levels of activity with depression were not stronger 
than those for more moderate activity levels, both were stronger than associations of the 
lowest level of physical activity; however, different measures and criteria were used to 
classify people into activity exposure groups that were not equivalent across studies, 
making it impossible to accurately convert the findings to a standard estimate of physical 
activity volume at each level (e.g., MET-hours or kilocalories per kilogram). Among the 
nearly half of studies that provided enough information to determine whether active 
people were meeting existing WHO recommendations, associations were stronger when 
people met or exceeded the recommended exposure; however, of the studies included in 
this review and those that were excluded for statistical reasons, just three directly 
examined the protective benefits of meeting the physical activity recommendations 
exactly as defined by the WHO. Two used data from different younger and middle-age 
cohorts within the Australian Longitudinal Study on Women’s Health and so examine 
exclusively women,4, 5 and one was Manuscript Three from this dissertation. 
Therefore, the results of this review extend the evidence that justifies physician advice 
recommending physical activity as preventive medicine. However, in order to answer the 
question of how much physical activity should be recommended, this review also 
highlighted the need for studies that directly test the protective benefits of meeting the 
WHO physical activity guidelines. 
Cross-Sectional Analyses – Manuscript Two 
The dearth of evidence for or against the protective benefits of meeting the physical 
activity guidelines for depression was highlighted in Manuscript One. Manuscript Two 
built on these findings by establishing cross-sectional associations between the guidelines 





Mitchelstown Cohort Study.7 Odds of elevated depressive symptoms were lower among 
those meeting physical activity guidelines (OR, 95%CI) in crude (0.51, 0.45-0.59) and 
adjusted (0.56, 0.47-0.66) analyses. The findings are consistent with previous cross-
sectional findings,8-10 and the magnitude of the observed associations were similar to 
previous findings among 178,867 adults in low- and middle-income countries.11  
A potential dose–response relationship was observed, such that crude and adjusted odds 
were lowest for the highest physical activity category. Compared to the Low physical 
activity tertile, the Middle and High tertiles were associated with 26% (0.74, 0.61-0.89) 
and 51% (0.46, 0.39-0.53) lower odds of elevated depressive symptoms, respectively. 
This supports previous cross-sectional studies that have also observed a dose-response 
relationship between physical activity and depression, although prospective cohort 
studies1 and randomized trials12, 13 have provided limited support.  
Prospective Analyses – Manuscript Three 
The cross-sectional findings from Manuscript Two supported and laid the foundations for 
the prospective analyses conducted in Manuscript Three. Among 4,146 people from 
Waves One and Two of TILDA, meeting physical activity guidelines was non-
significantly associated with approximately 23% (0.77, 0.58-1.04) lower odds of incident 
depression.14 The magnitude of this association is consistent with our meta-analytic 
findings of 19-25% lower odds of elevated depressive symptoms among active compared 
with less active people.1 Similar to many of the studies included in our review, this 
association was not statistically significant, potentially due to a low incidence rate that 
precluded good precision of the point estimate.  
Unlike the findings from our cross-sectional study, a dose-response between physical 





associations may be driven by sex-related differences. Among females, Moderate 
volumes of physical activity exhibited greater protective effects than High (31% vs 13%), 
while there was a smaller difference between volumes among males (47% vs 31%). This 
supports previous findings in a smaller sample of elderly Koreans that reported larger 
effects for mild physical activity than above-moderate, in addition to larger effects 
overall.15  
Biological Plausibility 
It is biologically plausible that customary physical activity protects against onset of 
depression symptoms. Combination monoaminergic therapy has been shown to be 
superior to monotherapy in treatment-resistant depression,16 and exercise training has 
brain monoaminergic17,18 and neurotrophic19, 20 effects. Limited evidence from animal 
models of depression18, 21, 22 and randomized controlled trials of major depression have 
shown that the efficacy of exercise training is comparable, but not additive, to 
pharmacotherapy,23, 24 consistent with redundant or similar biochemical mechanisms. 
Summary of Findings – Anxiety 
Systematic Review and Meta-Analysis – Manuscript Four 
Following the focus on depression, the same approach was implemented to examine 
another important mental health outcome: anxiety. To our knowledge, this is the first 
systematic review and meta-analysis of prospective cohort studies to explore whether 
physical activity is associated with lower odds of developing anxiety.25 Findings from 24 
prospective cohort studies (median follow-up 4.75 years) of over 80,000 adults were 
accumulated and evaluated. A small, significant, cumulative association (OR, 95%CI)  





not included in the meta-analysis also reported small, inverse associations between 
physical activity and anxiety symptoms.26-29 Although analyses included only three 
studies within each category, stronger associations between physical activity and lower 
odds of a subsequent diagnosis of any anxiety disorder (0.66, 0.53-0.82) and a subsequent 
diagnosis of GAD specifically (0.54, 0.32-0.92) were also found. A moderate degree of 
heterogeneity was found for outcomes of self-reported anxiety symptoms and a diagnosis 
of any anxiety disorder; however, the small number of studies included in analyses 
precluded any meaningful attempt to provide quantitative examination (i.e., meta-
regression analysis) of potential sources of variability. It is generally important for meta-
analyses to go further than simply producing overall summaries of effect and explore the 
possible causes of any heterogeneity, as this can increase the interpretability and both the 
scientific and clinical value of the results. 
There was insufficient data to quantitatively assess a dose-response, and findings 
appeared to be mixed. To assess a dose-response, it is preferable to use a physical activity 
measure that considers both the amount of physical activity and the intensity at which it 
is performed (i.e., volume). Six studies30-35 that used a physical activity measure of 
volume reported findings for more than one dose. Of these, three32, 34, 35 supported lower 
odds for increased dose of physical activity. Among the six36-40 studies that measured a 
single parameter of physical activity, two37, 38 reported stronger associations for increased 
amounts of physical activity. Three32, 35, 38 of the four39 studies that measured some sort 
of dose-response and used a diagnosis/self-reported diagnosis of an anxiety disorder 
found stronger associations with increased amounts of physical activity. Additionally, of 
the studies included in this review, just two directly examined the protective benefits of 
meeting the physical activity recommendations exactly as defined by the WHO.31, 32 





Cross-Sectional Analyses – Manuscript Five 
The dearth of evidence for or against the protective benefits of meeting the physical 
activity guidelines for anxiety was highlighted in Manuscript Four. Manuscript Five built 
on these findings by establishing cross-sectional associations between the guidelines and 
depression by pooling data for 7,784 Irish adults in Wave One of TILDA and The 
Mitchelstown Cohort Study. Approximately 24.5% of the sample reported elevated 
anxiety symptoms, slightly above norms in other elderly cohorts.41 Odds of elevated 
depressive symptoms were lower among those meeting physical activity guidelines (OR, 
95%CI) in crude (0.51, 0.45-0.59) and adjusted (0.56, 0.47-0.66) analyses. The magnitude 
of the present findings are consistent with cross-sectional associations between meeting 
recommended levels of physical activity and elevated worry symptoms,32 and smaller 
than associations with elevated depressive symptoms among Irish adults,7, 14 and, smaller 
than cross-sectional associations of sedentary behaviour with anxiety.42 
A full dose-response between physical activity and anxiety was not supported in the 
current study. However, compared to low physical activity, exceeding recommended 
physical activity levels was significantly associated with 13.6% lower odds of anxiety in 
the harmonized dataset. The magnitude of associations for moderate physical activity 
were similar to the high category, but not statistically significant. This is potentially 
driven by the lower number of respondents in the moderate category (n=407; 6.7%) 
compared with the other categories. The absence of a dose-response is consistent with 
previous associations of physical activity with anxiety symptoms measured with the 
HADS-A.31, 43 However, dose-responses have been observed for diagnosed GAD44 and 





Prospective Analyses – Manuscripts Six and Seven 
The cross-sectional findings from Manuscript Five supported and laid the foundations for 
the prospective analyses conducted in Manuscripts Six and Seven. To our knowledge, 
these are the first studies to examine prospective associations of meeting physical activity 
recommendations with any anxiety outcomes. Using data from Waves One and Two of 
TILDA, associations between meeting physical activity guidelines and incident anxiety 
symptoms and status (as measured by the HADS-A; n=4,146)31 and incident GAD (as 
measured by the CIDI-SF; n=3,236)32 were examined. Associations (OR, 95%CI) were 
weak and imprecise for incident anxiety (0.94, 0.63-1.40), but stronger for incident GAD 
(0.43, 0.19-0.99). Similarly, a dose-response was observed for incident GAD (Moderate: 
0.74. 0.17-3.22; High: 0.38, 0.15-0.95), but not anxiety symptoms (Moderate: 1.44, 0.89-
2.32; High: 0.96, 0.56-1.63). 
The stronger associations observed for diagnosed GAD compared to self-reported anxiety 
symptoms is consistent with our meta-analytic findings.25 The association with anxiety 
symptoms was weak compared with previous cross-sectional45 and prospective cohort46 
studies, although similarly small reductions in anxiety symptoms to those observed in the 
present study have previously been observed in older adults.47 In addition to the 
limitations of the HADS-A in this population group that were outlined previously, it also 
has a recall timeframe of just one week. This potentially exposes it to acute fluctuations 
in state anxiety that inevitably occur over the course of the multi-year follow-up periods, 
possibly explaining the imprecise point estimate.  
Biological Plausibility 
Experimental evidence has demonstrated the benefits of exercise alone and or as an 





symptoms.51-53 The available evidence has provided some support for the biological 
plausibility of the association between physical activity and reduced anxiety. People with 
GAD54 and social phobia55 display decreased hippocampal volumes, while there is an 
increasing body of literature demonstrating that exercise can improve hippocampal 
functioning56 and volume.20 A comprehensive narrative review concluded that 
inflammation, oxidative and nitrogen stress, and subsequent alteration of neurotrophins, 
neurogenesis, and neuroplasticity likely play a role in the pathogenesis of anxiety 
disorders, and physical activity is known to influence these same pathways.57 
Implications 
The physical activity guidelines were developed and are promoted based on evidence for 
the public health impact of increasing population levels of regular physical activity to 
meet these minimum levels.58 However, no studies had assessed the benefits of meeting 
these minimum physical activity levels for anxiety, and few studies for depression, yet 
these are disorders that affect nearly everyone at some point and have significant personal 
and economic burdens. This dissertation has key implications for two primary areas: 
mental health policy and physical activity policy. 
Firstly, despite the large number of studies conducted in this area, there has been no 
consensus on how much physical activity one should do to protect mental health, and 
whether there are additional benefits to higher volumes of activity. This is reflected in the 
WHO guidelines for depression, for example, in which physical activity as a prevention 
is given a single, vague sentence: “exercise programmes for the elderly can also be 
effective in depression prevention.”59 Most other organisations, including national bodies 
such as the Health Service Executive in Ireland or Royal College of Psychiatrists in the 





However, recent advice for people with depression from the Royal College of 
Psychiatrists in the UK (see 
www.rcpsych.ac.uk/expertadvice/treatmentswellbeing/physicalactivity.aspx) and the 
National Institute for Health and Care Excellence (see 
https://www.nice.org.uk/guidance/ph16/chapter/1-Recommendations#physical-activity) 
recommends that physical activity, in particular walking, interventions led by 
physiotherapists, exercise scientists, and fitness professionals may be beneficial. This 
dissertation underscores the positive impact of increasing population physical activity 
levels to meet the minimum recommendations on depression and, in particular, anxiety. 
National and international mental health organisations can use the current findings to 
develop and promote guidelines on how much physical activity should be recommended 
to protect against anxiety and depression. This has the potential to pay strong dividends 
in the current mental health crisis.  
Secondly, this dissertation has key implications for the policy approach to physical 
activity promotion which requires collaboration and interaction among policy makers 
from several different sectors, each tackling the physical activity goal for different reasons 
but with the same agenda to increase population physical activity.60 If policy makers 
within the mental health sector can be convinced that physical inactivity is a problem that 
needs to be addressed, then they can change their public policy or allocate their public 
funds in ways designed to address this problem and work towards the same goal as PA 
policy makers, albeit with slightly different motivating factors. 
Limitations 
Firstly, it has been demonstrated both that low physical activity can precede onset of 





activity.61 Therefore, the cross-sectional studies included in this dissertation cannot 
provide causal information because these studies lack temporal sequence. In the 
prospective cohort studies it is clear that the low physical activity preceded the anxiety 
and depression, thereby nullifying this potential issue; however, there are other reasons, 
such as illnesses or socioeconomic status, which could also partially explain the 
prospective associations observed between physical activity and anxiety and depression. 
Although efforts to control for relevant factors were made in the study designs and 
statistical models, it remains probable that some relevant factors may have not been fully 
accounted for. 
Secondly, physical activity was measured by self-report. In general, self-report measures 
of physical activity demonstrate greater variability in properties of methodological 
effectiveness than physical activity device-measured.62 Self-report measures may also be 
susceptible to overreporting, potentially resulting from misclassification of sedentary or 
light activity as moderate, or overestimation of activity duration;62, 63 however, there is 
no evidence to suggest that reporting error should differ according to mental health status. 
Additionally, differences between self-report and device measured physical activity may 
be partially attributable to conceptual differences.64 For example, accelerometer-based 
monitors quantify acceleration at a fixed point of the body (i.e., hip, wrist, thigh, etc.) 
over short periods determined by the device settings, whereas self-report instruments 
measure reported time periods of longer duration engaged in specific behaviours, many 
of which are non-continuous in nature.64 Therefore, on occasion it may be preferable to 
use self-report instruments; for example, assessing compliance with physical activity 
guidelines, which were developed based on epidemiological relationships between self-
reported physical activity and health outcomes. Moreover, if physical activity exposure 





physical activity occurred, misclassification would underestimate the magnitude of this 
reduction as inactive people who were classified as active would have increased 
likelihood of anxiety. Nonetheless, future research would benefit from corroborating self-
reported physical activity exposure with device-based assessments and, in selecting the 
physical activity measure used, should consider not only its feasibility and practicality, 
but also its methodological effectiveness.62 
Thirdly, two manuscripts in this dissertation used the HADS-A to measure anxiety. As 
previously mentioned, this measure focuses primarily on cognitive symptoms; however, 
anxiety symptom expression can differ between age groups,63, 64 and older adults may 
tend to experience and/or report more somatic symptoms.65 Additionally, the HADS-A 
has a recall timeframe of just one week, which potentially exposes it to acute fluctuations 
in state anxiety that inevitably occur over the course of the multi-year follow-up periods. 
Therefore, it is possible that the HADS-A was a less than optimal measure of anxiety 
symptoms and status given the current population and study designs. 
Finally, in Manuscript Seven, GAD was assessed using the PSWQ-A at Wave One and 
CIDI-SF at Wave Two. Using different measures of GAD at Waves 1 and 2 is not ideal; 
however; the CIDI-SF was only introduced in Wave 2 of TILDA. 
Future research 
Future research to understand how we increase the uptake and adherence to physical 
activity is required. These are complex processes that are influenced by many inter-
dependent, multidisciplinary, and multilevel determinants. Broadly, two categories of 
determinants can be identified: individual, such as biological, demographic or 
psychological, and contextual, such as socio-cultural and physical environments. 





health behaviours; however, unlike contextual level determinants, they cannot be changed 
by health promotion interventions as they are not modifiable. Both individual level and 
contextual level determinants interact with each other in mediating and moderating 
pathways. Understanding of all levels of influence can inform development of multilevel 
interventions that offer the best chance for success.66 Individual level determinants are 
widely studied; however, contextual variables are less studied, but are thought to have 
widespread effects. The combination and interaction of these factors are expected to 
influence physical activity; however, despite the large number of studies and reviews 
available, prospective, multi-level studies are needed to better study determinants of 
physical activity.67 
Secondly, the mechanisms of the protective effect of physical activity on mental health 
remain unclear. To date, no epidemiological studies have examined potential mediators 
of the physical activity-GAD relationship, and just one for physical activity-depression. 
Therefore, future research should explore whether specific biomarkers (i.e., adiposity; 
inflammatory markers; metabolic factors; heart rate variability) mediate the physical 
activity-mental health relationship.  
Thirdly, the antidepressant and anxiolytic effects of resistance training and other muscle 
strengthening exercises have been well established; however, the possible protective 
benefits of this exercise mode has received significantly less attention than aerobic 
exercise. There is a need for epidemiological studies to examine the possible protective 
benefits of muscle strengthening activities and, in particular, the benefits of meeting the 






Fourthly, there is a need for large epidemiological studies that use better validated and 
more reliable measures of physical activity, depression, and anxiety. Many 
epidemiological studies include self-report measures of physical activity; however, as 
highlighted above, there are limitations to self-reported activity. In order to move the field 
forward, there is a strong need to move beyond self-reported physical activity alone and 
for future studies to incorporate stronger device measures of activity, corroborated by 
detailed self-reported activity. For example, strategies such as ecological momentary 
assessment can time-link self-report and device measured physical activity, in addition to 
gathering real-time self-reports of behaviours, contexts, emotional states, beliefs, 
attitudes, and perceptions in naturalistic settings. Similarly, there is a need for studies that 
move beyond self-reported symptom measures mental health and to incorporate a clinical 
diagnosis of anxiety and depressive disorders. 
Finally, this dissertation established cross-sectional relationships between physical 
activity and depression and anxiety among Irish adults. Next, it established that physical 
activity as a predictor of future mental health. However, the two meta-analyses of 
longitudinal associations of physical activity with depression and anxiety demonstrated 
that the question of how changes in physical activity are associated with changes in 
mental health across time has not been properly addressed by previous research.1, 25 
Specifically, of studies that assessed change in physical activity exposure using a measure 
of volume and adjusted for confounders, just one study has done so for anxiety 
symptoms27 and two for depression.15, 68 This question is important to further our 
understanding and substantially strengthen the scientific support for the role of physical 
activity in the prevention of depression and anxiety. Therefore, future research should 
move beyond the prospective two-occasion predictions-across time analyses and examine 





associations of change between variables should be examined from a traditional between-
person perspective (i.e., if people change their physical activity relative to others, does 
their mental health also change relative to others?) and a within-person perspective (i.e., 
if individuals deviate from the expected curve in physical activity at a specific time-point, 
will they also differ from expected in mental health at that same time point?). 
Conclusions  
This dissertation consisted of seven studies, including two meta-analyses, two cross-
sectional cohort studies, and three prospective cohort studies, that are either Published 
(n=4) or In Review (n=3) at high impact, peer-reviewed Psychiatry, Geriatrics and 
Gerontology, and Public, Environmental, and Occupational Health journals. These 
studies: (i) examined cross-sectional and prospective associations of meeting WHO 
physical activity recommendations with depression, anxiety, and GAD, and (ii) 
determined whether associations of physical activity with depression, anxiety, and GAD 
were stronger with increased dose of physical activity. To overcome data sharing 
challenges and access the necessary data, close collaboration with DEDIPAC-KH was 
required; the subsequent research was facilitated by 14 high-profile researchers across 
eight countries, further establishing a strong international network for future 
collaboration.  
This dissertation provides the first thorough examination of the mental health benefits of 
meeting WHO physical activity recommendations, and the findings support that meeting 
the recommendations (i) is cross-sectionally associated with lower odds of anxiety and 
depression, and (ii) may confer a small-to-moderate protective effect against developing 
depression, anxiety, and GAD among adults. Additionally, in prospective analyses, there 





was not apparent for anxiety or depression. These findings provide key evidence that was 
required by national and international organisations to develop and promote specific 
recommendations on how much physical activity can protect against anxiety and 
depression. This should strongly contribute to efforts to prevent or ameliorate the 
significant personal and economic burdens associated with depression and anxiety 
symptoms and disorders. 
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Abbreviations: ALSWH=Australian Longitudinal Study on Women's Health; BDI=Beck Depression 
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D=Centre for Epidemiological Studies Depression scale; CIDI=Composite International Diagnostic 
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DSM=Statistical Manual of Mental Disorders; EPDS=Edinburgh Postnatal Depression Scale; ELSA= 
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SHIp=Study of Health in Pomerania; SHLSE=Survey of Health and Living Status of the Elderly; 
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SWAN=Study of Women’s Health Across the Nation; TILDA=The Irish Longitudinal Study on Aging; 
TLSA=Taiwan Longitudinal Study on Aging; WHI-OS=Women's Health Initiative Observational Study; 







eTable 2. Modifiers  
Gender. Proportion (%) of the cohort that was reported as female. 
Years of follow-up.  Range:  3 months to 37 years. Median of 4 years; interquartile range: 
2-8 years).  Eight studies less than one year: 6 during pregnancy or post-partum (Demissie 
2011;e38 Demissie 2013;e39 Symons-Downs 2008,e102; Da Costa 2003;e35 Shakeel 2018;e96 
Szegda, 2018e103), elderly six months after hospital discharge (Lee 2017, study 216), and 
cancer patients six months after diagnosis (Boyes 2013e16). 
Study Design. Outcome assessment: [1] followed a single baseline exposure of physical 
activity, [2] a single baseline exposure of physical activity but a change in depression 
outcome, [3] a change in physical activity, [4] a change in both physical activity exposure 
and depression outcome. 
Exposure dose. Physical activity exposure was: [1] binary or a correlation, [2] low, [3] 
moderate, or [4] high; based on study-defined levels. 
Recommended dose. Physical activity exposure met public health guidelines for 
moderate or vigorous leisure time physical activity as reported or calculated as weekly 
metabolic equivalents (MET▪minutes) or volume (frequency, time, and intensity). 
Physical activity measure. Physical activity was measured  by: [1] single or multiple 
questions assessing participation in exercise, sports, or physical activity (defined as 
bodily movement produced by skeletal muscles that requires energy expenditure) as 
frequency, [2] time or distance, [3] as meeting public health guidelines for moderate or 
vigorous physical activity, [4] a validated measure that estimated total volume (i.e., 





Depression measure. Incident depression or change in depressive symptoms was the 
outcome: [1] depressive symptoms, assessed by a validated symptom questionnaire, [2] 
established cut-scores or tertiles, quartiles or quintile scores on validated screening tests 
for probable depression, [3] a self-report of depression diagnosis made by a physician, 
















eFigure 1. PRISMA Flow Diagram 
PRISMA 2009 Flow Diagram 
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Appendix 2: Supplementary Materials from Manuscript Two 
Supplementary Table 1. Odds ratios (OR) and 95% confidence intervals (CI) derived 
from binominal logistic regression analyses as indicators of association between physical 




Model 1  
PA Guidelines  
Not Meeting PA guidelines REF 
Meeting PA guidelines 0.557 (0.474 to 0.655) 
Age (years)  
80+ REF 
70-79 1.887 (1.107 to 3.215) 
60-69 2.028 (1.217 to 3.378) 
50-59 2.529 (1.525 to 4.192) 
<50 2.134 (1.120 to 4.067) 
Sex  
Male REF 
Female 1.537 (1.315 to 1.796) 
BMI  
Normal REF 
Underweight 1.161 (0.443 to 3.041) 
Overweight 0.935 (0.770 to 1.136) 
Obese 1.268 (1.042 to 1.543) 
Model 2  
PA Tertiles  
Low  REF 
Middle  0.736 (0.606 to 0.893) 
High  0.489 (0.404 to 0.591) 
Age (years)  
80+ REF 
70-79 1.906 (1.118 to 3.250) 
60-69 2.058 (1.235 to 3.430) 
50-59 2.578 (1.554 to 4.275) 
<50 2.165 (1.135 to 4.127) 
Sex  
Male REF 
Female 1.519 (1.300 to 1.775) 
BMI  
Normal REF 
Underweight 1.119 (0.427 to 2.931) 
Overweight 0.931 (0.767 to 1.131) 
Obese 1.265 (1.040 to 1.539) 






Appendix 3: Supplementary Materials from Manuscript Three 
Supplementary Table 1. Proportion of people with baseline depression by levels of 
physical activity (PA) and significant covariates 
 
Walking Tertiles 
















        
50-59 65/475 76/698 53/661 82/962 112/872 112/872 13/130 69/832 
60-69 55/435 49/586 29/550 38/804 95/767 95/767 7/109 31/695 
70-79 35/321 18/279 18/296 13/357 58/539 58/539 4/57 9/300 
80+ 8/115 3/87 1/53 1/74 11/181 11/181 0/17 1/57 
Sex         
Male 46/524 44/670 32/779 39/1113 83/860 83/860 6/122 33/991 








        
















82/378 82/378 2/36 30/285 
Social 
Class 








19/310 25/460 11/364 18/567 37/567 37/567 2/86 16/481 
Non-
manual 
12/183 20/252 11/237 20/304 23/368 23/368 5/58 15/246 
Skilled 
Manual 
16/148 8/149 9/148 9/222 24/223 24/223 1/21 8/201 
Semi-
skilled 
19/118 11/150 14/185 15/235 29/218 29/218 2/32 13/203 
Unskilled 3/40 8/40 7/54 5/56 13/78 13/78 2/7 3/49 
Farmers 2/67 2/71 4/148 4/210 4/76 4/76 1/12 3/198 
Not 
Working 






Supplementary Table 2. Proportion of people with follow-up depression by levels of 
physical activity (PA) and significant covariates 
 
Walking Tertiles 






(Cases/persons at risk) 
Covariate Low Moderate High Yes No Low Moderate High 
Sex         
Male 24/478 26/626 22/747 34/1074 38/777 38/777 3/116 31/958 
Female 49/705 44/878 42/712 51/989 84/1306 84/1306 7/173 44/816 
Smoking 
status 
        
Current 21/196 17/189 9/200 19/289 28/296 28/296 1/34 18/255 
Past/Never 52/987 53/1315 55/1259 66/1774 94/1787 94/1787 9/255 57/1519 
Social 
Class 
        
Professional 
Workers 




9/291 14/435 9/353 14/549 18/530 18/530 6/84 8/465 
Non-manual 14/171 13/232 13/226 6/284 24/345 24/345 2/53 14/231 
Skilled 
Manual 
8/132 8/141 11/139 13/213 14/199 14/199 0/20 13/193 
Semi-
skilled 
10/99 10/139 4/171 12/220 12/189 12/189 0/30 12/190 
Unskilled 1/37 2/32 2/47 4/51 1/65 1/65 0/5 4/46 
Farmers 3/65 2/69 2/144 6/206 1/72 1/72 0/11 6/195 
Not 
Working 






Appendix 4: Supplementary Materials from Manuscript Four 
eFigure 1. Flow chart of article inclusion and exclusion 
  





(n = 2523) 
Full-text articles 
assessed for eligibility 
(n=295) 
Full-text articles excluded, 
with reasons 
(Cross-sectional: n=101) 
(No association reported: 
n=98) 
(No anxiety measure: n=46) 
(No PA measure n=22) 
 (Follow-up too short: n=2) 
(PA recalled retrospectively: 
n=1) 
(PA measure not a measure of 
Studies included in 
qualitative synthesis 
(n=24) 








Appendix 5: Supplementary Materials from Manuscript Seven 
Supplementary Table 1. Proportion of people with GAD at Waves 1 and 2 by levels of 
moderate-to-vigorous physical activity (MVPA) and significant covariates 
 Wave 1 Wave 2 
 
Meeting MVPA Guidelines 
(Cases/persons at risk) 
Meeting MVPA Guidelines 
(Cases/persons at risk) 
Covariate No Yes No Yes 
Age (years)     
50-59 197/775 173/847 - - 
60-69 128/660 97/722 - - 
70-79 66/450 33/307 - - 
80+ 15/131 5/58 - - 
Sex     
Male 93/749 105/982 4/656 1/877 
Female 313/1267 203/952 17/954 7/749 
Smoking 
status 
    
Current - - 7/222 3/209 
Past/Never - - 14/1388 5/1417 
Depressive Symptoms     






Supplementary Table 2. Odds ratios (OR) and 95% confidence intervals (CI) derived 
from binominal logistic regression analyses as indicators of a dose-response association 






















     





















     







































     





















     



















ap<0.05; bp<0.01; cp<0.001 
Model 1 adjusted for, age and sex 
Model 2 adjusted for Model 1 and waist circumference, social class, and smoking 
Model 3 adjusted for Model 2 and depressive symptoms 
Abbreviations: MVPA: moderate-to-vigorous physical activity; REF: reference 
category 
 
